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CHAPTER I 
INTRODUCTION: LIPOPROTEINS AND HYPERLIPOPROTEINEMIAS 
THE MAJOR LIPOPROTEIN CLASSES 
The llpl·ds in blood are insoluble and circulate as lipid-
protein complexes. The free fatty acids (FFA) are bound to albu-
min. The other lipids (cholesterol, triglycerides and phospho-
lipids) aggregate with other proteins, forming lipoproteins 
(1, 2) . 
The lipoproteins show differences in density, electrophore-
tic mobility, size and chemical composition. Based on these 
differences in physical and chemical characteristics they can be 
divided into several groups by means of ultracentnfugation (3, 
4, 5), electrophoresis (6, 7), precipitation techniques (8, 9), 
or column chromatography (10). Ultracentnfugation and electro-
phoresis are the mostly used methods for separation of the lipo-
proteins. With both techniques the serum lipoproteins can gener-
ally be divided into 4 major classes. The nomenclature used for 
the different classes has been derived from the method used for 
the separation of the lipoproteins. 
On the basis of ultracentnfugation these classes are called: 
- chylomicrons 
- very low density lipoproteins (VLDL) 
- low density lipoproteins (LDL) 
- high density lipoproteins (HDL) 
Both physical characteristics and chemical composition are 
given in table 1 and figure l. Although there are different clas-
ses of lipoproteins, the lipoproteins of each class are poly-
disperse, i.e. they have a range of physical properties, as a 
result of the variation in chemical composition. Therefore, the 
values given in table 1 are the average values for each class. 
Chylomicrons 
This class of lipoproteins has the lowest density caused by 
the high content of triglycerides (12, 13). These triglycerides 
are mainly of exogenous origin: derived from the fat in the food 
(1). In persons with a normal lipid metabolism the chylomicrons 
are absent after an overnight fast. In some pathological cases 
however, chylomicrons may still be present 12-14 h after the last 
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Ν) 
Table 1 
Physical characteristics and chemical composition (percent of dry weight) 
of the major lipoprotein classes (11) 
chylomicrons VLDL LDL HDL 
Physical characteristics: 
S f value
( 1 ) 
density (g/ml) 
(2) 
mobility 
molecular weight 
size nm 
> 400 
< 0.95 
origin 
io 9- i o 1 0 
7500 100 ,000 
20 - 400 
0.95 - 1.006 
a 2 (pre-S) 
5 - 10 χ 10 6 
3000 - 8000 
0 - 1 2 
1.006 - 1.063 
2.1 - 2.6 χ 10 
2050 - 2200 
1.063 
а 
2 χ IO5 
750 - 1000 
1.21 
Chemical composition: 
protein 1 - 2 
triglycerides 80 - 95 
unesterified cholesterol 1 - 3 
esterified cholesterol 2 - 4 
phospholipids 3 - 6 
carbohydrates ? 
70 
10 
50 
10 
5 
15 - 20 
< 1 
25 
10 
8 
37 
22 
+ 1 
45 - 55 
3 
15 
22 
30 
1 
Lipoprotein flotation rate in Svedberg units (10 m/sec/N/kg) in a NaCl solution of 
(2) 
(3) 
density 1.063 g/ml (26 C) 
Paper electrophoresis 
Determined by electron microscopy 
APOLIPOPROTEINS Apo В 
Apo С 
PREPARATIVE 
ULTRACENTRIFUGATION 
ANALYTICAL 
ULTRACENTRIFUGATION 
POLYACRYLAMIDE 
ELECTROPHORESIS 
AGAROSE 
ELECTROPHORESIS 
Very low Very-high 
Chylomicrons d.ns.ty Low d « n t l t y H.gh density ^ 
lipoprottms "POP™»""« Upoprot.ms
 | i p o p r o t i l f t t 
LDL, LDL a H D L j H D L i 
(•DL) 
chylomicrons 
Fig. 1. Distribution of plasma lipoproteins when separated by 
ui traeen tri fugation and by electrophoresis on agarose 
and Polyacrylamide gel. Separation on Polyacrylamide gel, 
unlike agarose, is influenced particularly by the dia­
meter of the lipoprotein molecules. Also shown is the 
approximate distribution of the three main groups of apo-
lipoproteins, apo-A, apo-B and apo-C. The term inter­
mediate density lipoprotein (IDL 
density range 1.006-1 
from: B. Lewis (14)). 
LDL ) , refers to the 
.019. (Reprinted with permission 
meal (1). When chylomicrons are present in serum, the serum may 
be expected to be turbid. Chylomicrons can be detected by elec­
trophoresis: they show no mobility and remain at the origin. 
Another qualitative test is inspection of serum after having 
left it at 4 С for 18-24 h. If chylomicrons are present they 
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float to the meniscus (15). 
Very low density lipoproteins (VLDL) 
The VLDL are mainly synthesized in the liver and they trans-
port endogenous triglycerides (16). They also contain cholesterol, 
phospholipids and protein (17). VLDL is known to contain several 
apoproteins including apo B, which is common to VLDL and LDL, and 
apo C, which is common to VLDL and HDL (18, 19, 20). 
Despite the molecular heterogeneity, VLDL are usually detec-
table after electrophoresis as a discrete band, having a. (usually 
called pre-ß) mobility on paper, cellulose acetate and agarose. 
VLDL are therefore also called pre-8 lipoproteins. On Polyacryla-
mide gel they move more slowly than the LDL, owing to their larger 
molecular diameter (figure 1). 
After electrophoresis on agarose in some cases two bands are 
visible in the pre-3 region. The second band may either represent 
"slow" pre-ß lipoproteins having a density below 1.006 g/ml (21), 
or "sinking" pre-3 lipoproteins with a density greater than 1.006 
g/ml (22). 
Low density lipoproteins (LDL) 
The ma^or constituents of LDL are cholesterol and cholesterol-
esters; 60% of the cholesterol content of plasma is in the LDL 
(1, 17) . 
With physical methods LDL can be separated m two components. 
In the density range 1.006-1.019 g/ml, the so called intermediate 
lipoproteins are isolated (LDL or IDL; Sf 12-20), which differ 
from the LDL.. The latter lipoproteins are isolated in the den-
sity range 1.019-1.063 g/ml (Sf 0-12) (figure 1). The lipid and 
protein composition of LDL1 is between that of VLDL and LDL- (14). 
Both LDL sub-fractions have β mobility on electrophoresis. The 
LDL are therefore also called β lipoproteins. They contain mainly 
apo В as the protein component (18). 
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High density lipoproteins (HDL) 
On electrophoresis HDL have α mobility. Therefore, they are 
also called α lipoproteins. In terms of density the HDL are 
heterogenous. HDL., which is a minor component, is isolated with 
the LDL in the density range just below 1.063 g/ml. HOL^ and HDL., 
are isolated in the density ranges 1.063-1.125 and 1.125-1.21 
g/ml respectively (figure 1). The HDL_ have a larger diameter 
and contain a higher percentage of lipid material than the HDL, 
(23). 
All three HDL subfractions contain a considerable amount of 
protein (table 1). The proteins of the HDL are the apoprotein 
components apo A (80%), a minor amount of apo В and also apo С 
(24) . 
APOLIPOPROTEINS 
The proteins forming complexes with lipids are specific for 
the lipoproteins. The protein-parts of the lipoproteins are cal­
led apolipoproteins or shortly apoproteins. 
In earlier years the apoproteins received little attention 
as compared to the lipid components. In the past five years much 
information about the structure and functions of the apoproteins 
has become available. 
Various classifications of these apoproteins have been pro­
posed but the one that has gained the most widespread usage has 
been derived from that originally suggested by Alaupouvic (25). 
The major protein of HDL is apoprotein A (apo A), the main pro­
tein of LDL is apoprotein В (apo B) and the main proteins of 
VLDL are the apoproteins В and C. The latter is a constituent 
of HDL as well (figure 1 and table 2) (18, 19, 25). The apopro­
teins A and С are the collective names for heterogenous groups of 
proteins. Apoprotein A consists of two proteins, apo A and apo 
A (26), each having glutamine as the carboxy-terminal amino 
acid. VLDL also contain significant amounts of three small mole­
cular weight proteins of the apoprotein С family (apo C T, apo Gl­
and apo C T ) . Their carboxy'-terminal amino acids are serine, 
glutamic acid and alanine respectively (27). These proteins also 
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Table 2 
Classification of apolipoprotems (25) 
ABC nomen- Lipo-
clature protein 
C-termmal Synonyms 
Apo-A-I HDL Glutamine 
Apo-A-II HDL Glutamine 
Apo-B LDL, VLDL Serine 
Apo-C-I HDL, VLDL Serine 
Apo-C-II HDL, VLDL Glutamine 
Apo-C-III HDL, VLDL Alanine 
Apo-D HDL 
Apo-E HDL, VLDL Alanine 
Fraction III apo-LP-Gln-I 
Fraction IV apo-LP-Gln-II 
Fraction V 
Fraction V 
Fraction V 
Thin line polypeptide 
A r g i n i n e - n c h p e p t i d e 
apo-LP-Ser 
apo-LP-Ser 
apo-LP-Glu 
apo-LP-Ala 
occur as minor components of HDL. Because of the low protein con­
tent of chylomicrons, little is known of their apoprotein compo­
sition, although all the classes already mentioned have been 
isolated from this lipoprotein class. Arginine-rich apoprotein 
(apo Ε), so called because of its high content (about 10%) of 
arginine, is a recently recognised apoprotein (20, 28) consis­
tently found in VLDL, HDL and in the intermediate density lipo­
protein (IDL) formed during the catabolism of VLDL to LDL. Apo E 
is however absent m LDL. Another recently discovered apoprotein 
known as "thm-line polypeptide", and also called apo D, is pre­
sent in a subgroup of HDL (25, 29). 
The presence of the same apoproteins in different lipopro­
teins indicates interrelationships between the lipoprotein clas­
ses. The important role of apoproteins in the metabolism of the 
different lipoproteins has indeed been demonstrated in several 
studies (30-33). 
16 
LIPOPROTEIN METABOLISM 
The present knowledge of the metabolism of lipoproteins and 
of their interrelationships will here be given briefly. For more 
detailed information on this subject the reader may be referred 
to the excellent publication by Lewis (14). Some knowledge m 
this respect is essential for an understanding of the pathogene-
sis of the hyperlipoproteinemias. 
Generally, it can be stated that the concentration of a 
lipoprotein class is determined by two processes: the rate of 
production and the rate of clearance (catabolism). An elevated 
lipoprotein concentration is caused by an increase in production, 
a clearance defect or by a combination of both factors. 
On the following pages the processes which influence the 
turnover of each lipoprotein class are described. 
Chylomicrons and very low density lipoproteins (VLDL) 
The chylomicrons arise from the gastrointestinal tract, they 
transport dietary lipids from the small intestine to the sites of 
utilization in the tissues (1). 
The VLDL are mainly formed in the liver and transport endo-
genous lipids. The major precursors for the VLDL synthesis in the 
liver are glucose and fatty acids (34, 35). 
The conventional view on triglyceride transport — chylo-
microns transporting exogenous triglycerides and VLDL transpor-
ting endogenous triglycerides — requires some revision. The 
triglycende-nch lipoproteins cover a large range as to particle 
size, density and chemical composition (16). No chemical or 
physicochemical criteria are known by which chylomicrons and VLDL 
can be distinguished clearly. Therefore it seems acceptable to 
regard them as one group. The bigger particles, which have the 
highest triglyceride percentage, mainly transport exogenous tri-
glycerides. The smaller ones play a major role m the transport 
of endogenous fat (16). 
Chylomicrons contain only a minute amount of protein, which 
is hardly sufficient to cover the surface of the particle com-
pletely. There is evidence that chylomicrons acquire additional 
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apolipoprotein С from HDL. Especially the transfer of apo С is 
important, as this apoprotein activates lipoprotein lipase (31, 
36) . 
The VLDL are secreted by the liver and intestinal mucosa in 
nascent form, cniefly containing apo В in their protein fraction 
and with a very low apo С content. In just the same way as the 
chylomicrons, the VLDL receive the apo C T T peptide from the HDL, 
which is necessary for the activation of lipoprotein lipase (31, 
37). 
There is evidence that the VLDL and chylomicrons are cata-
bolized also in the same way. In this respect the enzyme lipo­
protein lipase, which is situated at the endothelial surface, 
plays an important role. In general this enzyme is activated by 
insulin, apo С and heparin. Its activity is decreased by other 
apo C's, glucagon, ACTH and TSH (14). 
Chylomicrons and VLDL may share a common and saturable re­
moval mechanism (38). This implies, that, if the mechanism is 
too heavily loaded by one class of tnglyceride-rich lipoproteins, 
the removal of the other class will be impaired. In general, 
larger triglycende-rich lipoproteins are metabolized more rapid­
ly than smaller ones (39). Thus chylomicrons are the preferred 
substrate and heavy chylomicronemia would be expected to restrict 
VLDL catabolism, but patients with severe primary elevation of 
VLDL levels can nevertheless show a decreased clearance of chylo­
microns (38) . 
In the catabolism of chylomicrons and VLDL, lipoprotein 
lipase combines with its substrate at the endothelial surface 
(40). The enzyme is then activated by the apoprotein С _ derived 
from HDL (31, 41). By the activity of lipoprotein lipase the tri­
glycerides m the lipoproteins are partially hydrolysed. It ap­
pears from recent studies, that the triglycende-rich lipopro­
teins are possibly catabolized in a stepwise manner. When part of 
the triglycerides has been hydrolysed, the particles re-enter the 
circulation so that the process is repetitive (42). 
As a result of the stepwise hydrolysis of chylomicron-
triglycerides by lipoprotein lipase, smaller particles arise 
containing less triglycerides, but retaining their cholesterol 
ester and phospholipid cargo (43). These chylomicron remnants are 
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ultimately cleared in the liver (39, 43). 
In the same manner, the activity of lipoprotein lipase 
results in VLDL particles containing less triglycerides, phos­
pholipids and apo С but an unchanged amount of apo В and of 
arginine-nch apoproteins. Thus both apo В and most of the 
arginine-nch apoproteins remain, while apo С components are 
rapidly transferred to HDL, whereas the other apo С components 
are slowly transferred to HDL (14, 30, 44). The product of VLDL 
catabolism is a lipoprotein with intermediate density: IDL 
(d = 1.006-1.019 g/ml) (30). 
The role of HDL in the degradation of VLDL is rather com­
plex. Firstly, HDL supplies the apo C T T, necessary for the acti­
vation of lipoprotein lipase (31, 36). Secondly, HDL is essential 
for the esterification of cholesterol being the specific substrate 
for the enzyme LCAT (lecithin: cholesterol acyl transferase) (45). 
Nascent VLDL only'contain free cholesterol at their surface. As 
the particle becomes smaller during degradation, the surface 
component cholesterol becomes redundant (46). Thus cholesterol 
is partially transferred to HDL, where it is esterified. The 
cholesterol esters formed in this manner are partially trans­
ferred back to the VLDL particles (45). 
Apparently the activity of lipoprotein lipase is a major 
determinant in the catabolism of triglyceride-nch lipoproteins. 
This activity can be determined after injection of heparin 
into the circulation, as heparin releases the enzyme from the 
normal endothelial site into the blood plasma. However, after 
injection of heparin, other lipolytic enzymes such as monoglyce-
nde hydrolase and a triglyceride lipase of hepatic origin, are 
also released (47). Extrahepatic lipase can be distinguished 
from hepatic lipase by a variety of methods (14). 
The function of hepatic triglyceride lipase still has to be 
elucidated. It is possible that hepatic lipase plays an important 
role in hydrolysis of the residue of triglycerides in the rem­
nants of VLDL and chylomicrons. Lewis et al. (14) have shown that 
both hepatic lipase and extrahepatic lipase can hydrolyse all the 
lipoproteins with a density < 1.019 g/ml. The hepatic lipase, 
however, showed the greatest affinity for the smallest particles 
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and the least affinity for chylomicrons, whereas extrahepatic 
lipoprotein lipase had the greatest affinity for chylomicrons. 
Therefore, it is possible, that hepatic lipase hydrolyses tri­
glycerides from the VLDL at a later stage of their degration (48). 
Low density lipoproteins (LDL) 
The LDL arise exclusively as the metabolic product of VLDL 
(30). If apo В in the VLDL is labelled with I, the radioactive 
apo В rapidly becomes demonstrable m the denser part of the VLDL 
spectrum with S_ values of 20-60. Subsequently the apo В radio­
activity arises in the LDL fraction (d = 1.006-1.019 g/ml; 
S f = 12-20) and accumulates finally in the LDL- (d = 1.019-1.063 
g/ml; S, = 0-12). At least in normal subjects the turnover rates 
of apo-B in the VLDL-fraction and in the LDL-fraction seem to be 
almost the same. This suggests that all VLDL particles are de­
graded to LDL particles (49) . As stated earlier, the conversion 
of VLDL into LDL is accompanied with considerable changes in 
their composition; most triglycerides and apolipoprotein С are 
lost, while some free cholesterol and phospholipid present in 
VLDL are transferred to HDL. 
Although it had been suggested that LDL are degraded in the 
liver (50), more recent studies favour extrahepatic tissues as 
the place of degradation (51). Skin fibroblasts and vascular 
smooth muscle cells were shown to be able of catabolizing LDL 
(52, 53). 
High density lipoproteins (HDL) 
The HDL are of hepatic origin and contain in nascent form 
both apo A and apo С (24). The nascent HDL is a lipid bilayer 
with a discoid form containing phospholipid, protein and un-
esterified cholesterol (54). The discs are converted into the 
spherical particles of mature HDL. In this conversion LCAT plays 
an important role since it transfers fatty acids from lecithin 
to free cholesterol, which seems the initiating step for this 
structural change (54). Since apo A activates LCAT, it is sug­
gested that the enzyme combines with nascent HDL through a 
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specific interaction. The free cholesterol, taken up by HDL is 
then converted into cholesterol esters, which are transferred to 
the core of the particle (45). 
The bidirectional exchange (31, 36, 55) of apo С between HDL 
and VLDL has already been discussed. 
HDL probably serves as the centripetal transport system for 
cholesterol. Free cholesterol is taken up by HDL, from the peri­
pheral tissues and from VLDL and then transported to the liver 
(14) . 
The major place of HDL degradation is the liver. It is not 
known whether apo A , apo A and apo С are catabolized separate­
ly or as one unit. Extrahepatic catabolism of HDL m smooth 
muscle cells may also occur (53). 
CLASSIFICATION OF HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA 
Until the 1950's only cholesterol, phospholipids and total 
lipids were measured in serum. Specific methods for triglyceride 
determination in plasma were introduced around 1960 and hyper-
lipidemia could be divided into: hypercholesterolemia, hypertri­
glyceridemia and a combination of both. The next step to a clas­
sification of hyperlipidemia was the introduction of a method 
for lipoprotein electrophoresis on paper. The results obtained 
with this method were in good agreement with the results ob­
tained with the analytical ultracentrifuge (6). This simple 
procedure was then applied to large numbers of hyperlipidemic 
sera by Frednckson, Levy and Lees (1). The basis for this 
approach was, that most of the lipids in plasma are present as 
lipoproteins. Therefore, hyperlipidemia always means that the 
concentration of one or more lipoproteins is elevated. So, hyper­
lipidemia should be translated into hyperlipoproteinemia. 
Frednckson et al. introduced a classification system based 
on the serum lipoprotein pattern. Five, later six, types of 
hyperlipoproteinemia were described (1, 15) (table 3). 
The pathogenesis of these different types of hyperlipopro­
teinemia has not been elucidated completely in all cases. Type I 
hyperlipoproteinemia is a condition resulting from the deficiency 
of the extrahepatic lipoprotein lipase (1). Type II hyperlipopro-
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Type I 
Type II A 
Type II В 
Type III 
Type IV 
Type V 
chylomicrons I I I 
LDL ttt 
LDL I I I 
VLDLl 
ß-VLDL 
VLDL of abnormal 
composition 
VLDL tit 
chylomicrons 1 
VLDL Î I I 
normal to moderately markedly elevated "cream layer"* above 
elevated clear to slightly 
turbid plasma 
elevated 
elevated 
elevated 
normal to slightly 
elevated 
normal 
moderately 
elevated 
clear 
slightly to 
moderately turbid 
moderately to turbid to frankly 
markedly elevated opaque mostly also 
"cream layer"* 
moderately to turbid to frankly 
markedly elevated opaque 
•normal to moderately markedly elevated turbid to frankly 
elevated opaque always also 
"cream layer" 
tememia, at least in the primary form, seems m most cases to 
be caused by a defect in the catabolism of LDL (56). In type III 
hyperlipoproteinemia an impediment in the breakdown of VLDL is 
supposed to exist, causing an accumulation of cholesterol-rich 
VLDL (IDL) in the plasma (57). Type IV and V hyperlipoproteinemia 
may be caused by an increased production rate of VLDL by the 
liver, by a reduced clearance of VLDL and chylomicrons or by a 
combination of both mechanisms (14). 
In former years the classification was done on the basis of 
the values of serum cholesterol and triglycerides, and on the 
semi-quantitative data obtained with the lipoprotein electropho-
resis on paper. Classification was easy when either the choles-
terol or the triglyceride concentration in serum was elevated. 
In the former case tne LDL are elevated (type II A) and in the 
latter case there is an elevation of VLDL or chylomicrons (type 
IV or V, type I being extremely rare. The presence or absence of 
chylomicrons in the electrophoretic pattern was then decisive for 
the diagnosis of type V or IV respectively). 
Classification was difficult when both the cholesterol and 
the triglyceride concentration were elevated. The semi-quantita-
tive results obtained from the lipoprotein electrophoresis do 
not give sufficient information to distinguish between type II B, 
type III or type IV. In order to overcome this problem the con-
centrations of the individual lipoproteins have to be measured 
quantitatively. 
For the diagnosis of type III hyperlipoproteinemia addition-
al information is required. In this disorder the VLDL have ß-
mobility on paper. So it is necessary to subject the VLDL-frac-
tion, obtained by ultracentrifugation, to electrophoresis (15). 
In order to get the most complete information for the proper 
classification of a subject with hyperlipidemia the following 
tests should be carried out: 
- Measurement of serum cholesterol and triglycerides. 
- Quantitative measurement of VLDL, LDL and HDL. 
- Electrophoresis of serum and of the d < 1.006 and 
d > 1.006 g/ml fractions to examine the presence of 
abnormal lipoproteins and the possibility of type III 
hyperlipoproteinemia. 
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PURPOSE OF THIS INVESTIGATION 
The purpose of the investigation described in this thesis 
was to develop reliable methods for the classification of pa-
tients with hyperlipidemia. An evaluation of the methods for the 
determination of cholesterol and triglycerides is given in chap-
ters 2 and 3. Furthermore, different methods for the quantitative 
measurement of lipoproteins were studied. In the literature 
several methods for the measurement of lipoproteins have been 
described in which the use of an ultracentrifuge was avoided. 
Especially the dual precipitation method of Wilson and Spiger 
(58) seemed to be a promising alternative. The results obtained 
with this method and with the ultracentrifugation method were 
compared. This study resulted in a reliable quantitative deter-
mination of lipoproteins (chapter 4). 
For the diagnosis of the different types of hyperlipopro-
teinemia, especially for the detection of the abnormal lipopro-
tein pattern of type III, a sensitive and reliable electrophore-
sis method is indispensable. Therefore, an improved agarose gel 
method was developed, which has a high capacity and a good 
reproducibility. By means of this method it was attempted to 
standardize the description of electrophoretic lipoprotein 
patterns by studying the sera of a large group of normal and 
hyperlipoproteinemic subjects (chapter 5). Special attention 
was paid to the appearance of lipoproteins with intermediate 
ß— pre-ß-mobility. 
In recent years quantitative in stead of qualitative crite-
ria for the presence of ß-VLDL have been advocated in order to 
facilitate the diagnosis of type III hyperlipoproteinemia (59, 
60). These quantitative criteria are based on the lipid compo-
sition of the VLDL-fraction. In chapter 6 the quantitative 
criteria are compared with the electrophoretic patterns de-
scribed in chapter 5. This study resulted in a better approxi-
mation of the diagnosis of type III hyperlipoproteinemia. 
PRACTICAL CONSEQUENCES 
After completion of the studies described in this thesis it 
24 
has been possible to translate all hyperlipidemias, detected in 
our department, into hyperlipoproteinemias. A correct classifi­
cation of hyperlipoproteinemia may benefit the treatment of these 
patients. 
The following routine has been introduced. Sera which show 
an elevation of both cholesterol and triglyceride levels are 
analysed for their lipoprotein pattern. The concentrations of 
VLDL, LDL and HDL are measured. The concentrations of these 
lipoproteins are estimated by means of their cholesterol con­
tent. VLDL-cholesterol is measured after isolation of VLDL by 
ultracentnfugation of serum at its own density. HDL-cholesterol 
is determined m the (LDL + HDL)-fraction after precipitation of 
2 + 
LDL with heparin/Μη . LDL-cholesterol is calculated by subtrac­
tion of VLDL-cholesterol and HDL-cholesterol from total serum 
cholesterol (chapter 4). Cholesterol is determined in these 
fractions with the method described by Röschlau et al. (chapter 
2). Triglycerides in the VLDL-fraction and in serum are deter-
mined by a semi-automated method (chapter 3). 
Beside these quantitative determinations, in most cases the 
lipoprotein pattern of serum and of the d < 1.006 and d > 1.006 
g/ml fractions on agarose gel electrophoresis is also studied. 
Also the presence of a creamy layer of chylomicrons and the 
turbidity of serum is noticed. 
When the diagnosis of type III hyperlipoproteinemia is 
considered, the amount of intermediate lipoproteins in the VLDL-
fraction after electrophoresis and the chemical composition of 
this fraction (expressed in the ratios VLDL-chol/serum TG and 
VLDL-chol/VLDL-TG) are taken into account. 
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ABSTRACT 
Various chemical and enzymatic methods for the determination 
of cholesterol m serum were studied, namely the Huang method, an 
automated version of this method, the Röschlau method and several 
procedures based on the method of Allam et al. In order to have 
the disposal of a reliable method for the determination of cho-
lesterol for research purposes and for use in the routine clini-
cal chemistry laboratory, these methods were compared as to 
accuracy, precision, interferences, manageability, efficiency 
and costs. 
The method of Röschlau was found to be suitable for the de-
termination of cholesterol for research purposes. The results 
obtained with this method agreed well with those of the Abell-
Kendall method. No interferences could be detected and the 
precision was satisfactory. 
All the methods studied for the use in the routine clinical 
chemistry laboratory were unsatisfactory for at least one of the 
above mentioned factors. In a study in which 24 analysts parti-
cipated, the chemical method of Huang and the automated version 
of the Huang method showed considerable interference by bilirubin; 
the precision proved also to be less than in the enzymatic methods 
of Allain and Röschlau. The precision of the Allam method in 
daily work appeared to be even better than the precision of the 
Röschlau method. However, a high serum triglyceride concentration 
showed in the Allain method a considerable interference; the re-
sults were too high when not corrected for the turbidity and too 
low after the correction. The CHOD-PAP method — another Allain-
like procedure — in which a detergent is used that eliminates 
the turbidity during incubation, did result in accurate values 
when lipemic sera were analysed. An elevated TG concentration al-
so showed an interference in the automated chemical method; the 
degree of interference was related to the serum TG concentration. 
Furthermore, the concentrations found with this method were 
dependent on the extent of dilution of the lipemic sera. 
The chemical methods, especially the Huang hand method, 
were found to be impopular, because of the use of strong acid 
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reagents. The Allain method proved to be the most popular method, 
but this method was also more expensive. 
Taking into account all these points it was concluded that 
an Allain-like procedure containing a detergent (CHOD-PAP method) 
is probably the most suitable method for use in the routine 
laboratory. 
The accuracy of the different methods, especially of the 
Röschlau method was studied thoroughly. Although the Röschlau 
method showed very good agreement with the Abell-Kendall method 
when native serum was analysed, the accuracy of this method was 
found to be unsatisfactory in the control survey organized by the 
KCA (Quality Control Chemical Analysis). Our values obtained for 
three control sera were on the average 7.8% lower than the target 
values. These target values had been established by the Center 
for Disease Control (CDC), Atlanta, USA. It could be shown that 
improper calibration of our procedure was not the cause of the 
disagreement. However, the sera of the KCA were only meant to 
serve as control in the chemical methods. 
It was found that most control sera are not suitable to 
serve as control for accuracy both in the chemical methods and 
in the enzymatic methods. This is caused by the high bilirubin 
concentration of most sera which interferes in the chemical 
methods, or by the appearance of atypical reactions when anal-
ysed with enzymatic methods. 
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GENERAL INTRODUCTION 
An elevateci serum cholesterol concentration is one of the 
most important risk factors for cardiovascular diseases (1, 2). 
Therefore, the estimation of total cholesterol in serum is being 
carried out daily in most clinical chemistry laboratories. 
The methods for the determination of cholesterol 
Various methods for the determination of cholesterol have 
been proposed, many being no more than minute variations of older 
ones. It is not our intention to discuss all these procedures at 
length. They are only mentioned here to give an insight into the 
variety of methods; some of these have become obsolete and others 
are still being used. 
Cholesterol can be determined by: 
- Gravimevry. This procedure was first described by Windaus in 
1910 (3). After saponification of the cholesterol esters, 
cholesterol is precipitated with digitonine. The resulting 
digitonide is weighed. 
- Nephelome try. Cholesterol digitonide is suspended and quanti­
fied by nephelometric measurement (4). 
- Gas chromatography. In this procedure cholesterol is deter­
mined after saponification of the esters and extraction (5). 
- Thin layer chromatography. After extraction of the lipids from 
serum, free and esterified cholesterol are separated by thin 
layer chromatography. These compounds are then determined 
separately using photoreflectometric analysis after development 
of the chromatogram (6). 
- Colorirne try. Several methods for the direct or indirect measure­
ment of cholesterol have been described. The most used color 
reactions are: 
- The Liebermann-Burchard reaction using H^SO. in acetic-
anhydride (7, Θ) . 
- The FeCl3-H2S04 method, first described by Zlatkis, Zak and 
Boyle (9). 
- The method of Pearson, Stern and McGavack using p-toluene-
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sulfonic acid (10) 
- The enzypiatic methods using cholesterol oxidase which gener-
ates H-09. This compound is tnen determined using colorimetry, 
fluorometry or electrochemical procedures (11-16). 
At present, cholesterol in serum is mostly determined using one 
of the coloniretric methods. 
General proalems in methodology 
Cholesterol in serum is always combined with phospholipids, 
proteins and triglycerides forming lipoproteins. Approximately 
25% of the total cholesterol in serum occurs in free form, the 
other 75% in an ester linkage (17). 
In the various colorimetrie methods the free and estenfied 
cholesterol may give different intensities of color with various 
reagents. Webster (18) has shown that any procedure in which a 
Liebermann-Burchard-type reaction is used and which does not in-
clude saponification, results in seemingly high values for total 
cholesterol when pure cholesterol is used as a standard. In the 
method of Zlatkis (9) or Pearson (10) the same colour intensity 
is produced with free and estenfied cholesterol, thereby elimi-
nating the need for saponification. 
The standardization of the methods has always been a com-
plicated problem, especially in those procedures in which choles-
terol esters and free cholesterol react differently. The most 
reliable approach to circumvent this problem has been the con-
version of all cholesterol esters into free cholesterol by means 
of chemical hydrolysis. 
Cholesterol is a steroid. Therefore, an interference might 
be expected from other steroids since most reactions used in the 
determination of cholesterol also take place with other steroids. 
Fortunately, the concentrations of these compounds are usually 
too low to interfere (19). The most important source of inter-
ference is caused by bilirubin, because this compound does react 
in most methods. Furthermore, turbidity or hemolysis in the serum 
samples may represent a serious problem, at least in the direct 
determinations where no prior purifications are carried out (20). 
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In the light of the increasing number of requests for the 
determination of cholesterol, the method which is used must be 
simple and easy to perform. Although the earlier studies snowed 
the necessity for purification of cholesterol before the end 
point reaction is started, the direct methods, without prior 
purifications, became more popular. Indeed, some direct methods 
have been described which seem to have a rather good agreement 
with the reference methods (21, 22). 
Definitive and reference methods for the determination of 
cholesterol 
According to the Committee on Standards of the International 
Federation of Clinical Chemistry (IFCC) a "definitive" method can 
be defined as: "A method which, after exhaustive investigation, 
is found to have no known source of inaccuracy or ambiguity" (23). 
Such a definitive method does not exist for the determination of 
cholesterol. Mass spectrometry combined with isotopie dilution is 
m progress to become a definitive method. With such a definitive 
method the "true value" can be established. 
A "reference" method as defined by IFCC — ("A reference 
method is one which after exhaustive investigation has been 
shown to have negligible inaccuracy in comparison with its im-
precision") — does not exist either. However, the term refer-
ence method is used here for the best method available. In the 
history of cholesterol determination at least three methods may 
be considered reference methods. The first acceptable reference 
method was the gravimetric method of Wmdaus (3). Later, as the 
colorimetrie procedures were generally used, Schoenheimer and 
S p e m e (24) and Abell et al. (25) developed methods using the 
Liebermann-Burchard reaction, which are now generally accepted 
as reference methods. At present especially the latter method is 
the most used reference method, because the Abell method is 
thought to have an acceptable inaccuracy. 
In the Abell-Kendall procedure, the cholesterol esters are 
saponified. Afterwards, free cholesterol is separated from inter-
fering factors by extraction. The colour is produced with the 
Liebermann-Burchard reagent. 
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The introduction of the enzymatic methods can be considered 
as a step in the direction towards another reference method (20). 
In these methods cholesterol is oxidized using cholesterol oxi-
dase. The H20_ which is generated is then determined using color-
imetrie, fluorometnc or electrochemical detection (11-16). 
The enzymatic methods are very simple in terms of usage and 
they may be more precise than the described reference procedures 
(20). It may be expected that in the near future an enzymatic 
method will be developed, which will become generally accepted 
as a reference method. The present enzymatic methods are, at 
least theoretically, not free from interferences. 
Selection of methods 
Serum cholesterol determination is increasingly requested 
for the diagnosis and follow-up of the treatment of hypercholes-
terolemia. A reliable cholesterol determination is also a pre-
requisite for research of lipoproteins, since the isolated lipo-
proteins are mostly determined in terms of their cholesterol 
content (26). 
In general the chemical methods lack specificity. The dis-
advantage of these methods is that concentrated agressive rea-
gents are needed. Relatively few studies describe the mechanisms 
for these reactions. This is partly caused by the difficulty to 
define products that are relatively unstable. Because'the 
Liebermann-Burchard reaction is used in this study, the litera-
ture was searched for the mechanism of this reaction. The reac-
tion involves oxidative mechanisms, which results in a series 
of conjugated cholestapolyenes. Protonation of these polyenes 
results in the final product, the pentaenylic cation (27, 28), 
which exhibits an absorption maximum in the spectrum at 620 nm. 
The enzymatic methods are becoming more popular because the 
reagents are easier to handle. Furthermore, the enzymatic proce-
dures for cholesterol are more easily accepted than other tech-
niques, because they are better understood m terms of their 
reaction-sequence mechanism (11, 12). A disadvantage of the 
enzymatic methods has been the high costs of the enzymes. Im-
purity of the enzymes and the eventual occurrence of inhibitoy 
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factors are other drawbacks. 
We looked for the most convenient method for the measurement 
of lipoproteins for research purposes and for routine use in the 
clinical laboratory. Various chemical and enzymatic methods were 
compared. Applying a number of criteria the most suitable methods 
for both purposes were selected. 
VALIDATION OF THE RÖSCHLAU METHOD FOR RESEARCH PURPOSES 
Introduction 
High demands are made upon a method for the determination of 
cholesterol used in the research laboratory. The method must have 
a high precision and the inaccuracy must be minimal. 
The chemical method according to Abell-Kendall (25) is 
generally accepted as a reference method. This chemical method 
is highly specific, inexpensive, accurate and rather sensitive. 
A disadvantage of the method is, that the procedure comprises 
several reaction steps. Therefore, the number of sera that can 
be analysed in one series is small. 
At present, there is an increasing interest in using the 
enzymatic method according to Röschlau (16, 29, 30). This method 
has been shown to agree with the Abell-Kendall method (11). 
Bilirubin (20 mg/100 ml; 342 pmol/l), hemoglobin (500 mg/100 ml; 
312 pmol/l) and anticoagulant did not disturb the determination. 
Also in lipemic sera the procedure resulted in accurate values. 
However, as the colour reaction is based on the generated 
H^O- and not on the cholestenon, two problems may arise. Firstly, 
the H^O- may react with other reducing compounds in stead of the 
components in the colour reagent resulting in lower values (20, 
31, 32). Secondly, H^O- can also be produced in other (enzymatic) 
reactions. 
Some enzymatic methods have been described using other types 
of colorimetrie reactions (12, 14). In these methods a sample 
blank determination is omitted. Because high concentrations of 
triglycerides or bilirubin may result in inaccurate values (12, 
33), these methods can not be considered very useful for research 
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purposes. 
The Röschlau method is, in comparison with the Abell-Kendall 
method, technically less complicated; more sera can be analysed 
in a series. 
To validate the Röschlau method on its accuracy it was com-
pared with the Abell-Kendall method. Also the precision of the 
Röschlau method was investigated, as well as the interference of 
bilirubin and triglycerides. 
Materials and Methods 
The Abell-Kendall procedure was carried out as described by 
the "Nederlands Normalisatie-Instituut" (NEN 2414) (34): 0.2 ml 
of serum is mixed with 2 ml of freshly prepared alcoholic KOH 
solution (2.1 g of KOH, dissolved in 10 ml of water and, after 
cooling, diluted to 100 ml with absolute ethanol). The tubes are 
closed, mixed and placed in a water bath of 37 С for 60 minutes. 
Afterwards, the tubes are cooled again and then: 4 ml of petro-
leumbenzin (60-80 ) and 2 ml of water are added and the tubes 
are shaken for 1 minute. After centnfugation for 5 minutes, 2 
ml of the upper layers are evaporated to dryness under a stream 
of dried air. Afterwards, the tubes are placed in a water bath 
of 25 + 1 C. The residues are dissolved in 5 ml of cholesterol 
reagent (acetic-acid: acetic anhydride: sulfuric acid (95-97%) 
1:2:1 v/v/v). The content is mixed and after incubation in the 
water bath for exactly 30 minutes, the absorbances are measured 
at 62 0 nm. 
In the Röschlau method, the cholesterol esters are enzymat-
ically hydrolysed by cholesterol esterase (EC 3.1.1.13) to free 
cholesterol and fatty acids. In the presence of oxygen, free 
cholesterol is transformed by cholesterol oxidase (EC 1.1.3.6) 
4 
into Δ -cholestenone under formation of H_09. The latter compound 
does oxidize methanol to formaldehyde in the presence of catalase. 
The formaldehyde that is formed, is condensed with ammonium-ions 
and acetylacetone producing a fluorescent and yellow coloured 
product (3,5-diacetyl-l,4-dihydrolutidine). 
The Röschlau method was performed with the test combination 
obtained from Boehnnger Mannheim GmbH. Using Preciset standard 
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solutions, the determination was carried out according to the 
prescription given by the manufacturer with only slight modifi­
cations. We used 50 μΐ instead of 20 )1 of serum. After mixing 
with 5 ml of buffered enzyme-reagent, 2.5 ml of the mixture was 
incubated with 20 yl of the cholesterol oxidase solution. The 
remaining mixture was used for the sample blank determination. 
Dividing the 5 ml incubation mixture into equal parts of 2.5 ml 
by pipetting proved to be rather tine consuming. It appeared 
however, that this could also be performed by decanting approxi­
mately half of the mixture into another tube. It is not necessary 
to use exactly 2.5 ml of the mixture for the determination, be­
cause the cholesterol oxidase is present in excess. 
Results 
Comparbsor, of the results cbsatred Jtbh tne ^osjrlaj r<~piho<2 a^a 
the Abe 11-<enia"I nevhod 
The cholesterol concentrations of 42 samples (24 clear sera 
and 18 d < 1.006 fractions isolated by ultracentrifugation) were 
determined with the Röschlau method and with the reference method 
of Abell-Kendall. The results of both methods agreed well. The 
results obtained for 18 bilirubin-rich sera and for 22 lipemic 
sera did also agree well; there was no significant difference 
between the results of both methods (figure 1 and table 1). 
Reaooery exper%ments using the Rosahla^ method 
Known amounts of aqueous cholesterol solutions that were 
added to normal, lipemic or bilirubm-nch serum were recovered 
quantitatively (table 2). 
Lvnearzty of tne relation between absorbance and aonaentratton 
With the use of 50 yl of standard solutions a calibration 
curve was established. The calibration curve was linear in the 
concentration range 0-20.7 mmol/l (figure 2). The linearity was 
also studied by diluting a clear serum with high cholesterol 
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Table 1 
Comparison of the cholesterol levels obtained with the Abell-Kendall method (x) and the 
Röschlau method (y) for 42 clear sera and d < 1.006 lipoprotein fractions, for 18 
bilirubin-nch sera and for 22 lipemic sera. 
linear regression and cholesterol (rmol/l) Student's 
correi, coeff. mean + S.D. t-test* 
clear sera and d < 1.006 fractions 
η = 42 
bilirubin-nch sera η = 18 
mean brlirubrn cone: 93 + 38 umol/L 
range: 39 - 221 μιηοΐ/ΐ 
lipemic sera η = 22 
mean TG cone: 7.3 + 2.7 mmol/1 
range: 4.3 - 13.0 mmol/1 
У 
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Y 
r 
Y 
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= 
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= 
= 
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4 
7 
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+ 
+ 
+ 
+ 
+ 
+ 
3 
3 
2 
2 
1 
1 
74 
83 
.63 
.56 
.97 
.96 
Ρ 
Ρ 
Ρ 
> 
> 
> 
0 
0 
0 
4 
0ί 
1 
* paired observations 
1 6 -
H 
14
 Ί 
12-
-| 
10-
-
θ -
-
6 -
" 
4 -
2 -
-
/ / 
/ 
/ 
7 
У 
/ 
У 
/ 
/ 
А 
/ m 
/ у = х 
/ 
m clear serum 
о I ipoprotei η fraction d < i 0 0 6 
τ bilirubin - r i c h serum 
Δ hpemic serum 
8 10 12 14 16 
Abel I-Kendall (mmol/I) 
Fig. 1. Comparison of cholesterol concentrations obtained by the 
Roschlau method and the method of Abel1-Kendal1 m Θ2 
samples (clear sera, d < 1.006 fractions, bi1irubin-rich 
sera and lipemic sera). To make a good judgement possible, 
the ideal regression line (y=x) has also been drawn. 
concentration (cholesterol: 15.5 imral/l; TG: 1.8 mmol/l) and a 
lipemic serum (cholesterol: 8.5 mmol/l; TG: 26.0 mmol/l). When 
50 yl of the dilutions were used in the assay, a linear relation 
between the absorbance and the concentration was observed in all 
cases (figure 3). 
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Table 2 
Results of the recovery experiments in which known amounts of 
aqueous cholesterol standards were added to normal, bilirubin-
rich or lipemic serum 
serum cholesterol concentration of recovery 
cone, (mmol/1) standard added % 
(mmol/l) 
normal serum A 5.20 2.59 103 
3.89 102 
5.18 99 
normal serum В 7.52 2.59 98 
3.89 92 
5.18 102 
bilirubin-rich serum 3.68 2.59 102 
bilirubin cone: 120 pmol/l 3.89 98 
5.18 100 
lipemic serum 8.25 2.59 95 
TG cone: 5.2 mmol/l 3.89 99 
5.18 98 
The sample volume 
It was examined if it was possible to use larger sample 
volumes of sera with a low cholesterol level. Serum with a nor­
mal cholesterol concentration was diluted one to tenfold with 
saline and increasing amounts of the diluted samples varying 
from 20 μΐ tot 200 μΐ were used in the cholesterol determination. 
The results are given in table 3. 
It can be concluded, that varying sample volumes can be 
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used in the determination. Corrections for volume increase should 
be made for sample volumes larger than 50 μΐ. 
absorbance 
1600 
1200 
0800 
0400 
12 
ι г 
16 20 
cholesterol (mmol/l ) 
Fig. Calibration curve of the Röschlau method using 50 yl of 
the different standard solutions. 
Intevfevenaes 
The possibility of a positive interference by bilirubin was 
studied by performing cholesterol determinations in solutions of 
bilirubin dissolved in bovine albumin solutions*. The bilirubin 
solutions had concentrations of 20-370 ymol/l. In all cases the 
Kindly provided by Dr. C.L.J. Vink, St. Joseph Hospital, Eindhoven 
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cholesterol (mmol/1 ) 
1. 2, 3, 4, 5. 6, 7. θ, 
'8 '8 '8 '8 '8 '8 '8 '8 
dilution grade of serum 
Fig. 3. Cholesterol determination with the Röschlau method in 
severa^ dilutions of clear serum (o) and of lipemic 
serum (TG concentration 26.0 mmol/1) (·). 
increase of the colour m the sample could be corrected by the 
sample blank, which was carried out for each individual sample. 
Comparison of the Röschlau method with the Abell method 
has shown, that there was good agreement between the results 
of both methods obtained for bilirubin-rich sera (table 1 and 
figure 1). This demonstrates, that there is no net interference. 
The complete recovery of cholesterol added to bilirubin-rich 
sera is a proof again, that no negative interference of bilirubin 
in the Röschlau method could be established (table 2). 
A possible interference of a high triglyceride concentration 
has been shown to be absent with help of the results shown in 
table 1, 2 and figure 3. 
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Table 3 
Determination of cholesterol with the Röschlau method 
using a varying volume of the sample 
volume of 
sample 
dilution concentration (mmol/1) 
before correction after correction 
for differences in end-volume 
20 yl 
40 ul 
50 μΐ 
100 μΐ 
200 μΐ 
undiluted 
1:1 diluted 
2:5 diluted 
1:5 diluted 
1:10 -diluted 
6.15 
6.08 
6.05 
5.90 
5.82 
6.15 
6.10 
6.09 
6.01 
6.05 
A method for the determination of cholesterol for research 
purposes must be applicable especially to lipoprotein fractions. 
Fractions obtained by ultracentrifugation may have high concen­
trations of NaBr added to serum to elevate the density. There­
fore, the possibility of interference by this salt had to be 
checked. After ultracentrifugation at d = 1.063 g/ml, the top 
and bottom fractions contain 86.2 g of NaBr per litre. From 12 
samples the cholesterol values for the top and bottom fractions 
were added, this resulted in values which were 101.4 + 3.9% of 
the total serum cholesterol content. Approximately the same sums 
of top and bottom cholesterol were obtained after isolation at 
d = 1.006 g/ml: 100.8 + 3.2% (n=12). In this case the fractions 
did not contain NaBr. So interference by NaBr in the Röschlau 
method could be excluded. 
Precision and accuracy 
The precision of a method is the agreement between replicate 
measurements. The accuracy can be defined as the agreement be-
tween the best estimate of a quantity and its "true value" (23). 
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If one wants to express the precision and accuracy in numerical 
values, one uses the terms г р есгзгос and гпасалгаау. The im-
ргеагвгоі is the standard deviation or the coefficient of varia­
tion. The гпаааигазу is the numerical difference between the 
mean of a set of replicate measurements and the "true value" 
(23) . 
— "Pveoision" and "ас''чу'сиь" of zhe р^ е йъ д р ооеал^е 
For the determination of cholesterol with the Röschlau 
method only small quantities of sample are needed (20 or 50 yl). 
Therefore, the precision of the method is not only determined 
by the quality of the sample pipette, but also by proper use of 
that pipette. 
The "precision" and "accuracy" of various micropipettes for 
sampling 20 ul and 50 ul proportions of plasma and of aqueous 
standard (Preciset) were determined by pipetting these solutions 
in tenfold. The volumes were calculated by weighing after cor-
rection for the densities. It was known, that the amount sampled 
by some pipettes was dependent on the viscosity of the solutions. 
Therefore, the sampling was carried out with and without prior 
rinsing of these pipettes with the solutions. 
The "precision" of the various pipettes was expressed as 
the coefficient of variation, while the "inaccuracy" was expres-
sed as: 
.volume of standard - volume of plasma, -.„ло ( *• ) χ 100% 
volume of plasma 
The results are summarized in table 4. 
From the table it can be concluded, that the "precision" and 
"accuracy" of the SMI pipettes is the best. Prior rinsing of the 
other pipettes did not result in better "precision" or "accuracy". 
Sampling of 50 μΐ volumes can be carried out more precisely than 
sampling of 20 i-l volumes. To obtain reliable results the use of 
an accurate and precise pipette is an essential condition. There­
fore, the 50 yl pipette of SMI was always used. 
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Table 4 
The "imprecision" and "inaccuracy" of the various micro-pipettes for pipetting 20 or 50 μΐ 
proportions of plasma or aqueous cholesterol standard solution tenfold 
"imprecision" "inaccuracy" 
pipette prior rinsing plasma standard mean 
% % % % 
Eppendorfa 
Eppendorf 
SMI b 
OxfordC 
Oxford 
Eppendorf 
Eppendorf 
SMI 
20 
20 
20 
20 
20 
50 
50 
50 
Hi 
μΐ 
μΐ 
Pi 
μΐ 
μΐ 
μΐ 
μΐ 
no 
yes 
no 
no 
yes 
no 
yes 
no 
2.38 
2.46 
1.94 
1.90 
1.26 
2.83 
1.98 
0.53 
1.73 
1.76 
1.46 
2.62 
3.26 
1.40 
1.20 
0.60 
2.06 
2.11 
1.70 
2.26 
2.26 
2.12 
1.59 
0.57 
+ 2.10 
+ 7.70 
- 0.86 
- 3.36 
- 7.36 
- 4.20 
+ 4.12 
- 0.67 
obtained from Eppendorf GmbH, Hamburg, W-Germany 
obtained from Scientific Manufacturing Industries, Emeryville, USA 
obtained from Oxford Laboratories International Inc. Foster City, California, USA 
- FreabsioK ana accuracy of the deі^την nation 
The day-to-day variation of the method based on the determi­
nation of control sera with mean concentrations of 3.2, 6.2 and 
7.4 mmol of cholesterol per litre and expressed as the coeffi­
cient of variation amounted to 2.1%, 1.3% and 1.7% respectively 
for 25 determinations. All these determinations were carried out 
by the same analyst. 
The precision of the method when the determinations were 
carried out by 24 different analysts will be discussed later 
(pg 69). 
The method met the criteria for precision laid down by the 
KCA*. In the KCA control survey 3 different standard sera Α., A-
and Α.. had to be analysed in duplicate during 30 runs (no more 
than 2 runs a day). The results were analysed using the instruc­
tions for computations of the Center for Disease Control (CDC, 
Atlanta, USA). These instructions are used in the cooperative 
cholesterol-triglycende standardization program. The "overall" 
standard deviation, the "within run" standard deviation and the 
"among run" standard deviation (S , S and S respectively) were 
' о w a 
calculated as given in the appendix to this chapter. 
The mean values obtained with our method were compared with 
the target values provided by the CDC. The latter values were 
the mean of 32 analyses with the manual Abell-Kendall method 
(4 samples per day during θ days). To evaluate the accuracy of 
the Röschlau method the limits for accuracy were also calculated 
(+ 5% of these target values). 
The results obtained with the Röschlau method in the KCA 
control survey are shown in table 5. 
From these data it appears, that the precision of the method 
meets the CDC criteria. The S values for the three standard sera 
о 
A , A- and Α.. were all within the limits. The accuracy of the 
*Kwaliteits Bewaking Che-nische Analyse t.b.v. Epidemiologisch 
Onderzoek (Quality Control Chemical Analysis for Epidemiological 
Investigation) . 
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Table 5 
Precision and accuracy of the Röschlau method with regard to the 
determination of cholesterol in the three control sera A , A_ 
and A. provided by the KCA. The precision is expressed as the 
"among run" standard deviation, the "within run" standard 
deviation and the "overall" standard deviation (S , S 
a w 
and S respectively). The target values were provided 
by the U.S. Center for Disease Control. The limits for 
accuracy were + 5% of these target values; the limits 
for precision were dependent on the concentration 
(see appendix to this chapter). 
n=30 found target value limits 
mean 
S 
a 
S 
w 
1.91 mmol/1 
0.07 mmol/1 
0.03 mmol/1 
0.07 mmol/1 
2.15 mmol/1 2.04-2.27 mmol/l 
< 0.18 mmol/l 
mean 
S 
a 
S 
w 
3.95 mmol/1 
0.07 mmol/1 
0.06 mmol/1 
0.09 mmol/l 
4.16 mmol/1 3.95-4.37 mmol/1 
< 0.18 mmol/1 
mean 
S 
a 
S 
w 
6.48 mmol/1 
0.14 mmol/1 
0.05 mmol/1 
0.15 mmol/l 
6.85 mmol/1 6.51-7.19 mmol/l 
< 0.21 mmol/1 
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Röschlau method is, however, not acceptable according to the 
criteria of the CDC. The values found with our method for the 
three sera are all beyond tne limits for accuracy. Our values 
were on the average 7.8% lower than the target values. 
Discussion 
The enzymatic method of Röschlau shows good agreement with 
the Abell-Kendall procedure. No interference by bilirubin or 
tnglydendes could be detected. The precision of the Röschlau 
method is excellent and is comparable with those of the Abell 
method (In our laboratory S values for the Abell method of 0.11, 
•' о ' 
0.11 and 0.15 mmol/l were obtained by analysing three standard 
sera with concentrations of 5.6, 6.7 and 7.6 mmol/l in tenfold). 
The lack of agreement between our values and the CDC values 
is surprising. Firstly, there was a good agreement between the 
Röschlau method and the Abell method when serum was analysed. 
Secondly, the standards used in the Röschlau method (Preciset 
standards obtained from Boehnnger Mannheim) always showed in 
the Abell method (standardized with solutions of cholesterol 
dissolved in ethanol) those values which would be expected. 
Thirdly, comparison of the Preciset standards with aqueous 
standard solutions prepared in our laboratory, again showed 
good agreement. Thus, the discrepancies between CDC-values and 
the values found in our laboratory cannot be explained by the 
inadequate calibration of our procedure. 
Another reason for the large differences may be the impos-
sibility to use these sera to check both the chemical methods 
and the enzymatic methods. As will be shown later (pg 12), con-
trol sera may show considerably lower values with the enzymatic 
methods as compared to the chemical methods. Thus, although there 
is generally good agreement between chemical and enzymatic meth-
ods when human serum is analysed, there may be a disagreement 
between both methods with regard to the analysis of prepared 
control sera. Several reasons may be responsible for this phe-
nomenon. Firstly, prepared control sera may contain cholesterol 
esters which are not completely available to enzymatic hydrolysis. 
Secondly, the sera may contain abnormal concentrations of 
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reducing compounds such as vitamin-C or urate, whicn react with 
the produced H^O-. 
The sera of the KCA were only rreant to serve as control in 
the chemical methods, therefore, it would be premature to con-
sider the Roschlau method inaccurate on analysis of only tnese 
three control sera. We do think, that there is enough evidence 
to consider the Röschlau method equivalent to the Abell-Kendall 
procedure. Because of its easy manageability, the Röschlau method 
was chosen for our research activities. 
THE CHOICE OF A SUITABLE METHOD FOR USE IN THE CLINICAL CHEMISTRY 
LABORATORY 
Introduction 
Obviously, a routine method has to fulfill other require-
ments than a research method. The accuracy and precision must be 
reasonable; moreover, it is important that the procedure can be 
performed easily and quickly. The method should also be as in-
expensive as possible. It should not be hazardous for the health 
of the analysts and the pollution of the environment should be 
minimal. 
The Röschlau method is probably too time-consuming and too 
expensive to be suitable for use in the clinical chemistry 
laboratory. Other enzymatic methods, for instance the method of 
Allain et al. (12) should be considered first, because it can be 
automated, while a sample blank determination is mostly super-
fluous. This method however, is also quite expensive. 
Chemical methods without extraction are simple and inexpen-
sive, but they are also less specific. More dangerous chemicals 
are used as compared to the enzymatic methods, but generally 
they can be automated easily. 
The suitability of the following methods has been evaluated 
for use in the clinical chemistry laboratory: 
- The Huang method (21) which is the most used cholesterol proce-
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dure in the Netherlands*. 
- An automated method based on the Huang procedure, which has 
been used for 5 years in our laboratory. 
- The Allain procedure, which is the most simple enzymatic method 
today. 
Firstly we compared the three selected methods with the 
Röschlau method. Secondly, the possible interferences in the 
three selected methods were also studied. Thirdly, to evaluate 
the precision of the methods in daily work, a study was done in 
which 24 analysts participated. In this way more insight may be 
gained into the suitability of the three selected methods for 
routine use as compared to a study carried out by only one 
analyst. 
In this study, 7 commercially available control sera were 
analysed. Large variations in the values were often obtained 
with the various methods for the same serum. In order to test 
the suitability of the different standard sera to serve as con-
trol for the cholesterol determination, it seemed useful to com-
pare the mean values which were obtained with the various methods 
for the same serum. The results were also informative for the 
accuracy of the three selected methods. 
Materials and methods 
Chemisai method aoaording to Huang (21) 
The procedure was carried out as proposed by the "Nederlands 
Normalisatie Instituut" (NEN 2415) (34), with slight modifica-
tions: 5 ml of cholesterol reagent (acetic acid: acetic-anhydride: 
sulfuric acid (95-97%) 3:6:1 v/v/v, containing 20 g of anhydrous 
Na-SO. per litre) was added to 0.1 ml of serum. After mixing, the 
samples were incubated for 20 minutes at room temperature and the 
absorbances were measured at 630 nm against a blank and compared 
with the absorbances of aqueous standards (Preciset standards 
'According to data provided by the Netherlands Foundation for 
Quality Control of Clinical Chemical Hospital Laboratories. 
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obtained from Boehringer Mannheim, West-Germany). 
Automated ehemical method 
In the automated chemical method an amount of serum is mixed 
in the continuous flow system with the cholesterol reagent in the 
ratio of approximately 1/50; subsequently the mixture is incu­
bated for 8 minutes at 40 С and afterwards the absorbance is 
recorded at 590 nm. The composition of the reagent is: acetic 
acid: acetic-anhydride: sulfuric acid (95-97%) 10:15:3 v/v/v, 
containing 10.7 g dimethylbenzenesulfonic acid and 17.9 g anhy­
drous Na_SO. per litre of reagent. 
The costs of the reagent for one determination are low. 
However, they are about two times higher than in the hand method. 
The flow scheme of the continuous flow system is shown in 
figure 4. The pump tubes for reagent and waste were changed 
every three days. Pump tubes and glass reaction coils were inter­
connected with acidiflex tubing (internal diameter 2 m m ) . After 
each run the system is cleaned by pumping air through the whole 
system for 20 minutes. 
water in 
1 
water out 
Î 
_JL 
SMC 
(WW-
bath40t 
4 5 m 
ml/min 
006 
100 
294 
140 
colorimeter 
filter 
590 η m 
sample 
reagent 
waste 
40/h 
sample-wash 
1-1 
from flow cell 
recorder 
F i g . 4 . Flow-scheme of t h e automated c h e m i c a l c h o l e s t e r o l p r o c e d u r e . 
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Епгупаіго method based on zhe procedure of Allain (12) 
In this method cholesterol is determined according to the 
following reactions: 
>. -i -i л_ cholesterol esterase
 v
 . . , , , _ . . . , 
cholesterol esters » cholesterol + fatty acids 
, , . , , _ cholesterol oxidase . , , , -, ,
 rT _ cholesterol + 0 ? } cholesterol-3-one + H-Oj 
ι ,, ^ . л • ^ • • Í. -, peroxidase . . . . , ,. _ 2 H-O + 4-aminoantipyrine + phenol ^ = > quinoneimme + HjO 
For this procedure the test combination of Nyegaard and Co 
(Oslo) was used. The procedure as proposed by Nyegaard was modi-
fied (table 6). A larger amount of sample was analysed with a 
larger, more diluted, amount of reagent. As the ratio enzymes to 
substrate was diminished, the reaction time at 37 С was length­
ened from 10 minutes to 1 hour to obtain a complete conversion 
of the esterified and free cholesterol to cholesterol-3-one. 
After a reaction time of one hour, the calibration curve was 
linear in the concentration range of 0-10.35 mmol/1. 
Table 6 
Modifications of the Nyegaard test combination 
proposed by 
Nyegaard 
20 ml 
10 μΐ 
1 ml 
10 minutes 
modified 
50 ml 
50 μΐ 
2 ml 
1 hour 
lyophilised reagent dissolved in 
volume of sample 
reagent volume per determination 
reaction time at 37 С 
It was expected that this modification would improve the 
precision of the method in routine use. As was stated earlier, 
a volume of 50 yl can be sampled more accurately than a volume 
of 10 μΐ. A reagent volume of 2 ml is necessary for a proper 
determination of the absorbance in the flow-through colorimeters, 
which are generally used for single tube methods. 
The Allain procedure is ten times more expensive than the 
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chemical method of Huang. 
Stvdy of acji/racy ard precisior. of ifte various v¡e ' loas 
The accuracy of the various methods was studied using the 
values obtained with the Röschlau method as reference. 
To judge the precision of the methods an investigation was 
done with the aid of 24 analysts. 
Eight control sera were prepared and were divided in small 
portions and kept at -16 С Most sera had an above-normal bili­
rubin concentration and two sera had an elevated triglyceride 
concentration. Serum X was extremely lipemic (pooled serum of 
patients with type V hyperlipoproteinemia). On 24 any given days, 
during a period of 4 months, these sera were examined in dupli­
cate by one of the analysts. A protocol served as instruction 
manual for preparation of the reagents, the proceeding of the 
determinations and the calculation of the results. During the 
whole period the same aqueous standards with concentrations of 
2, 4, 6, 8 and 10 mmol/l were used. These standards were pre­
pared according to the method of Vass (35). 
The cholesterol concentration in the different control sera 
were determined using the following four methods: 
- The Huang method. 
- The automated chemical method. 
- The enzymatic method of Allain using the modified Nyegaard 
procedure. 
- The Röschlau method. 
The results were analysed using the instructions for compu-
tations of the Center for Disease Control. The "among run" stan-
dard deviation, the "within run" standard deviation and the 
"overall" standard deviation (S , S and S respectively) were 
a w o r •' 
calculated as given in the appendix to this chapter. 
Results 
Comparison of the various methods with the Rosohlau procedure 
The results obtained with the various methods were compared 
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with those of the Röschlau method. The statistical analysis of 
the results is shown in table 7. 
From this table it can be concluded, that there is generally 
good agreement between the three selected methods and the Rösch-
lau method. The mean values of the three selected methods are 
slightly higher than the mean values of the Röschlau procedure. 
At a mean cholesterol concentration of approximately 7.2 mmol/l, 
the differences between the Huang method, the automated method 
and the Allain method on the one hand and the Röschlau method on 
the other hand, are: 0.32; 0.10 and 0.10 mmol/l, respectively. 
For the Huang method and the automated method these differences 
are significant. As will be seen in the following section, these 
differences are, at least partly, caused by the interference of 
bilirubin in the Huang method and in the automated method. 
Intevferenae of bilirubin 
The possibility of a positive interference by bilirubin was 
studied by performing cholesterol determinations in the bilirubin 
solutions, which had already been used in the validation study of 
the Röschlau method. From figure 5 it can be concluded, that 
bilirubin shows a positive interference in all the three selected 
methods. There is no interference in the Röschlau method, as has 
already been stated (page 45). In the two chemical methods the 
interference is considerable. At bilirubin concentrations under 
160 pmol/l the interference is linear with the concentration. The 
extent of the interference is then 0.009 mmol chol/ymol bilirubin. 
In solutions with bilirubin concentrations within the normal 
range for serum (< 10 pmol/l) the positive interference in the 
Huang method and in the automated method is approximately 0.15 
and 0.10 mmol of cholesterol per litre respectively. 
In the Allain method bilirubin interferes slightly; the 
interference can only be detected at concentrations above 50 
pmol/l. 
Interferenae of triglycérides 
The influence of a high TG concentration was also examined. 
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linear regression 
correi, coeff. 
chol. cone, χ (mean + SD) 
chol. cone, y (mean + SD) 
Student's t-test 
(paired observations) 
y = 1.02 χ + 0.20 y = 0.98 χ + 0.26 y = 1.00 χ + 0.14 
г = 1.00 г = 0.97 г = 0.99 
6.67 + 1.61 7.15 + 2.03 7.52 + 3.83 
6.99 + 1.70 7.25 + 2.04 7.62 + 3.85 
ρ < 0.001 ρ < 0.05 ρ > 0 .1 
apparent cholesterol (mmol/1) 
2Ь-
20 
15 
IO­
CS 
100 200 
— 1 1 Q — 
300 400 
bilirubin (pmol/l ) 
Fig. 5. The interference by bilirubin in the Huang method (Δ), 
the automated method (·), the Allain nethod (o) and the 
Roschlau method (D). The apparent cholesterol concen­
trations were determined in pure bilirubin standards 
dissolved m bovine albumin solution. 
The results obtained with the three selected methods were com­
pared with the results obtained with the Röschlau method. As 
stated before, the latter method is not influenced by an ele-
vated TG concentration in serum. The results are summarised in 
table 8. 
From these data it can be concluded, that the values ob-
tained in lipemic serum with the three selected methods differ 
significantly from the values obtained with the Röschlau method. 
For the Huang method the difference is in the same order as in 
clear sera (table 7). So, there is no interference by lipemia. 
With the Allain method the resulting values were considerably 
higher. Obviously this is caused by the turbidity, which is pro-
duced after mixing the lipemic serum with the reaction reagent. 
The necessity of correcting these values for their own blank 
values will be discussed later. The reason why too low values 
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TG cone, (mean + SD) 
TG cone, (range) 
linear regression 
corr. coeff. 
c h o l . c o n e , χ (mean + SD) 
c h o l . c o n e , y (mean + SD) 
7.0 + 4.3 
3 . 7 - 1 7 . 1 
7.8 + 6.2 
3.6 - 2 5 . 0 
7.7 + 3.0 
5 . 2 - 1 5 . 4 
y = 1.10 χ - 0 . 2 2 y = 0 . 6 6 χ_+ 1.57 y = 0 . 8 5 χ + 2 . 5 5 
г = 1.00 
8.80 + 3.40 
9 . 1 0 + 3 . 6 0 
г = 0 . 9 3 
7 . 8 4 + 2 . 3 6 
6 . 7 1 + 1.65 
г = 0 . 9 2 
7.6 + 2.0 
9 . 1 + 2 . 0 
were obtained with the automated method in lipemic sera is not 
clear. The difference between the results of this method and the 
Röschlau method appeared to be correlated with the triglyceride 
concentration of the serum (figure 6). 
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Fig. 6. The relation betweei the triglyceride concentration of 
serum and the difference between the cholesterol values 
(Δ cholesterol) fojnd with the automated Tiethod and the 
Roschlau nethod. 
After completion of the study concerning the precision and 
accuracy of the three selected methods (pg 69-73), from which 
it became clear that an Allain-like procedure may be the best 
method for use in the clinical chemistry laboratory, the inter­
ference by triglycerides in the Allain method and related proce­
dures was studied more thoroughly. We were especially interested 
62 
in the possibility of obtaining accurate values after correction 
for lipemia by a sample blank. Furthermore, the influence of our 
modification of the Nyegaard test combination was studied. At 
last, another Allain-like procedure, the choiesterol-oxidase-
£henol-4-amino£henazon (CHOD-PAP test combination, Boehringer 
Mannheim, W-Germany) was included in this study. In the CHOD-PAP 
method the detection of cholesterol proceeds via approximately 
the same reactions as given on page 56. However, in the last 
reaction step 4-aminophenazon in stead of 4-aminoantipyrine is 
used for the formation of the colour. It has been stated that, 
when the CHOD-PAP method is used, no blank correction is neces-
sary, because the reagent contains a detergent (hydroxypoly-
> 
ethoxydodecan) which clears the samples as the reaction proceeds 
(33, 36). 
For this purpose, the cholesterol concentrations in 13 
lipemic sera (mean TG cone. 8.1 + 3.1 mmol/1) were determined 
using the following methods: 
1. Abell-Kendall method (reference method). 
2. Röschlau method. 
3. Allain procedure using our modification of the Nyegaard test 
combination. The values were not corrected for a sample blank. 
4. The same procedure as in 3, but now each value was also cor-
rected for the serum blank by determination of the absorbance 
of a sample-saline mixture after incubation. 
5. Allain procedure using the Nyegaard test combination without 
modifications. 
6. The same procedure as in 5, but each value was corrected for 
serum blank. 
7. CHOD-PAP method. This procedure was performed according to the 
instructions given by the manufacturer, with the exception 
that the incubation time at 37 С was lengthened from 15 min. 
to 4 5 min. 
The results are summarized in table 9. Only the Röschlau 
method and the CHOD-PAP method are in good agreement with the 
results obtained with the reference procedure. The other methods 
give too high cholesterol values when not corrected for a blank. 
However, after correction for a sample blank, the results are 
much tog low. Thus, the correction for a sample blank does not 
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Table 9 
Statistical analysis of the results obtained with 7 different 
procedures in the determination of the cholesterol 
concentration in 13 lipemic sera. The results 
obtained with each procedure (y) were compared 
with the results obtained with the reference 
method of Abell-Kendall (x). 
method 
Abell-Kendall 1 
Röschlau 2 
Allain 3 
modified 
Allain with 4 
blank correction 
Allain 5 
unmodified 
Allain unmod. 6 
blank correction 
CHOD-PAP 7 
linear regression and 
correi, сое 
У 
г 
У 
г 
Y 
г 
У 
г 
У 
г 
У 
г 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
1.00 χ -
1.00 
0.96 χ + 
0.93 
0.82 χ -
0.97 
1.27 χ -
0.98 
1.02 χ -
0.76 
1.03 χ -
0.98 
ff 
0 
1 
0 
1 
2 
0 
08 
77 
20 
39 
57 
20 
cholesterol 
(mmol/1) 
mean + S.D. 
7.42 + 1.57 
7.36 + 1.58 
8.92 + 1.62 
5.87 + 1.67 
8.05 + 2.03 
4.97 + 2.10 
7.43 + 1.64 
Student's 
t-test* 
ρ > 0.05 
ρ < 0.001 
ρ < 0.001 
ρ < 0.005 
ρ < 0.001 
ρ > 0.2 
*paired observations versus the results obtained with the Abell-
Kendall method. 
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seem to be effective. Possibly, the sample blank correction would 
have been more effective when, for the determination of the sam­
ple blank value, the sample had been mixed with reagent con­
taining all the enzymes except cholesterol oxidase, instead of 
mixing with saline. Obviously, the turbidity of the sample-
reagent diminishes during incubation more than the turbidity of 
a sample-saline mixture. 
Мгзсеlla^eous гг езtzgatboys 
In the Чиагд method the influence of the variation of the 
ratio of sample to reagent was studied more thoroughly. 
The percentages of the recovery of aqueous standards which 
were added to serum appeared to be strongly dependent on the 
ratio total sample to reagent (table 10) . 
Table 10 
The influence of the ratio sample to reagent (v/v) in the Huang 
method on the recoveries of standards which were added to serum 
(mean of 4 determinations) 
volume of sample volume of ratio recovery 
serum standard reagent sample/reagent % 
50 pi 
50 pi 
70 pi 
70 pi 
100 pi 
100 pi 
50 
70 
50 
70 
100 
100 
Pi 
Pi 
Pi 
Pi 
Pi 
Pi 
5 
5 
5 
5 
5 
10 
ml 
ml 
ml 
ml 
ml 
ml 
1/50 
1/42 
1/42 
1/36 
1/25 
1/50 
103.2 
102.0 
99.4 
95.1 
76.8 
102.1 
The ratio sample to reagent strongly determines the height 
of the cholesterol concentration that was found. This could also 
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be ascertained in an experiment in which increasing amounts of 
serum were mixed with 5 ml of reagent (table 11). The concentra­
tions which were found, were expressed in percents of the con­
centration that was found if the sample to reagent ratio was 1/50. 
Table 11 
The relation between the ratio sample to reagent (v/v) and 
the cholesterol concentration m the Huang method as 
compared with the standard procedure (ratio 1/50) 
(mean of 4 determinations) 
volume of serum volume of ratio % of the 
reagent sample/reagent reference value 
20 μΐ 
50 μΐ 
70 ui 
100 yl 
120 jl 
150 yl 
170 yl 
200 yl 
250 yl 
5 
5 
5 
5 
5 
5 
5 
5 
5 
ml 
ml 
ml 
ml 
ml 
ml 
ml 
ml 
ml 
1/250 
1/100 
1/70 
1/50 
1/42 
1/33 
1/29 
1/25 
1/20 
105.6 
103.4 
102.1 
100.0 
97.7 
90.5 
85.3 
78.6 
63.5 
In the autoriated method the effect of dilution of serum was 
studied. Clear, lipemic and bilirubin-rich sera were analysed on 
cholesterol in various dilutions with 0.9% saline (table 12). 
It can be concluded, that dilution of clear sera does not 
influence the result. Bilirubin-rich sera show a tendency to get 
higher values with a higher dilution grade. For lipemic sera, 
however, the concentration that is found, is strongly related to 
the dilution grade. With increasing dilution considerably higher 
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concentrations are found. 
Table 12 
The influence of dilution on the cholesterol concentrations, 
that were found with the automated method in 7 clear sera, 7 
bilirubin-rich sera (mean bilirubin cone. 147 pmol/l) and 7 
lipemic sera (mean TG cone. 20.3 mmol/1) 
mixture clear serum bilirubin-rich lipemic 
serum serum 
undiluted 
serum:saline 
serum:saline 
serum:saline 
serum:saline 
serum:saline 
serum:saline 
serum:saline 
= 
= 
= 
= 
= 
= 
= 
7:1 
6:2 
5:3 
4:4 
3:5 
2:6 
1:7 
v/v 
v/v 
v/v 
v/v 
v/v 
v/v 
v/v 
9.0 
8.9 
8.9 
9.2 
9.0 
9.1 
8.9 
8.8 
6.0 
6.4 
6.3 
6.3 
6.4 
6.4 
6.6 
6.6 
7.4 
7.8 
8.0 
8.4 
8.9 
9.2 
9.9 
11.3 
Precision and aoauvaoy of the automated method in the KCA control 
survey 
Of the three methods only the automated method was tested 
by means of the KCA control survey (see also pg 50)· The same 
sera A^, A2 and A were analysed in duplicate during 30 runs. 
The results were analysed using the instructions for computations 
of the Center for Disease Control (see appendix to this chapter). 
The results that were obtained are shown in table 13. 
The precision of the method appears to be beyond the limits 
proposed by the CDC. The precision is only acceptable if sera are 
analysed with low cholesterol levels. However, in the normal 
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Table 13 
Precision and accuracy of the automated method with regard to 
the determination of cholesterol in three test sera A., 
A- and A? that were provided by the KCA. See table 5 
for definitions. 
n=30 found target values limits 
mean 
S 
a 
S 
w 
2.27 mmol/1 
0.14 mmol/1 
0.10 mmol/1 
0.18 mmol/1 
2.15 mmol/1 2.04-2.27 mmol/1 
< 0.18 mmol/1 
mean 
S 
a 
Sw 
4.42 mmo1/1 
0.21 mmol/1 
0.21 mmol/1 
0.30 iranol/1 
4.16 mmo1/1 3.95-4.37 mmol/1 
< 0.18 mmol/l 
mean 
S 
a 
Sw 
6.77 mmol/l 
0.31 mmol/1 
0.40 mmol/1 
0.51 mmol/l 
6.85 mmol/1 6.51-7.19 mmol/1 
< 0.21 mmol/1 
concentration range of human serum, the overall standard devia-
tion is too high. 
According to the criteria of the CDC, the accuracy of the 
method is reasonable, at least in the normal concentration range 
of human serum (A.,) . At rather low concentrations the values 
are somewhat too high. 
If we compare the mean values obtained with this method and 
the Röschlau method (table 5), it can be seen that the results of 
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the chemical method are higher tnan would be expected from the 
results of the comparative study between both methods (table 7). 
Substitution of the results of the Roschlau metiod for serum A1, 
Ap and Α., in the regression equation of table 7, y = 0.98 x + 0.26, 
gives the expected results for the automated method: 
A : 2.13 mmol/1; A2: 4.13 mmol/l and A^: 6.61 mmol/1. Tnese 
values are 11.5%, 4.6% and 2% (mean 5.3%) lower than was found 
in reality, which indicates that these sera are possibly not 
suitable to serve as control for accuracy in enzymatic choles­
terol methods (see also pg 72). 
Freczsior of the t^^ee se'^ea^ecL rpetrods α> a of tne Foschia^ 
rretPoa г . routzne ¿.se 
The precision of the three selected methods and of the 
Röschlau method was judged in a study in which 24 analysts par-
ticipated (described on pg 57). Generally the precision is 
related to the concentration. The precision of the different 
methods for the determination of hign or low concentrations will 
be described later. To obtain insight into the precision of the 
methods for the determination of cholesterol in the entire 
(normal and pathological) concentration range, it seemed useful 
to compare the mean of the combined standard deviations obtained 
for each method. In table 14 the mean of the "overall" standard 
deviations, the "within run" and "among run" standard deviations 
(S , S and S ) are given. The results obtained for serum X 
о w а
 ч 
(extremely lipemic) were not used as the variation m the values 
obtained with the different methods for this serum was considera­
bly greater than for the other sera. 
From these experiments the following conclusions can be 
drawn : 
- The overall standard deviation (imprecision) of the enzymatic 
methods is lower than the overall imprecision of the chemical 
methods. 
- The imprecision of the Allain method is even lower than that 
of the Röschlau method. 
- The two chemical methods have approximately the same impreci-
sion. 
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Table 14 
The mean of the "among run" standard deviations (S ), the 
a 
"within run" standard deviations (S ) and the "overall" 
w 
standard deviations (S ) of the results obtained by 
analysing all the standard sera (except serum X) by 
24 analysts with the use of 4 different methods 
method S (mmol/1) S (mmol/1) S (mmol/1 
a w о 
Huang 0.17 + 0.05 0.09 + 0.03 0.20 + 0.06 
automated 0.13 + 0.08 0.19 + 0.12 0.24 + 0.14 
Allain 0.11 + 0.05 0.06 + 0.02 0.12 + 0.05 
Röschlau 0.16 + 0.04 0.05 + 0.01 0.16 + 0.04 
- The within run imprecision of the three hand methods is only a 
rather small part of the overall imprecision. In the automated 
method, the within run imprecision is mainly responsible for 
the height of the overall imprecision of this method. Improve-
ment of the within run precision of the automated method would 
make it more suitable for routine purposes. 
To ;judge the precision of the different methods for the 
determination of high or low concentrations, the mean values 
which were found for S , were compared with the limits for pre-
cision for the different sera. These limits were related to the 
concentration of the sera (see appendix). The results are shown 
in table 15. 
It can be seen, that if sera with a low cholesterol concen-
tration are analysed, the precision of all methods meets the 
criteria of the CDC. However, when sera are analysed with normal 
or high cholesterol concentrations, the precision of the chemical 
methods does not meet the criteria of the CDC. The results also 
demonstrate, that none of the methods has a satisfactory preci-
sion for the determination of the cholesterol concentration in 
extreme lipemic serum. 
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monitrol 
autonorm 206 
autonorm 207 
liponorm 
ledertrol 
choles-trol D 
serum X 
3.3 
3.3 
5.3 
6.3 
6.4 
8.8 
8.8 
< 0.18 
< 0.18 
< 0.21 
< 0.21 
< 0.21 
< 0.23 
< 0.23 
0.12 
0.19 
0.18 
0.21 
ι 
0.22 
0.30 
1.13 
0 
0 
0 
. 4 8 
. 3 2 
. 7 0 
0.09 
0.10 
0.10 
0.13 
0.20 
0.17 
1.55 
0.15 
0.15 
0.12 
0.17 
0.24 
0.18 
0.49 
From the results shown m table 14 and 15 it can be con-
cluded that the Allain method has the best precision. 
Aaauracy of the three selected methcas, the suztability of 
standard sera to serve as control for different cholesterol 
pyocedures 
In table 16 the results are given of the mean concentrations 
of the standard sera, which were found with the various methods. 
Since most sera had abnormal bilirubin concentrations, the mean 
values are also given after correction for the bilirubin inter-
ference. This correction was made using the results shown in 
figure 5, where the apparent cholesterol concentration in the 
various methods is shown in relation to the bilirubin concentra-
tion of aqueous solutions. 
Using the four methods, large variations were found in the 
mean concentrations (table 16). There was also a large variation 
in the assigned values as given by the firms who provided these 
sera. Since these values are dependent on the method used it is 
impossible to compare our results with these values. 
It can be seen, that many control sera are not suitable to 
serve as control for accuracy of the cholesterol procedures. 
Most sera have an above-normal bilirubin concentration and the 
values obtained with the chemical methods may therefore be con-
siderably higher. However, after correction for the bilirubin 
interference, the values approximate the Röschlau values. 
For Precilip, Momtrol, Autonorm 206 and 207, there is in 
general good agreement between the values (after correction for 
bilirubin) that are obtained with the three selected methods and 
the Röschlau values (table 16). The values measured with the 
three selected methods are in these sera somewhat higher, but 
they are approximately the same as the expected values, which 
are obtained by substituting the Röschlau values in the regres-
sion equations mentioned in table 7. Thus, for Precilip, Momtrol, 
Autonorm 206 and 207, the differences of the values obtained with 
the three selected methods and the Röschlau method are caused 
primarily by the bilirubin interference and secondarily by small 
methodological differences. These sera are therefore suitable to 
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serve as control for accuracy both in the chemical methods and 
in the enzymatic methods, at least if corrected for the elevated 
bilirubin concentration. 
The other sera show large differences between most values 
obtained with the three selected methods and the Röschlau method. 
These differences cannot be explained by bilirubin interference 
and they are much larger than might be expected from the regres-
sion equations. Especially for Choles-trol D there is a striking 
difference between the values obtained with the chemical methods 
on the one hand and the enzymatic methods on the other hand. For 
Ledertrol, the same conclusion can be drawn, because the Allain 
value is seemingly high, owing to the turbidity caused by the 
elevated triglyceride concentration. After correction for the 
turbidity, this value, however, is even lower than the Röschlau 
value. The Ledertrol and Choles-trol D control sera are therefore 
not suited to serve as control for accuracy both in the chemical 
methods and in the enzymatic methods*. The reason for this dis-
crepancy is not quite clear. 
From table 16 it can again be seen, that for the lipemic 
serum X, the values of the automated methods are too low and 
that the Allain values are too high, while the Allain values 
are too low again after a correction has been made for the tur-
bidity . 
DISCUSSION 
This study has revealed many advantages and defects of the 
various methods that were considered for selection. It seems that 
the enzymatic method based on the procedure of Allain is the most 
suitable method for use in the clinical chemistry laboratory. The 
test-combination provided by Nyegaard has a satisfactory accuracy 
and an excellent precision. The precision of the Allain method 
appeared to be superior to the precision of the chemical methods. 
It was even better than that of the Röschlau method. The preci-
sion of both chemical methods with regard to the analysis of sera 
At present these sera are no longer available. 
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lb Table 16 
Mean values (without correction), bilirubin-corrected mean values and expected mean values of 
the cholesterol concentrations in different sera, measured by 24 analysts using 
4 different methods. The calculation of the bilirubin-corrected values and the 
expected values is described in the text. 
PRECILIP (bil. 18 umol/l; TG 0.87 mmol/l) 
mean mean corrected mean expected 
3.69 
3.68 
3.42 
3.23 
3.50 
3.50 
3.38 
3.23 
3.50 
3.43 
3.37 
MONITROL (bil. 19 ymol/l; TG 0.80 
mmol/l) 
3.52 
3.46 
3.40 
method 
Huang 
automated 
Allain 
Röschlau 
mean 
3.78 
3.67 
3.35 
3.26 
mean corr< 
3.58 
3.49 
3.32 
3.26 
AUTONORM 206 (bil. 30 umol/l; TG 0.47 mmol/l) 
mean mean corrected mean expected method 
AUTONORM 207 (bil. 81 ymol/l; TG 0.65 
mmol/l) 
mean mean corrected mean expected 
3.89 
3.75 
3.63 
3.33 
3.53 
3.45 
3.57 
3.33 
3.60 
3.52 
3.47 
Huang 
automated 
Allain 
Röschlau 
6.43 
6.19 
5.67 
5.30 
5.43 
5.33 
5.51 
5.30 
5.61 
5.45 
5.44 
mean mean corrected mean expected method 
7.02 6.66 6.58 Huang 
6.73 6.43 6.39 automated 
6.78 6.72 6.39 Allain 
6.25 6.25 Röschlau 
CHOLES-TROL D (bil. 3 ymol/l; TG 0.67 mmol/l) 
mean mean corrected mean expected method 
10.26 10.23 9.17 Huang 
10.30 10.27 8.87 automated 
9.38 9.38 8.93 Allain* 
Allain** 
8.79 8.79 Röschlau 
7 . 7 2 
7 . 3 1 
7 . 3 5 
6 . 3 6 
7 . 6 9 
7 . 2 8 
7 . 3 5 
6 . 3 6 
mean mean corrected mean expected 
6.69 
6.49 
6.50 
SERUM X (bil. 7 ymol/l; TG 25.7 
mmol/l) 
mean mean corrected mean expected 
8.96 8.89 9.20 
6.27 6.20 8.90 
11.72 11.72 8.96 
5.82 5.82 8.96 
8.82 8.82 
with concentrations in the normal and pathological range did not 
meet the criteria of the Center for Disease Control. 
The interference in the Allain method by bilirubin is mini­
mal; whereas the chemical methods are considerably interfered. 
However, in the Allain method there was a considerable inter­
ference by triglycerides. This makes this method unsuitable for 
the analysis of sera from patients witn hypertriglyceridemia. The 
CHOD-PAP test combination of Boehnnger is superior in this re­
spect. This reagent contains a detergent which clears the sample-
reagent mixture. Using this reagent, the sample blank of lipemic 
serum after an incubation of 45 minutes at 37 С is comparable 
to that of clear serum. 
Before introducing the CHOD-PAP method as a selected method, 
a similar study for determination of the precision and accuracy 
is needed. However, as the determination of cholesterol by both 
test combinations is founded on the same principle, it may be 
expected that the CHOD-PAP test combination will show the same 
advantages as the Nyegaard test combination. 
When lipemic sera were analysed with the automated chemical 
method, too low values were found. Moreover, the concentrations 
that were found were strongly related to the extent of dilution 
of the sera. The reason for the lowering of the values in the 
automated method is not clear. This phenomenon has been studied 
earlier by Moline and Barron (40). According to these authors 
one reason for obtaining too low values in the automated method 
was the separation of a lipid layer ("creaming out") in some 
samples while they were on the turntable waiting to be aspirated. 
However, in 50% of the sera studied by these authors no separa­
tion was visible. Nevertheless far too low values were obtained. 
According to Moline and Barron, the ratio cholesterol esters to 
free cholesterol was as little responsible for the phenomenon as 
the length of the reaction time. A possible explanation was sug­
gested: in some cases the cholesterol might be more firmly bound 
to a protein fraction and might therefore not be accessible for 
reaction. This phenomenon may vary with the type of hyperlipidemia 
of the patiënt. The authors concluded, that the accuracy of the 
automated direct method in hyperlipemic serum is doubtful. 
The problem was studied by us more thoroughly. It could be 
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shown that determination of cholesterol in lipemic sera with 
enzymatic or chemical hand methods resulted in accurate values. 
Thus no "inaccessibility" could be detected when hand methods 
with strong acid- or mild enzymatic reagents were used and this 
phenomenon seems to be inherent to the automated method only. 
When in the automated method the reagent of the Huang method was 
used and vice versa, the results obtained in the automated method 
were too low for both reagents, while the results obtained in the 
hand method were accurate. Thus the use of the reagent was not 
responsible. Nor was the reaction time. Using the Huang method 
it could be shown, that the formation of the colour with both 
reagents was maximal after only 4 minutes and afterwards the 
colour remained stable for 16 minutes. The tïme of maximal colour 
formation did not differ for lipemic sera and clear sera. As the 
reaction time in the automated method is 8 minutes, the time of 
incubation cannot"be responsible for the low values found in 
lipemic sera. A possible insufficient colour formation in the 
automated method when lipemic sera are analysed could also be 
excluded since the peak plateau ratio of 5 clear sera, 5 stan-
dards, 12 lipemic sera and 5 diluted lipemic sera 1:3 were the 
same in all cases (0.70 + 0.04). Finally, it could also be ob-
served that addition of triton X to lipemic serum (final concen-
tration 10%) also did not result in higher values. Despite this 
additional information it remains obscure why too low choles-
terol values were found m lipemic sera when analysed with the 
automated chemical method. 
The accuracy of the three selected methods is dubious, be-
cause the accuracy of our "reference" method may also be ques-
tioned. However, this drawback has to be seen in the light of 
the following discussion. The Röschlau method showed good agree-
ment with the Abell-Kendall method. The calibration of the pro-
cedure was also good: standards of different origin gave exactly 
the same results. Nevertheless in the KCA control survey the 
accuracy of the Röschlau method was unsatisfactory. As compared 
to the CDC values, the values of the Röschlau method were too 
low. One reason for the discrepancy of the CDC values and our 
values may be the unsuitability of the sera A , A- and A, to 
serve as control for accuracy both in the chemical and in the 
77 
enzymatic methods. As has been stated earlier, the enzymatically 
determined values of some control sera may be considerably lower 
than the chemically determined values. This phenomenon has al-
ready been described. Possible causes for the discrepancy may be: 
partial denaturation of the reconstituted freeze dried prepara-
tions, giving rise to differences in speed of colour formation 
and fading (38). Borner and Close (30) found, that control sera 
which were turbid did indeed show an atypical colour formation 
with an enzymatic reagent, as compared to native serum. Another 
reason may be the presence of abnormal cholesterol esters (44) 
and especially of cholesterol acetate (39) which are not conver-
ted into free cholesterol by the cholesterol esterase. One of 
these reasons may be responsible for the differences in the 
values for sera A , A_ and A, found m this study between the 
Röschlau method and the automated method. The values of the 
automated method for A , A? and A, were on the average 5.3% 
higher than might be expected. These expected values were ob-
tained by substitution of the Röschlau values which were found 
for A , A and A^ in the regression equation between the auto-
mated method and the Röschlau method. 
In the comparative study of the three methods and the 
Röschlau method it could be shown, that the values obtained with 
these methods are only slightly higher than the Röschlau values. 
Therefore, it can be reasoned, that these methods are likely to 
meet the CDC criteria concerning the accuracy. For the automated 
method it could indeed be shown, that the accuracy was reason-
ble. 
Bilirubin strongly interferes in both chemical methods. 
When bilirubin concentrations are below 160 ymol/1 the inter-
ference is linear with the concentration. The extent of the 
interference is then 0.009 mmol chol/umol bilirubin. Other 
investigators found an interference of 0.005 (22), 0.006 (34) 
and 0.018 (40) mmol chol/ymol bilirubin. According to Huang (21) 
the reaction with bilirubin is linear with the concentration 
when allowed to go to completion. The reaction is also indepen-
dent of the presence of cholesterol. The final colour is far 
more stable than that for cholesterol and absorbs more strongly 
than that of cholesterol. It is clear, that our results bear out 
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some of these conclusions. 
The degree of interference is very important in studies of 
accuracy; the more so as most control sera have an elevated 
bilirubin concentration. In our opinion bilirubin-rich control 
sera are not suitable to serve as controls in the cholesterol 
determination. 
Finally, it can be stated that the CHOD-PAP method, which 
is a procedure based on the method of Allain, is likely to be 
the most suitable method for routine use on condition that the 
precision of this procedure is the same as the precision of the 
Nyegaard test combination. 
Concerning the price of chemicals the Allain-like procedures 
are more expensive than the chemical methods. However, working 
with these procedures is more agreeable. The method is simple 
and quick and the. preparation of the reagent is simple too. The 
Huang method was considered to be the less pleasant one to work 
with; the automated method was not very popular either, due to 
the regular occurrence of troubles. In our opinion the higher 
costs of the Allain-like procedures are at least partly compen-
sated by improvement of the quality of the cholesterol determi-
nation. 
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APPENDIX 
COOPERATIVE CHOLESTEROL TRIGLYCERIDE STANDARDIZATION PROGRAM 
INSTRUCTIONS FOR COMPUTATIONS - PART I* 
SeIf-Evaluation 
To allow the director of a participating laboratory to make 
a self-evaluation of results obtained m Part I, the Lipid 
Standardization Laboratory suggests that each participant per-
form certan statistical calculations (Steps 1 through 8 below). 
All results, including the statistical calculations, should be 
forwarded to the Lipid Standardization Laboratory for review. 
In addition to the instructions for calculations, criteria 
for entering Part II are given in Steps 9 and 10. A participating 
laboratory is required to meet these criteria for each of the 
three serum pools before entering Part II. For each pool, two 
"statistics" will be used to ^udge performance. These are: 
1. The mean (average) of all reported concentrations (when 
compared to the "Expected Value" and the limits given in 
Step 9 or 10 - this will provide a measure of the 
accuracy of determinations in your laboratory). 
*Circular fron the Center for Disease Control, reproduced by kind 
perirission of D. Bayse, Ph.D. Director of Clinical Chemistry 
Division, Bureau of Laboratories, Center for Disease Control, 
Atlanta, Georgia, USA. 
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2. The overall standard deviation (when compared to the 
limits given in Step 9 or 10 - this will provide a 
measure of the precision* or reproducibility of deter­
minations made in your laboratory). 
Other measures of precision, specifically a "within runs" 
and an "among runs" standard deviation, should also be computed. 
These "components" can be helpful in identifying the source of 
error m determinations. 
Rather than attempt a complete written description of the 
calculations, a set of nypotnetical data will be used to illus­
trate the necessary steps. (See table 1). Note that a separate 
set of calculations must be performed for each of the three serum 
pools for both cholesterol and triglyceride analyses. 
Calculation 
N = number of runs in which a concentration was obtained for the 
χ 
first analysis. 
N = number of runs in which a concentration was obtained for the 
Y 
second analysis. 
N = total number of differences obtained. 
2 
Step 1. Compute Variance (S ) for First Analysis. 
[Sum of Squares of χ Values - Sum of χ Values Squared Nx J S 2 
χ N - 1 
X 
= 252700 - (1588)2 
10 = 252700 - 252174.4 
9 
= 58.400 
» Actually the standard deviation is a measure of the lack of 
precision. 
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J 
4 
5 
e 
7 
8 
9 
10 
S2 Overall = 
S Overall = 
2 
S Witnin = 
S Among * 
S Among 
M Mean 
58.400+ 
2 
= K39.07! 
9
·
7 5 0
 = 39.075 
> = 6.251 mg % 
= 1/13.771 
= 39.075-
- 1/25.29 
Î = 3.712 
13.778 = 25.297 
7 = 5.030 
= 159.21 mg % 
SUM 
± J J 
160 
161 
158 
173 
142 
158 
160 
1588 
No. of χ Cone 
»ν 
252700-
= 58.400 
25600 
25921 
24964 
29929 
20164 
24964 
25600 
252700 
•
 N
,r
 1 0 
(1588)2 
10 
SUM 
No. 
s\ 
1 3 0 
161 
Missing 
156 
170 
156 
158 
156 
1437 
of y Cone. Ν 
¿Ч70Ч 
25921 
Missing 
24336 
28900 
24336 
24964 
24336 
229599 
9 
229599-(1437)2 
9 
8 
= 19.750 
j 
1 
Missing 
2 
3 
14 
0 
4 
SUM 
Э 
1 
Missing 
4 
9 
196 
0 
16 
248' 
No. of x-y(ND) 9 
2ND = 18 
= 13.778 
2 
Compute Variance (S ) for Second Analysis. 
Sum of Squares of y Values - Sum of y Values Squared 
_ L ^ J 
Υ N - 1 
= 229599 - (1437)2 = 19.750 
2 
Compute Overall Variance (S overall) and Standard 
Deviation (S overall). 
_ S 2 + S 2 58.400 + 19.750 
(1) S overall = — ^ - ^ %• = = 
= 39.075 
= / s ^ overall = /з9.075 = (2) S overall ^S K3 6.25 mg % 
2 
Compute Variance (Ξ ) for Differences. 
2 _ Sum of Differences Squared 
D = 2 N D 
m = 13.778 
i о 
Compute Within Runs Standard Deviation (S within) 
S within = /l3.778 = 3.712 mg % 
2 
Compute Among Runs Variance (S among) and Standard 
Deviation (S among). 
2 2 2 
(1) If S overall < S within, set S among = 0 
2 2 
(2) If S overall > S within, set 
S 2 among = S 2 overall - S 2 within = 39.075 - 13.778 
= 25.297 
fe (3) S among = KS among = V25.297 = 5.030 mg % 
Ste'p 7. Compute Mean (M) 
Sum of All Measurements 
M = 
Total Number of Measurements 
1588 + 1437 
19 159.21 mg % 
Step 8. Summary 
(1) S overall = 6.25 mg % 
(2) S within = 3.71 mg % 
(3) S among = 5.03 mg % 
(4) M = 159.21 mg % 
Cholesterol limits 
Step 9. Tables 2 and 3 below give the limits on overall standard 
deviation (S overall) and mean (M). Note that all limits 
depend on the expected value (EV), a concentration estab-
lished by a large number of analyses (not less than 72) 
with the Manual Abell-Kendall method. 
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Table 2 
Upper Acceptable Limit on Overall Standard Deviation 
Cholesterol concentration EV 
mg/100 ml 
100 - 199 
200 - 299 
300 - 399 
400 - 499 
mmol/1 
2.59 - 5.17 
5.18 - 7.76 
7.77 -10.35 
10.36 -12.94 
upper limit on S overall 
mg/100 ml 
7.00 
8.00 
9.00 
10.00 
mmol/1 
0.18 
0.21 
0.23 
0.26 
Table 3 
Acceptable Limits on Mean 
Cholesterol concentration EV 
mg/100 ml mmol/1 
100 - 199 
200 - 299 
300 - 399 
400 - 499 
2.59 - 5.17 
5.18 - 7.76 
7.77 -10.35 
10.36 -12.94 
Acceptable limits for part I means 
lower upper 
EV - (.05 χ EV) 
EV - (.05 χ EV) 
EV - (.05 χ EV) 
EV - (.05 χ EV) 
EV + (.05 χ EV) 
EV + (.05 χ EV) 
EV + (.05 χ EV) 
EV + (.05 χ EV) 
For the hypothetical data, the overall standard deviation 
and mean for cholesterol were, respectively, 
S overall = 6.25 mg/100 ml 
M = 159.2 mg/100 ml or 159 mg/100 ml 
Suppose the established "expected value" for this pool is 
EV = 163 mg-/100 ml. Then the limits would be as follows: 
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Upper Limit on S overall = 7.0 ir.g/100 ml 
Lower Limit on Mean = 163 - (.05) (163) = 163 - 8 = 155 mg/100 ml 
Upper Limit on Mean = 163 + (.05) (163) = 163 + 8 = 171 mg/100 ml 
Since S overall = 6.25 is less than 7.0 and M = 159.2 is between 
155 and 171, the criteria have been met for this pool. 

CHAPTER III 
AN IMPROVED SEMI-AUTOMATED METHOD FOR THE COLORIMETRIC 
DETERMINATION OF TRIGLYCERIDES IN SERUM 
P.N.M. Demacker, J.B.H.A. van Oppenraay, H. Baadenhuijsen and 
A.P. Jansen 
Clinica Chimica Acta, 64, 45-50 (1975) 
Department of Internal Medicine, Division of Clinical Chemistry, 
Sint Radboudziekenhuis, University of Nijmegen, The Netherlands 
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ABSTRACT 
A semi-automated colorimetrie determination for triglycerides 
in serum is described. The extraction is performed m sample cups 
and a part of the upper layer is sampled automatically. The use 
of modified reagents leads to greater stability and results in 
only one phase in the continuous flow system. 
The method is simple and inexpensive and therefore convenient 
for most laboratories with increasing requests for triglyceride 
determinations m serum. 
The method also shows good reproducibility and excellent cor-
relation with an enzymatic method (Eggstein, M. and Kreuz, F.H. 
(1966) Klin. Wochenschr., 267-273). 
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INTRODLCTION 
Hyperlipemia is frequently accompanied by coronary heart 
disease. It is widely accepted that combined determination of 
cholesterol and triglycerides is the most reliable way to detect 
hyperlipemia in man (1). This is reflected in an increasing num-
ber of requests for serum triglyceride determinations in clinical 
laboratories. Hence, a simple and inexpensive automated method 
for this determination would be useful. 
Many semi- and fully automated applications have been 
described (2-7). However, most chemical methods, based on con-
tinuous flow, involve instable reagents, complex flow patterns 
and phase separations, while the enzymatic methods are expensive. 
Moreover, most semi-automated methods are laborious. 
A semi-automated chemical method is described here that 
meets most of the above-mentioned objections. The extraction of 
triglycerides is performed in large glass sample cups, based on 
the procedure as described by Royer and Ko (8). The extraction 
is performed manually in the sample cups and then they are placed 
in the sampler. After separation of the two phases, an aliquot of 
the upper layer is sampled automatically and the inter-sample 
wash takes place from an external reservoir. In our system the 
extract is analysed m a similar manner to that used by Royer 
and Ko (8). The triglyceride fatty acids are transesterifled and 
the glycerol liberated is oxidized to formaldehyde, which is then 
condensed in the Hantzsch reaction with acetylacetone and ammonia 
to give a colored (and fluorescent) product, 3,5-diacetyl-l,4-
dihydrolutidine. 
The use of a different periodate and acetylacetone reagent 
(9) leads to a greater stability; also, the water content in the 
continuous-flow system is restricted, as compared to the systems 
previously described. There is only one phase in the continuous-
flow system, and a stable baseline is obtained. 
The method has good reproducibility and shows excellent 
correlation with the enzymatic method of Eggstem and Kreuz (10). 
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MATERIALS AND METHODS 
Reagents 
1. Ехггааігог solvent, ^-nonane/isopropanol (2.0 : 3.5, 
ν : v). It is possible to use the inexpensive nonane-fraction 
(Fluka A.G., 74260) and isopropanol (Baker 8119). 
2. и'^Ъ-иъе svifsric aoid, 40 mmol/1. 
3. Saponification yeagent, dissolve 3.40 g of sodium methyl-
ate (Baker 2812) in 50 ml of distilled water, dilute to 1 litre 
with isopropanol. Allow the solution to stand overnight then pour 
into a clean bottle. During the following days slight precipita­
tion occurs on the inner wall of the bottle and the solution 
becomes clear. For best results the reagent should be prepared 
fresh every week. 
4. Ferzoaate reagent, dissolve 144 g of ammonium acetate in 
about 600 ml of distilled water. Add 100 ml of glacial acetic 
acid and 3.48 g of potassium periodate, dilute to 1 litre with 
distilled water and dissolve overnight by continuous stirring. 
The reagent is stable for at least three months (9). 
5. Aaetylaoetone reagent, dilute 30 ml of acetylacetone 
(Merck 9600) to 1 litre with isopropanol. This solution remains 
stable for at least three months (9). 
6. Standard. A stock standard contains 50 mmol of triolein 
(Sigma Chemical Co.) per litre of extraction solvent. A working 
standard is prepared by dilution with extraction solvent and 
remains stable for at least three months at room temperature. 
A Cenco* sampler was modified for automatic sampling of a 
part of the upper layer. The pick-up mechanism moves in mutual 
perpendicular directions from the sample cups to an external 
reservoir with wash solution. The sampler plate is high enough 
to carry the sample cups. A Technicon sampler II may also be 
used (6, 11). As a wash solution, distilled water is used. The 
sample to wash ratio is 1 : 2; thirty samples can be analysed 
per hour. The reaction temperature is 55 C. Colorimetry is per­
formed with the flow scheme shown in fig. 1. A Cenco* pump and 
* Cenco Breda, The Netherlands 
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flow-through colorimeter (12) are used and a Vitatron recorder. 
The colorimeter is equipped with a 20-mm flowcell and a 420-r.m 
filter. Pump tubes and glass reaction coils are interconnected 
with polyethylene tubing (internal diameter 2 mrO . 
After each run the system is washed with water. The saponi-
fication-reagent pump tube and the waste pump tube are changed 
once a month; the other pump tubes are changed every four months. 
ml/min wash 
0 42" sample 
*solvaf lex 
3 0 / h 
sample-wash 
1-2 
Fig. 1. Flow diagram 
Extraction 
0.2 ml of serum is pipetted into cylindrical glass sample 
cups (40 mm χ 14 mm, capacity 4.5 ml); 2.5 ml of extraction sol­
vent and 0.5 ml of dilute sulfuric acid are added with a dispenser 
(Oxford). The cups are then closed with polyethylene caps. 
For the calibration, 0.2 ml of working standards is pipetted 
into the sample cups. The solvent is evaporated under a stream 
of air, or by standing overnight at a slightly heated place. 
Subsequently 0.2 ml of water is added to obtain similar condi­
tions for standards and serum in the extraction step. Many stan­
dards and samples can be handled simultaneously. 
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The cups are shaken manually for one minute and the phases 
are allowed to separate. The cups are then placed in the sample 
plate and the analysis of the triglycerides in the upper phase 
is performed in the continuous-flow system. 
RESULTS AND DISCUSSION 
Extraction 
Recently, fully automated applications for the colorimetrie 
determination of triglycerides have been described (3, 4). How­
ever, the modification of the sampler into an extractor-sampler 
appears complicated, while the advantages of this modification 
are minimal. It does not save time, for tjie pipetting of the 
samples, which takes most of the time cannot be automated, since 
calibration with standards is then impossible. Manual extraction 
warrants a better control of the extraction step. 
The use of the inexpensive nonane-fraction (4), instead of 
pure nonane, did not influence the specificity of the extraction. 
α-L-Lecithin, bilirubin, glucose and glycerol did not show an 
important interference (table 1). 
Experiments with triolein showed recoveries of 93-104% (n=9). 
Table 1 
Interference in the triglyceride determination 
Extraction of: Triglyceride value 
Found Expected 
0.1 ml serum + 0.1 ml distilled water 1.39 1.43 
0.1 ml serum + 0.1 ml glycerol 10 mmol/1 1.41 1.43 
0.1 ml serum + 0.1 ml glucose 12 mmol/1 1.3Θ 1.43 
0.1 ml serum + 0.1 ml bilirubin (110 ymol/l) 1.42 1.43 
m albumin solution 
0.2 ml serum + 0.2 ml a-L-lecithin 10 mmol/1 2.92 2.86 
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Reaction conditons 
With the given optimal reagent concentrations a peak-plateau 
ratio of 0.74 was obtained. The peak-plateau ratio was not in­
fluenced appreciably by variation of the sample amount between 
0.32 and 0.60 ml/min, but the peak height can so be regulated 
without the risk of disturbing the one-phase system. The peak 
height was also affected by the temperature; an elevation of the 
temperature to 60 С caused an increase of the peak height of 
20%. 
Sample-wash conditions 
The peak height was proportional to the sample time between 
20 and 45 s and the peak-plateau ratio increased from 0.27 to 
0.82. For the mter-sample wash, water appeared superior to 
heptane or isopropanol. With a sample and wash time of 40 and 
80 s, respectively, the recording continually returns to the 
baseline level, even after a sample with a very high triglyceride 
content. The carryover is negligible and the reproducibility of 
the lower concentrations is better then with a sample and wash 
time of 30 and 60 s (fig. 2). Therefore, a sample and wash time 
of 40 and 80 s is preferred, although the capacity of the system 
is lower than in most of the systems previously described. 
Waste 
The method is inexpensive, but the pollution by the organic 
solvents is high. In our opinion it is desirable to gather and 
burn the waste. 
Reproducibility and assay precision 
The within-day precision of the method for specimens with 
triglyceride values of 0.8 and 2.9 mmol/l was 1.5 and 2.3% 
respectively, (n=10) and the day-to-day precision was 4.4 and 
3.3% (n=20). 
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The sample cups on the sample plate were not covered. The 
possible error due to evaporation of the upper layer appeared to 
be negligible. The weight loss of the nonane extract due to 
evaporation during the longest time on the sample plate, amounted 
to only 1.7% at 2 5 0C. 
Qbsorbance 
Fig. 2. Recorder tracing of peak appearance of standards and 
extracts for the proposed triglyceride method. The peaks 
were recorded from right to left. 
Comparison of this method with the enzymatic method of 
Eggstein and Kreuz (10, 13) gave a regression equation Y = 1.04 
X - 0.03, the correlation coefficient was 0.999 (n=71) (fig. 3). 
In the enzymatic method the triglyceride values were corrected 
for free glycerol (0.15 mmol/1). 
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new method (mmol/l) 
x.y 
y= 104x -0 03 
r = 0999 
n: 71 
θ 10 12 14 
enzymatic method (mmol/l) 
Fig. 3. Graphic comparison of the proposed method with the 
enzymatic method. 
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ABSTRACT 
The dual-precipitation method for quantitative measurement 
of lipoproteins as described by Wilson and Spiger (J. Lab. Clin. 
Med. 82, 473 (1973)) was evaluated for normo- and hyperlipemia 
sera, by comparison with the results obtained with ultracentn-
fugation. If serum with an above-normal triglyceride concentra-
tion is analysed, the very-low-density lipoprotein cholesterol 
value obtained with the precipitation method is usually too low. 
For measurement of high-density lipoprotein cholesterol the 
ultracentnfugation and precipitation procedures give comparable 
results, but the latter method is preferred because sinking 
pre-ß-lipoproteins present in the high-density lipoprotein frac-
tion isolated by means of the ultracentrifuge may result in 
falsely high values for cholesterol in that fraction. Therefore, 
at least for the determination of very-low-density lipoprotein 
cholesterol in hyperlipemic serum, the use of an ultracentrifuge 
remains necessary. Because few laboratories have an ultra-
centrifuge at their disposal, it seemed important to look at 
the stability of sera in view of the forwarding of samples. 
Also, a way of increasing the efficiency of the ultracentrifuge 
was studied. Sera can be stored for a week at 4 С or for 54 h 
at room temperature without noticeable effect on lipoprotein 
values. Moreover, reliable values can be obtained with an ultra-
o 
centnfugation time of 8 h (0.8 χ 10 g.min). 
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INTRODUCTION 
In order to obviate the use of an ultracentrifjge, a varxety 
of methods for the quantitative measurement of the lipoproteins 
without ultracentrifugation have been described (1-8). Depending 
on the purpose of the examination, these methods are more or less 
useful. 
In many studies a reliable quantitative method must be used. 
For this reason we compared results obtained by the dual-precipi-
tation method as described by Wilson and Spiger (1, 9) with the 
results obtained after ultracentrifugation. 
The most suitable method for the combined determination of 
VLDL and HDL* was further evaluated by establishing the reprodu-
cibility. This method was also used to examine the stability of 
the serum lipoproteins during storage under different conditions. 
Finally, we investigated whether the duration of ultra-
centrif ugation could be decreased from 16 to 8 h, in order to 
double the capacity of the ultracentrifuge. 
MATERIAL AND METHODS 
Venous blood was sampled without venous congestion from 
patients or from normal subjects, who in either case had fasted 
overnight. 
UItraeentrifugation 
Solutions of a density 1.006 and 1.120 g/ml were prepared 
according to Hatch and Lees (10). The d = 1.006 density solution 
was prepared by dissolving 11.400 g of NaCl and 0.100 g of 
*Nonstandard abbreviations used: VLDL, very-low-density lipopro-
teins (d < 1.006 g/ml; S > 20); LDL, low-density lipoproteins 
(1.006 < d < 1.063 g/ml; S = 0-20); HDL, high-density lipopro-
teins (d > 1.063 g/ml); TG, triglycerides (trlacylglycerols); chol, 
cholesterol; SOS, sodium dodecyl sulfate; HDL , HDL fraction 
isolated by means of ultracentnfugation; HDL , HDL fraction 
isolated by means of precipitation of other lipoproteins; EDTA, 
ethylenediaminetetraacetate. 
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EDTA-NA9 in approximately 500 ml of aqua destillate. After 
addition of 1 ml 1 N NaOH the solution was diluted to 1000 ml 
with aqua destillate at 20 C, subsequently 3 ml additional H_0 
were added. The d = 1.120 density solution was prepared by dis­
solving 86.24 g KBr in 500 ml of the d = 1.006 density solution 
at 20 C. The density of the solutions was controlled by pycno-
metry. The isolation procedure is based on the constant serum 
background density of 1.006 g/ml (11). 
Unless otherwise stated, the serum was ultracentnfuged 
immediately. For the isolation of VLDL, 1-3 ml of serum, the 
volume depending on the turbidity, was diluted to 6 ml with the 
d = 1.006 solution. 
For the isolation of HDL, 3 ml of serum, undilutec, or 
diluted with an equal volume of the d = 1.006 solution if an 
above-normal TG concentration caused turbidity of the serum, 
was mixed with 3 ml of the d = 1.120 solution. Ultracentnfu-
gation was performed for 16 h (40,000 rpm, 14 0C) in an IEC В 60 
ultracentrifuge (Damon/IEC, Needham Heights, Mass. 02194, USA), 
using rotor 468 (168,600 χ g; capacity 20 χ 9 ml). The rotor 
was stopped without using the brake. The upper layers containing 
the VLDL or the VLDL + LDL were aspirated by means of a rubber-
bulb pipette. Volumes of isolated VLDL and HDL fractions were 
calculated by weighing, after correction for the densities. The 
cholesterol concentration of the different fractions was always 
converted to 1 litre of serum. 
For the study concerning more efficient use of the ultra-
centrifuge, ultracentnfugation time was decreased from 16 h to 
8 8 
8 h (i.e., from 1.6 χ 10 g.min to 0.8 χ 10 g.min). In the 16 
or 8 h is included one-third of the time necessary for starting 
and stopping the rotor. For the ultracentnf ugation of 8 h the 
rotor was at full speed for 7 h and 40 m m . This study was per­
formed both at the densities 1.006 and 1.063 g/ml. Here also, 
the lipoproteins were isolated by aspirating the top 3 ml. 
Precipitation of VLDL 
The VLDL concentration in the serum was expressed in terms 
of the cholesterol content of these lipoproteins, according to 
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the method of Burstem and Scholnick (6) with ultrafiltration of 
the remaining supernate as proposed by Wilson and Spiger (9). Two 
milliliters of fresh serum were mixed with 0.2 ml of 75 g/liter 
sodium dodecyl sulfate (Fluka AG) solution in 0.15 mol/liter 
saline. The samples were incubated for 2 h at 35 С and subse­
quently centnfuged at 10/000 χ g for 10 min. 
In most sera, the VLDL aggregated as a pellicle at the top 
of the tube. If this was the case, 0.5-1 ml of the subnatant 
fluid was isolated and filtered through a 0.20-,jm (average pore 
size) filter (cat. No. 11307; Sartonus, Göttingen, West Germany). 
Sometimes the aggregated VLDL appeared flaky or formed a granular 
mass at the top of the tube. In that case the VLDL were removed 
by filtration through a 0.20-pm filter. (The filter holder 
(Sartonus, Cat. No. 16517, diameter 25 mm) also contained a 
1.2-μιη filter to minimize subsequent clogging of the underlying 
0.20-ym filter.) 
After determination of the cholesterol content of the sub­
natant fluid, the (LDL + HDL)-chol value was corrected for 
dilution. The value for VLDL-chol was obtained by subtracting 
the (LDL + HDL)-chol value from that for total serum cholesterol. 
Precipitation of VLDL + LDL 
The HDL-chol concentration was determined after precipitation 
2+ 
of the VLDL + LDL with heparin/Μη according to the method of 
Burstein and Samaille (2), slightly modified. Two milliliters of 
fresh serum, or 2 ml of the d > 1.006 ultracentrifuge fraction 
containing the LDL + HDL, was mixed with 0.2 ml of equal parts 
of a 40 g/liter sodium heparmate solution (Organon, Oss; 156 
U/mg) and a 1 mol/liter MnCl_ solution. 
After centnfugation of the tubes for 10 min at 10,000 χ g, 
the supernatant fluid, containing the HDL, was removed with a 
Pasteur pipette. If the supernatant fluid was not clear, it was 
filtered through a Millipore filter (0.20 ym) . Strongly lipemic 
sera were diluted with an equal volume of 0.9% saline before the 
precipitation procedure. After determination of the cholesterol 
content, the HDL-chol values were corrected for dilution. 
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Analytical methods 
The cholesterol content in the lipoprotein fractions was 
determined with the method of Röschlau et al. (12). The analysis 
was performed with 50 ¿1 of sample, and commercially available 
reagent was used (Boehnnger Mannheirr, West-Germany) . 
The between-day precision of this method, based on the 
variation of three standard sera with concentrations of 3.2, 6.2, 
and 7.4 mmol cholesterol/liter and expressed as coefficients of 
variation, was 2.1, 1.3, and 1.7% for n=25. 
In experiments preceding this study we established that the 
HDL-chol values obtained after ultracentnfugation (HDL ) were 
always higher than the values obtained after precipitation (HDL ), 
the mean difference amounting to 0.16 mmol/liter, which was 
highly significant (p < 0.001). 
It appeared that a blank solution with the same Mn concen-
tration as the HDL fraction showed with the Röschlau reagent 
Ρ 
(without chelator) a negative cholesterol concentration of 0.17 
mmol/liter. Thus, the differences between the HDL and HDL 
Ρ 2+ u 
values are related to the blank value of the heparin/Μη solu­
tion in the cholesterol determination. The fact that the Röschlau 
method gives an apparent negative cholesterol concentration for 
2 + the Mn solution is surprising, because in the Roschlau method 
each determination is corrected for its own blank. 
After addition of the chelator to the reaction reagent 
(4 or 10 mmol/liter), the blank value diminished to -0.07 
mmol/liter. As better precision was obtained with the ethylene-
diammetetraacetate concentration of 10 mmol/liter we prefer 
this concentration above the concentration used by Steele et al. 
(13) . 
Triglycerides were determined by a semi-automated colon-
metric method (14). 
The protein content of the lipoprotein fractions was meas-
ured by the method of Lowry et al. (15), with bovine serum 
albumin as a standard. Any turbidity in the samples caused by 
a high lipid concentration was eliminated by extraction with 
diethyl ether at room temperature before measuring the absorbance. 
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Statistical methods 
The correlation between results obtained with different 
methods or under different conditions was tested with Pearson's 
correlation test. Student's t-test for paired observations was 
used to test the differences for significance. 
RESULTS 
Precipitation of VLDL 
Corparison b)tth the ubtra^entvLfngatbon methoa 
We compared the values for (LDL + HDL)-chol obtained after 
removal of the VLDL by means of ultracentrifugation or precipi-
tation (fig. 1). The mean serum TG concentration of the hyper-
triglyceridemic subjects (serum of patients with hyperlipopro-
teinemia type II B, III, IV, or V) was 5.1 + 3.5 mmol/liter 
(range, 2.0-15.1 mmol/liter). 
It is shown that the values obtained with both methods are 
in agreement if the serum TG concentration is normal. However, 
at above-normal TG concentrations the values for (LDL + HDL)-chol 
obtained after precipitation mostly were higher than the values 
obtained after ultracentrifugation. Application of the precipi-
tation procedure for the determination of (LDL + HDL)-chol in 
type III patients gave values that were much higher than the 
values obtained after ultracentrifugation (fig. 1). 
The reasons for these differences may be incomplete precipi-
tation or incomplete removal of the precipitated VLDL, as has 
been suggested earlier (6, 9). Indeed, even after repeated 
ultrafiltration through a 0.20-jm filter, the LDL + HDL fraction 
in extremely lipemic serum remained opalescent after precipita-
tion of the VLDL. 
Efforts to improve the aompleteness of the précipitation 
To obtain a complete precipitation of the VLDL in highly 
lipemic serum, Burstem and Scholnick (6) proposed to dilute 
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(LDL+HDUp mmol cho l / l 
14-
• normal serum TG 
o elevated serum TG Û Type III serum 
2 4 
- 1 
6 
(LDL· ö 10 12 14 HDL)., mmol cho l / l 
Fig. 1. Comparison of the ultracentrι fugation method with the 
precipitation method for the determination of (LDL + 
HDL)-chol, in sera from 69 patients. 
Only one sample from each patient was used. The values 
for (LDL + HDL)-chol obtained with the SDS precipitation 
method in sera with elevated TG concentrations (> 2 
mmol/liter) mostly are higher than the values obtained 
with the ultracentrifugation method. The VLDL-chol values 
are therefore lower. 
the serum two- or four-fold with clear normal serum. However, 
when we applied this procedure we obtained values for VLDL-chol 
that were not reproducible. The need to use fresh serum and the 
fact that the (LDL + HDL)-chol values of the serum used for 
dilution have to be known make this alternative method laborious 
and inaccurate. Moreover, it appeared to be difficult to choose 
which sera should be diluted. 
Lipemic sera often contain a high concentration of VLDL 
together with a diminished concentration of LDL and HDL. There-
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fore, we investigated the effect of the addition of concentrated 
lipoprotein fractions to lipemic serum, to completely precipitate 
the VLDL. Table 1 shows the results of a two- or fourfold dilu-
tion of a lipemic serum (TG and chol concentrations of 35.2 and 
11.5 mmol/liter, respectively) with concentrated solutions of 
LDL + HDL (d > 1.006), LDL (1.006 < d < 1.063), or HDL (d > 1.063) 
Table 1 
Influence of concentrated lipoprotein solutions, added to a 
lipemic serun (TG: 35.2 mmol/liter; Choi: 11.5 mmol/liter), 
on (LDL + HDL)-chol values obtained after precipitation of 
the VLDL in this serum with SDS 
Mixture Proportion (LDL + HDL)-chol 
Found Expected" 
mmol/liter 
Serum + saline 
Serum + (LDL + HDL) 
Serum + LDL 
Serum + HDL 
Serum + (LDL + HDL) 
Serum + LDL 
Serum + HDL 
1:1 
1:1 
1 :1 
1:1 
1:3 
1:3 
1:3 
3 . 7 8 
1 0 . 8 2 
8 . 4 2 
4 . 3 1 
1 2 . 4 7 
9 . 7 4 
3 . 0 0 
0 . 7 5 
7 . 7 2 
5 . 7 5 
1.99 
1 0 . 8 3 
7 . 8 9 
2 . 2 3 
Based on ultracentnfugation 
Before addition, the concentrated lipoprotein solutions were 
dialysed for 24 h to remove salts, against 40 mmol/liter tris 
(hydroxymethyl)methylamine buffer (pH = 7.4) containing 10 mg 
of chelator per liter. The LDL + HDL solution contained 13.9 
mmol of cholesterol per liter, the LDL fraction 10.0 iranol/liter, 
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and the HDL fraction 2.5 mmol/liter. This indicated that these 
solutions were concentrated two- to threefold. The fractions 
LDL + HDL and HDL also contained serum proteins. 
It appeared that even after a fourfold dilution with these 
concentrated solutions the (LDL + HDL)-chol values after preci­
pitation remained higher than after ultracentnfugation (table 1). 
As already suggested by Burstein and Scholnick (6), it may be 
possible that the VLDL with low S, value are not precipitated 
by SDS. If this is true, dilution with either clear normal serum 
or concentrated lipoprotein solutions will not always be effec­
tive . 
Precipitation of VLDL + LDL 
Influenae of VLD^ сопаепігаЬгоп 
HDL-chol was determined by means of the precipitation pro­
cedure in normolipemic or hyperlipemic serum (x) and in the 
d > 1.006 fraction of this serum obtained after ultracentnfuga-
tion (y). A good agreement was found between χ and у (у = 0.97x 
+ 0.05, r = 0.98, η = 45). No significant difference could be 
detected between the values (p > 0.5). Even for lipemic sera with 
TG concentrations above 3 mmol/liter, good results were obtained 
with both methods if the sera were diluted with an equal volume 
of saline before precipitation. Ultrafiltration always yielded 
a clear supernatant fluid if not all of the precipitate could be 
removed after centrifugation. 
From our data we conclude that if the precipitation is per­
formed in either serum or in the d > 1.006 fraction, similar 
results are to be expected. The presence of VLDL in a wide con­
centration range does not influence the precipitation of the 
remaining LDL. 
Comparison of the ргеагргіаЬгоп and ultraoentrifugation methods 
for deterrmnation of HDL-ohol 
The HDL values of 105 sera determined after precipitation 
Ρ 
of the LDL in the d > 1.006 fraction were compared with the HDL 
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values. It appeared that the HDL values are somewhat higher than 
the HDL values (table 2). The nean difference between HDL and 
Ρ u 
HDL was 0.03 mmol/liter. This small but significant difference 
(p < 0.05) was caused by analysing sinking pre-0-positive samples, 
Ігрорсо еггs 
Some sera contain a minor amount of lipoproteins in the 
density range of 1.050-1.080 with pre-ß irigration on electro-
phoresis, "sinking pre-p-lipoprotems" (16-18). The presence of 
relatively high concentrations of these lipoproteins is reflected 
as a visible lipoprotein band with pre-J migration in the d > 
1.006 fraction (16). In these cases HDL values may exceed HDL 
u ^ ρ 
values, because taese lipoproteins are partly recovered in the 
HDL fraction. Being precipitated together with the β- and pre-
ß-lipoproteins, they are not present in the HDL fraction (16). 
In the patients who had sinking pre-ß-lipoproteins in their 
serum, the HDL value was indeed higher than the HDL value 
u ^ ρ 
(figure 2). In 72 of the 105 cases, the d > 1.006 fraction was 
analysed for the presence of sinking pre-3-lipoproteins. In this 
manner, nine sinking pre-ß-positive samples could be selected. 
The HDL value of these samples was always more than 0.15 mmol/ 
liter higher than the HDL value. In the remaining 33 cases, the 
analysis was repeated if the difference between the HDL and 
HDL value exceeded 0.15 mmol/liter. Agarose gel electrophoresis 
of the d > 1.006 fraction was also done with these. In this 
manner, two sinking pre-ß-pcsitive samples could be discovered. 
The mean difference between the HDL and HDL value in these 
u ρ 
sinking pre-S-positive samples was 0.29 + 0.13 mmol/liter (range, 
0.15-0.57 mmol/liter). From these results we conclude that use 
of the ultracentrifuge procedure with sinking pre-ß-positive 
samples may result in falsely high HDL-chol values. 
Elimination of the sinking pre-ß-positive samples in the 
comparison study results in a better correlation between results 
by the two methods for determination of HDL-chol (table 2); now 
there is no significant difference between the results (p > 0.4). 
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Table 2 
Values for HDL-chol obtained by ultracentrif ligation (HDL ) and by precipitation in the 
d > 1.006 fraction of these sera (HDL ) a 
Ρ 
linear regression and concentration (HDL - HDL ) Student's 
^
3
 U £_ 
correi, coeff. mean + SD (mmol/liter) t-test 
All samples 
(n = 105) 
Sinking pre-ß-
negative samples 
(n = 94) 
HDL =0.86 HDL +0.14 
ρ U 
r = 0.90 
HDL =0.94 HDL +0.07 
Ρ u 
r = 0.94 
HDL
u 
HDL 
Ρ 
HDL
u 
HDL p 
= 
~ 
= 
= 
1.22 + 0.33 
1.18 + 0.32 
1.19 + 0.33 
1.18 + 0.33 
0.03 + 0.15 
0.004 +0.12 
ρ < 0.05 
ρ > 0.4 
aSpecial attention was paid to the presence of sinking pre-ß-lipoproteins in the serum 
OJ 
HDLp mmol choL/l 
2 4
Ί 
1.6 2.0 2 4 
HDLU mmol chol/l 
Fig. 2. Comparison of the u1tracentrifugation method with the 
precipitation method for the determination of HDL-chol 
in sera from 105 patients. 
Only one sample from each patient was used. Note the 
good agreement between methods. The HDL-chol values 
determined after ultracentrι fugation in samples con­
taining sinking pre-3-1ipoproteins are always higher 
than the HDL-chol values determined after precipitation. 
Reproducibility of the final method 
From the results mentioned we concluded that the method of 
choice for lipoprotein analysis should consist of isolation of 
the VLDL by ultracentrifugation and isolation of the HDL by 
precipitation of the other lipoproteins in serum or in the 
d > 1.006 fraction. 
In one patient, with type IV hyperlipoproteinemia, who was 
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in a steady state on metabolic-ward conditions, the lipoprotem-
cholesterol concentrations were measured daily for eight days. 
The VLDL- and IIDL-ciol concentrations were déterminée after 
isolation by means of the ultracentrifuge. The procedure was 
performed every other day, and the sera collected the day before 
were kept at 4° C. 
Although there may have been slight variations in the real 
lipoprotein concentrations, the day-to-day vanatior of the 
measured concentrations gives a good irsight into the reprodu-
cibility of the methods (table 3). 
Table 3 
Mean, SD, and. CV of serum chol, TG, and lipoprotem-chol 
concentrations, determined daily during eight days 
in serum from a type IV patient who was m a steady state 
Mean + SD Range CV, % 
mmol/liter 
Serum c h o l e s t ' 
Serum t n g l y c ' 
VLDL-chol 
HDL-chol 
L D L - c h o l a 
e r o 
e n 
1 
d e s 
6, 
3 , 
2 . 
0 , 
3 , 
. 3 0 
. 7 9 
. 2 4 
. 6 9 
. 3 6 
+ 
+ 
+ 
+ 
+ 
0 . 
0 , 
0 . 
0 . 
0 , 
. 1 8 
. 2 4 
. 2 1 
. 0 5 
. 1 4 
6 . 
3 . 
2 , 
0 . 
3 , 
. 2 1 
. 3 4 
. 1 1 
. 6 0 
. 1 1 
- 6 
- 4 
- 2, 
- 0, 
- 3 , 
. 6 1 
. 1 0 
. 7 0 
. 7 4 
. 5 2 
2 
6 , 
9 , 
7 . 
4 , 
. 9 
. 3 
. 3 
. 8 
. 1 
LDL-chol was calculated by subtracting VLDL-chol and HDL-
chol from serum cholesterol 
The reproducibility of the precipitation method for the 
determination of HDL-chol was studied in the serum of a patient 
with type II В hyperlipoproteinemia (serum chol: 8.85 mmol/liter; 
serum TG: 3.94 mmol/liter). When this serum was precipitated 
after dilution with an equal volume of saline and analysed for 
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HDL-chol 10 tines the same day, the CV was 3.4% (mean, 1.20 + 0.04 
mmol/liter). The day-to-day CV was 4.6% when this serum was ana­
lysed every other day for 12 days (i.e., η = 6). 
Stability of the serum 
With the combined ultracentrifugation/precipitation method 
we studied the stability of serum obtained from normal subjects 
and patients with different types of hyperlipoproteinemia. Table 
4 shows that the serum chol and TG concentrations of 20 sera 
during storage for one week at 4 С remained constant. The same 
held for the chol concentration of the VLDL, LDL, and HDL frac­
tions. There were no statistically significant changes. The 
influence of storage for 54 h at room temperature was also 
studied (table 4). No significant differences could be detected 
between the chol concentrations in serum or the HDL fraction. 
For serum TG, VLDL-chol, and LDL-chol there were small but sig­
nificant differences; the mean differences before and after 
storage at room temperature were +0.06, -0.10, and +0.13 mmol/ 
liter, respectively. These differences were almost the same for 
the normal subjects and for the patients with different types of 
hyperlipoproteinemia. Sera of type IV or type V patients with a 
TG concentration above 6 mmol/liter were the least stable, the 
earlier-mentioned differences being about two to three times 
greater. 
Results on shortening ultracentrifugation time 
We wondered whether the sample-processing capacity of the 
ultracentrifuge could be doubled by halving the ultracentrifu-
gation time, without altering the results of the analysis. From 
24 patients with different types of hyperlipoproteinemia the 
amounts of chol, TG, and protein in the top layers, isolated at 
densities 1.006 and 1.063 g/ml, were compared (table 5). 
At densities 1.006 and 1.063 g/ml, the clear layer at the 
middle of the centrifuge tube after centnfugation for 8 h was 
only slightly shorter than after 16 h. In all cases it was 
possible to aspirate the lipoproteins quantitatively, without 
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linear regression and concentration 
correi, coeff. 
(χ - y) 
mean + SD, mmol/liter 
Student's 
t-test 
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= 
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1.02 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
2.00 
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1.66 
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0 
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0 
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03 
02 
.05 
+ 
+ 
+ 
+ 
+ 
0 
0 
0 
0 
0 
12 
18 
10 
20 
.07 
ρ > 0.1 
0.05·^ρ<0.1 
ρ > 0.1 
ρ > 0.5 
ρ > 0. 1 
linear regression and concentration 
correi, coeff. 
(x - У) 
mean + SD, mmol/liter 
Student's 
t-test 
Serum cholesterol 
Serum triglycerides 
VLDL-chol 
LDL-chol 
HDL-chol 
y = l.Olx - 0.10 
r = 1.00 
y = 1.Olx - 0.09 
r = 1.00 
У 
r 
У 
r 
У 
r 
= 
= 
= 
= 
= 
= 
0 
0 
1 
1 
0 
0 
99x 
99 
Olx 
00 
98x 
95 
+ 
-
0 
0 
13 
18 
X 
У 
χ 
У 
χ 
У 
χ 
У 
7.88 + 2.60 
7.85 + 2.60 
3.20 + 1.80 
3.13 + 1.80 
1.72 + 1.22 
1.83 + 1.21 
5.07 + 2.60 
4.93 + 2.60 
0.02 + 0.01 ρ > 0.4 
0.06 + 0.10 ρ < 0.01 
-0.10 + 0.J 7 ρ < 0.005 
0.13 + 0.16 ρ < 0.005 
χ = 1.14 + 0.30 0.03+0.10 
y = 1.10 + 0.31 
ρ > 0.2 
Table 5 
Values for chol, TG, and protein in the top layers after ultracentrifugation for 
16 h (χ) or 8 h (y) 
linear regression and concentration 
correi, coeff. 
(χ - y) 
mean + SD, mmol/liter 
Student's 
t-test 
Cholesterol, mmol/liter 
Triglycerides, mmol/liter 
Protein, mg/liter 
У 
r 
η 
У 
г 
η 
У 
г 
η 
= 
_ 
= 
l.OOx + 
1.00 
48 
l.Olx -
1.00 
20 
І.Обх + 
1.00 
20 
0.13 
0.01 
3.40 
χ 
У 
χ 
У 
χ 
У 
= 
: 
= 
3.06 + 2.81 
3.20 + 2.82 
2.53 + 1.69 
2.54 + 1.72 
892 + 593 
975 + 613 
-0.13 
-0.02 
-79 
+ 
+ 
+ 
0.09 
0.08 
50 
Ρ 
Ρ 
Ρ 
< 0 
> 0 
< 0 
001 
1 
001 
visible aspirating some of the lipoproteins at the bottom of the 
centrifuge tube. 
The results demonstrate only small differences between the 
values for chol, TG, and protein in the top layers, whether ob-
tained after ultracentrifugation for 16 h or 8 h. These differ-
ences were similar for the top layers isolated at the densities 
1.006 and 1.063 g/ml. Therefore, the results obtained at both 
densities were analysed together. 
For TG there was no significant difference (p > 0.10), but 
the values for chol and protein obtained after ultracentrifuga-
tion for 8 h were somewhat higher than those after 16 h. For 
chol the mean difference amounted to -0.13 mmol/liter (p < 0.001). 
This difference was very constant, thus independent of the chol 
content of the top and bottom fractions and independent of the 
density at which the sample was ultracentrifuged. Compared to 
the total chol content of the top fractions, the difference is 
negligible. 
The mean difference between the protein contents of the top 
layers isolated after ultracentrifugation for 16 h or 8 h was 
-79 mg/liter (table 5). After 8 h of ultracentrifugation the 
non-VLDL proteins possibly are not sedimented completely, but 
the amount present m the top fractions is only 0.1% of the 
protein isolated in the bottom fractions. From the results we 
conclude that, for the quantitative determination of cholesterol 
in the VLDL-, (VLDL + LDL)- or HDL-fTactions, an ultracentrifu-
gation time of 8 h is sufficient. Although the top fractions 
still contain traces of serum proteins, this does not influence 
determination of the lipoproteins. A longer ultracentrifugation 
time only seems necessary if reliable information concerning the 
apoprotein composition of the lipoprotein fractions is required. 
DISCUSSION 
The dual-precipitation method as described by Wilson and 
Spiger (1, 9) for the quantitative measurement of the lipoprotein 
concentrations is not a reliable method. With the SDS precipi-
tation method too-low values for VLDL-chol are usually obtained 
with lipemic sera. Especially in the case of type III hyperlipo-
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proteinemia there is a striking difference between the values 
for VLDL-chol as obtained by the ultracentnfugation and SDS-
precipitation methods. This finding is in contrast with the 
results of Wilson and Spiger (1), who found very good agreement 
between the values obtained by the two methods. 
Ononogby and Lewis (19) determined the VLDL directly after 
centnfugation and washing of the sedimented VLDL. However, in 
our hands the VLDL mostly aggregated at the top of the tube 
after centnf ugation and in those cases a direct determination 
of the VLDL seems impossible. That Ononogby and Lewis could 
collect the VLDL at the bottom of the centrifuge tube in all 
cases is strange, because we used the same method. In the hands 
of these authors the precipitation method correlated well with 
the ultracentnfugation procedure. However, except for the cor­
relation coefficient other statistical variables were not given 
and sera with above-normal TG concentrations were not considered 
separately. 
Our data indicate that the commonly used heparin/Μη pro­
cedure gives reliable estimates of HDL-chol, in unfractionated 
serum as well as in the d > 1.006 fraction. Values obtained with 
the precipitation method are comparable with those obtained after 
ultracentnf ugation. The latter method sometimes gives falsely 
high values if serum is analysed that contains a high concentra­
tion of sinking pre-ß-lipoproteins. This finding is important in 
view of Millers' hypothesis (20) that there is a negative cor-
relation between the serum HDL concentration and atherosclerotic 
disease and the relation found by others between the presence of 
sinking pre-3-lipoproteins and atherosclerosis (21, 22). If the 
ultracentnfugation method is used to determine HDL-chol in 
sinking pre-ß-positive serum, this may lead to false conclusions 
concerning the risk for atherosclerosis. 
Presumably due to the presence of high concentrations of 
sinking pre-ß-lipoproteins in the HDL fraction, the HDL values 
were m 10% of our determinations more than 0.15 mmol of chol 
per liter higher than the HDL values. 
Ρ 
Bachonc et al. (23) found that in sinking pre-ß-negative 
samples the HDL values were 0.31 mmol/liter higher than the 
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HDL values, while these differences were 1.32 mmol/liter for 
Ρ 
the sinking pre-3-positive samples. 
It is difficult to compare our results with those of Bachonc 
et al., for several reasons. Firstly, in both investigations re­
latively snail groups of patients were studied; secondly, differ­
ent methods were used for the cholesterol determination; and 
thirdly, the sensitivity of the agarose methods for the detection 
of sinking pre-3-lipoproteins may differ. 
For the time being there is no reliable alternative to the 
ultracentnfugation procedure for the determination of VLDL-chol. 
The ultracentrifuge is not only necessary for investigations 
requiring reliable results, but it is also indispensable for the 
phenotyping of patients with inherited hyperlipoproteinemia, 
because the alternative methods are not of value in the case of 
type III hyperlipoproteinemia. Thus, the presence of type III 
has first to be excluded before one can apply these alternative 
methods. However, diagnosis of type III hyperlipoproteinemia is 
only possible by means of analysis of the VLDL fraction, isolated 
by ultracentnf ugation (24). 
A drawback of the ultracentrifuge is its cost. Our results 
demonstrate that the capacity of the ultracentrifuge can be 
doubled by halving the ultracentnf ugation time. With this 
procedural modification the ultracentrifuge can be used more 
efficently. Although the lipoprotein top fraction may then con­
tain traces of other serum proteins, this does not appreciably 
influence the measurement of the contents of chol and TG in this 
fraction. 
On storage of the serum at 4 С or at room temperature the 
lipoproteins are rather stable: values before and after storage 
for 54 h at room temperature agree well. The stability of lipo­
proteins in serum of type IV and type V patients after storage 
at room temperature is somewhat lower. However, even after 
storage for 54 h at room temperature reliable values for the 
concentrations of lipoproteins are obtained. These results 
support the guidelines for storage of sera collected for lipo­
protein analysis as given by Beaumont et al. (25). 
Consequently, those laboratories having no facilities for 
ultracentnf ugation can send their sera to a central laboratory 
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by overnight post or refrigerated. If the analysis is performed 
there within a week after blood collection and the sera remain 
ireanwhile at 4 C, results may be expected that are more reliable 
than the results obtained with the dual-precipitation method. 
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ABSTRACT 
By means of a modified agarose gel electrophoresis method a 
good and reproducible separation of human serum lipoproteins was 
obtained. Based on the amount of lipid material m the inter­
mediate β- pre ß-region after electrophoresis of serum and of the 
VLDL-fraction, 182 normo- and hyperlipemic sera of different 
subjects could be divided into 5 groups. 
The 92 sera of group 1 showed a good separation of the β 
and pre-ß band after electrophoresis, their VLDL-fraction did 
not show any trailing. The 32 and 28 sera of group 2 and 3 res-
respectively showed a trailing pre-ß band after electrophoresis 
of the VLDL-fraction. The trailing band in the VLDL-fraction of 
the sera classified in group 2 was slight and showed a gradual 
fading. The trailing of this band in the VLDL-fraction of the 
sera classified in group 3 was strong and its end was abrupt. 
The sera arranged in group 3 also showed an incomplete electro-
phoretic separation of the β and pre-ß bands. After electropho-
resis the 15 sera classified in group 4 showed an extra band 
both in serum and in the VLDL-fraction. The 15 sera of group 5 
showed a rather broad ß band after electrophoresis of serum and 
also an extra band after electrophoresis of the VLDL-fraction. 
The classification of individual serum samples in one of 
these groups was found to be highly reproducible. The same was 
found for the classification of individual subjects. 
This classification system could be used to attain a more 
precise diagnosis of type III hyperlipoproteinemia, by comparing 
the electrophoretic patterns with quantitative data concerning 
the chemical composition of the VLDL. 
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INTRODUCTION 
The laboratory diagnosis of type III hyperlipoproteinemia is 
a problem of current interest. Since 1967 demonstration of the 
presence of VLDL* with 3-mobility on paper electrophoresis has 
been considered as the diagnostic method (1). However, the detec-
tion of 3-VLDL is rather subjective and dependent on several 
variable factors, such as tne choice of the supporting medium, 
the buffer, the separation time and the freshness of the serum 
(2, 3). As yet, the lipoprotein electrophoresis on agarose, 
which is the most commonly used method, has not been standardized. 
Recently, other methods were introduced based on the deter-
mination of the chol/TG ratio of the VLDL-fraction.(4, 5). It has 
been suggested, that quantitative criteria based on the chemical 
composition of the VLDL are more specific than the qualitative 
demonstration of the presence of B-VLDL (6). However, these quan-
titative tests have not been standardized either and the defined 
limits are related to the subjective criterion of the presence 
of ß-VLDL. The lack of standardization of the electrophoretic 
method could lead to differences in the electrophoretic pattern 
of the VLDL of type III hyperlipoproteinemia and hence also to 
differently defined limits for the quantitative methods. 
In order to achieve more precision in the diagnosis of type 
III hyperlipoproteinemia it seemed necessary, as a first step, 
to study the electrophoretic behaviour of VLDL in a large number 
of normo- and hyperlipemic sera. 
The purpose of this study was to describe the different 
electrophoretic migration patterns of the lipoproteins in the 
β- pre 3-region, obtained with the application of an improved 
agarose method. From the electrophoresis of serum and the 
d < 1.006 and d > 1.006 g/ml fractions, five different patterns 
emerged, which made a division of the subjects in five groups 
*ABBREVIATIONS 
VLDL: very low density lipoproteins (d < 1.006 g/nl; S > 20) 
сnol cholesterol 
TG : triglycerides ( trlacyIglycerols) 
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possible. In order to get insight into the reliability of this 
classification, we studied the reproducibility of the method. 
MATERIALS AND METHODS 
Lipoprotein isolation 
Venous blood was sampled from the subjects without venosta-
sis after an overnight fast. 
Usually ultracentrifugation was performed immediately after 
the blood had been drawn off. Occasionally the serum was stored 
at 4 С for a maximum of 4 days. Ultracentnfugation was carried 
out as described in chapter 4. The VLDL were isolated after dilu­
tion of 1-3 ml of serum, the volume depending on the turbidity, 
to 6 ml with the d = 1.006 solution. Ultracentrifugation was 
carried out during 16 h (40,000 rev/min, 14 0C) in the IEC В 60 
ultracentrifuge (Damon/IEC, Needham Heights, Mass. 02194), using 
rotor 468 (168,000 χ g; capacity 20 χ 9 ml). After the VLDL were 
isolated by aspiration of the top 3 ml, agarose gel electrophore­
sis was done of the top and bottom fractions and of total serum. 
Agarose gel electrophoresis 
Agarose gel electrophoresis of serum and lipoprotein frac­
tions was done according to directives given by Noble (7) and 
Johansson (8). The electrophoretic separation was performed in 
the Behring electrophoresis box (Behring Hoechst A.G. Frankfurt) 
under cooling with running tap water (12 C). Spongy housekeeping 
viscose canvas of a 0.5 cm thickness (Spongo Kluten, Kongsfoss 
Fabnkker A.S. Oslo) was used as bridges between the agarose 
plate and the buffer reservoirs. 
For preparing the agarose solution, 0.63 g agarose (B.D.H. 
Chemicals no 33006) was dissolved in 50 ml of buffer by boiling 
(1.45 g veronal and 9.19 g sodium veronal per litre, pH = 8.65). 
After the agarose had been dissolved completely, 40 ml of cold 
buffer was added and the solution was allowed to cool to 55-60 C; 
then 1.0 ml 20% albumin solution (Institut Mérieux S.A. Lyon, 
France) was added. The mixture was gently spread on two glass 
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plates (200 χ 100 χ 2 mm), which were laid down horizontally and 
framed with strips greased with vaseline. Slitformmg devices 
with teetn of 10 χ 1 mm were immediately placed m the hot 
agarose. After one hour the plates were placed at 4 С in a box 
containing a humid cloth. Best separation was obtained when the 
plate was one to five days old. 
Before filling the slits, 0.1 ml of sample was mixed with 
0.1 ml 1.7% agarose solution. The slits were completely filled 
with approximately 20 ^1 of this solution by means of a Hamilton 
syringe. To one of the serum samples 25 \1 1% bromphenol blue in 
barbital buffer was added, as a marker for the albumin band. 
Serum and lipoprotein fractions were always run side by side on 
the same plate at approximately 185 V and 90 mA during 2-2^ hours. 
The electrophoresis was stopped, wnen the blje coloured albumin 
front had migrated 5^ -6 cm from the origin. Then the plate was 
immediately transferred to a 5% TCA solution for fixation, rinsed 
in water and covered with wet Whattman no 3 paper. After drying 
the plate in tne stove at 60 C, it was coloured witn Sudan Black 
(8): 0.4 g Sudan Black В was partly dissolved in 120 ml of etha­
nol and then 80 ml of a Zn-acetate solution was added. The mix­
ture was boiled, cooled to room temperature and filtered. The 
solution was stored in a brown bottle and discarded if it had 
turned black browr. The plate was stained in this solution for 
2-3 hours and afterwards rinsed several times in ethanol-water 
1:1 . 
The choice of the viscose canvas has a great influence upon 
the successful separation of the lipoproteins. With new canvas 
a good separation was obtained after approximately 5 runs. Be­
tween the runs the viscose canvas should be kept at 4 C. For a 
good separation of the lipoprotein bands, the thickness of the 
gel layer should not exceed 1.5 mm, because at a greater thick­
ness the time of separation becomes too long. This results in 
unacceptable diffusion and in insufficient cooling. The buffer 
should be changed every month or after approximately 20 runs. 
The drying of the plate can be quickened as pointed out by 
Johansson (8), but we prefer drying in the stove at 60 C. 
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Lipid analysis 
Cholesterol was determined witn tne methoa of Röschlau et 
al. (9), which bas slightly modified (cnapter 2). 
Triglycerides were determined by a semi-automated colon-
iretric irethod as described in chapter 3. 
Subject selection 
The blood samples were obtained froir 182 rorno- and hyper-
lipemic patients, who visited the outpatient clinic of our 
department. These patients were not assetibled at random. On 
purpose, all our supposed type III patients were included. 
Patients with secondary forms of hyperlipoproteinema and 
patients treated with lipid lowering drugs were excluded. Hyper-
lipoproteinemia in the presence of diabetes was not considered 
secondary for the purpose of this study. 
RESULTS 
Classification of the patients' serum based on the amount of 
lipid material in the intermediate is— pre-^ region after agarose 
electrophoresis 
In a study of the conditions resulting in an optimal sepa-
ration of lipoproteins on agarose, it was observed that tne 
lipoprotein pattern after agarose gel electrophoresis showed 
striking differences from serun to serum. When the patterns of 
total serum were compared, it appeared that the separation of 
the ύ and pre-p band was sometimes very good and sometimes in­
complete. The electrophoretic patterns of the VLDL-fraction of 
these sera also showed striding differences. The VLDL-fraction 
was visible as a homogeneous band without trailing, or with a 
slight to moderate trailing. In some cases an extra band with a 
slower migration was visible, beside the normal pre-¿ bard. 
When for serum a good separation of the β and pre--< band 
was obtained with this agarose procedure, the VLDL-fraction 
always behaved as a homogeneous band. The VLDL-fraction of a 
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serum with incomplete separation of the 3 and pre-|3 bands after 
electrophoresis, always showed a trailing pre-3 band. If an extra 
band was visible in the electrophoretic pattern of serum, the 
VLDL-fraction did often show this band. A second band in the 
VLDL-fraction was also visible if total serum produced a rather 
broad β band. 
On the basis of the amount of lipoproteins m the inter­
mediate 8— pre-3-region after electropnoresis of serum and the 
d < 1.006 and d > 1.006 g/ml fractions, the patients' sera could 
be arranged in five groups (figure 1). 
m m 
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Fig. 1. The characteristic electrophoretic pattern of serum and 
the d < 1.006 (VLDL) and d > 1.006 fractions used for 
classification of the subjects in the groups 1-5. From 
left to right in each group is shown serum, VLDL-frac-
tion (d < 1.006), d > 1.006 fraction. 
The characteristics for the different groups were: 
Group 1. Good separation between the β and pre-ß band in 
serum. 
The pre-ß band in the VLDL-fraction does not show any trail-
ing. 
Group 2. Reasonable separation between the β and pre-ß band. 
The pre-ß band in the VLDL-fraction shows some trailing, 
but there is no overlap with the lipoproteins of the d > 1.006 
fraction. Apart from this trail the pre-ß band in serum, as well 
as m the VLDL-fraction is stained homogeneously. 
Group 3. Incomplete separation between the β and pre-ß band 
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in serum. Sometimes an intermediate band seems present. 
The pre-3 band in the VLDL-fraction is rather broad. Some­
times it looks, as if the VLDL-fraction is split up in two bands 
by means of electrophoresis, but in any case the pre-p band ends 
abruptly without gradual fading. There is a slight overlap be­
tween the electrophoretic migration of the lipoproteins in the 
d > 1.006 and the d < 1.006 fractions. 
Group 4. Between the 3 and pre-3 bands an extra band with 
intermediate migration is clearly visible after electrophoresis 
of serum. 
The VLDL-fraction clearly produces two bands: one with the 
original pre-3-mobility and one with intermediate 3— pre-B-
mobility. There is a slight overlap between this intermediate 
band in the d < 1.006 fraction and the β band in the d > 1.006 
fraction. One should be careful not to confuse these intermediate 
3— pre-3_lipoproteins of rather low density with the sinking pre-
@-lipoproteins having also intermediate 3— pre-ß-mobility, but 
with a considerably higher density (10, 11). These sinking pre-
3-lipoproteins are therefore isolated in the d > 1.006 fraction. 
Group 5. Electrophoresis of serum shows a widened 3 band 
containing lipoproteins with β and intermediate ß— pre-ß-
migration. The widened S band is not stained homogeneously, but 
a division into two bands can not be detected. Fairly well 
separated from this widened S band there are also lipoproteins 
present with normal pre-ß-mobility. If the serum is several days 
old, the pre-3 and the widened β bands are not so clearly visible 
and the separation seems incomplete as compared to fresh serum. 
Furthermore the widened 3 band is then stained homogeneously. 
The VLDL-fraction produces the same pattern as the VLDL-
fraction of group 4, but the intermediate band is broader and 
the electrophoretic mobility is considerably lower. If serum is 
not fresh there is again an apparently incomplete separation 
between the pre-ß band and this intermediate band. In all cases 
there is a considerable overlap between the intermediate band in 
the VLDL-fraction and the remaining lipoproteins in the d > 1.006 
fraction. 
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Comparison with the classification of Frednckson 
The sera of 182 normo- and hyperlipemic subjects were divi-
ded into the different groups according to the criteria given 
above. In table 1 the distribution of the sera over the different 
groups is shown. Also the mean cholesterol and triglyceride con-
centration of the sera in the different groups are given. The 
sera were arranged in the different types of hyperlipoproteinemia 
according to the criteria of Frednckson et al. (12). In accor-
dance with these criteria the upper limits of the normal range 
for.VLDL-chol and LDL-chol were considered to be 1.2 and 5.44 
mmol/1. The latter limit was thought to be dependent on age, 
increasing from 4.40 mmol/1 (below 30 years of age) via 4.92 
mmol/l (between 30 and 50 years) to 5.44 mmol/l (above 50 years 
of age). The classification according to the criteria of Fre-
dnckson was only performed if the lipoprotein patterns of serum 
and of the d < 1.006 and d > 1.006 g/ml fractions were such as 
described for our groups 1 and 2. Patients with a LDL-chol con-
centration above the upper limit were classified as type II A, 
if the VLDL-chol concentration was normal. The diagnosis was 
type II B, when both LDL-chol and VLDL-chol were elevated. 
Patients were classified as type IV when the triglyceride con-
centration of serum and the VLDL-chol concentration were elevated, 
whereas LDL-chol was normal and chylomicrons were absent. The 
criteria for type V were the same as for type IV, but in this 
case also chylomicrons had to be present. The sera with the 
characteristics of our groups 3, 4 and 5 were not classified, 
in view of the presence of a considerable amount of lipid 
material in the intermediate ß— pre-ß-region after electropho-
resis of serum and the VLDL-fraction. In these cases the diagno-
sis of type III was considered (table 1). 
Reproducibility of the agarose method 
The reproducibility of the agarose method was studied by 
analysing one serum sample 15 times on the same plate (within-
assay variation). In figure 2 it can be seen, that the reprodu-
cibility of the method is good. Beside the normal β and pre-ß 
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Table 1 
Distribution of 182 subjects according to the amount of intermediate ß— pre-ß lipoproteins 
after agarose electrophoresis (groups 1 to 5) and according to the types of Frednckson 
Group 1 Group 2 Group 3 Group 4 Group 5 
number of subjects 92 32 28 15 15 
total cholesterol* 6.79 + 1.85 7.81 + 2.16 8.07 + 1.64 8.62 + 1.50 10.80 + 3.84 
total triglycerides* 3.98 + 2.99 4.97 + 4.60 4.16 + 1.57 4.83 + 2.00 5.27 + 2.69 
Classification according to Frednckson 
normal 4 3 5 
type II A 13 3 
type II В 8 10 
type IV and V 28 14 
unknown 0 0 28 15 15 
(type III possible) 
*mean + SD (mmol/1) 
l l l l l l l l l l l l l l l 
Fig. 2. Within-day-var lat ion of the agarose method. Serum of a 
patient arranged m group 4, was analysed 15-fola. The 
figure shows the reproducibility of the method. 
bands a faint extra band can clearly be observed in all cases. 
The VLDL-fraction of this serum clearly produced two bands on 
electrophoresis; therefore this serum was arranged in group 4. 
The between-day-variation was studied by analysing four 
different sera in fourfold on two different days. The results 
demonstrate again the good reproducibility of the agarose method 
(figure 3). 
Reproducibility of the classification 
Reproducibility of the assessment by the investigator 
The examination of each agarose plate was done twice, with 
an interval of one week, by one of the authors (P.D.), who was 
not aware of the names and the lipid values of the patients. In 
6% of the cases the first and second classification were not in 
agreement. Any disagreement was settled by a third observation. 
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Fig. 3. Between-day-varlation of the agarose method. Four differ­
ent sera were analysed in fourfold: in fresh condition 
(above) and after 48 hours (below). Although the serum 
is 48 hours older, the same pattern is obtained. The 
classification of the patients is: 
A 
В 
С 
D 
group 
group 
group 
group 
2 
3 
4 
1 
Reprodueibziity of the alassi fiaazion of the patzeni 
The reproducibility of the lipoprotein pattern and of the 
classification of the individual subjects was studied during 10 
months in two patients who were not treated and who were clas­
sified in group 4 and 5. During this time 10 samples of each 
patient were obtained and analysed 1 to 3 times. Totally 25 
analyses were done on each patient. Only one of the analyses of 
the patient arranged in group 4 did not meet the criteria for 
this group; this pattern showed the characteristics of group 3. 
Apart from the patient mentioned above, there were 4 other 
patients, who gave on one day a group 3 and on another day a 
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group 4 pattern. After a decision was made concerning the clas­
sification, the lipid values of the sera were compared. From 
table 2 it can be concluded, that serum cholesterol, triglyce­
rides and VLDL-cholesterol of the sera obtained from the 5 
patients arranged in either group 3 or 4 did not differ signi­
ficantly. In the frequency distribution of the different groups 
these patients are arranged both in group 3 and 4 (table 1). 
Table 2 
Comparison of the values for serum cholesterol and triglycerides 
and the VLDL-cholesterol concentration in the 5 patients, who 
were arranged in turn both m group 3 and group 4. 
Group 3 Group 4 Student's t-test 
serum cholesterol 8.5+1.4 8.6+1.1 p > 0 . 7 
serum triglycerides 5.4+2.3 4.2+1.1 p > 0 . 2 
VLDL-cholesterol 2.7+1.2 2.8+0.9 p > 0 . 8 
The effect of aging of sera 
The effect of aging of sera on the electrophoretic pattern 
was studied in 40 subjects, who were equally distributed over 
the five different groups. Serum and frequently also the 
d < 1.006 (VLDL) and the d -> 1.006 g/ml fractions were examined 
freshly and after approximately five days (mean 4.7 + 1.6 days; 
range 3-9 days). The effect of aging is shown in table 3. It can 
be seen, that in 85% of the cases the lipoprotein pattern of 
serum was unchanged; the bands might be less sharper, but the 
number of bands and the separation of the β and pre-S bands were 
the same. If after 3-9 days the sera were arranged m the dif­
ferent groups, based on the amount of intermediate lipid material 
in the 3— pre-3-region, in 39 cases (97%) the same classification 
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was obtained as compared to fresh samples. If the pattern had 
changed after storage, in most instances a faint intermediate 
band had merged into the pre-P band. In general the effect of 
aging resulted in less sharper bands and a tendency to merging 
into each other of the 6, the pre-ß and the eventually present 
intermediate bands. 
Table 3 
Effect of aging of serum upon the electrophoretic pattern and 
the classification of 40 subjects. Serum and in most cases also 
the d < 1.006 and tne d > 1.006 fractions were examined, in 
fresh condition and also after 3-9 days. 
η % 
lipoprotein pattern unchanged 34 85 
lipoprotein pattern changed, but the same 3 8 
classification 
lipoprotein pattern and classification changed, 2 5 
but the day before still unchanged 
lipoprotein pattern changed and also another 1 3 
classification 
DISCUSSION 
Reliable conclusions concerning the presence of ß-VLDL can 
only be drawn, if a reliable method for the electrophoresis of 
lipoproteins is used. The method used here, which is an improved 
version of the methods as described by Noble (7) and Johansson 
(8), has a good reproducibility and a high capacity. 
With this method the electrophoretic pattern of 182 normo-
and hyperlipemia sera was studied. Special attention was paid to 
the degree of separation between the β and pre-ß bands after 
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electrophoresis of serum, to the electrophoretic pattern of the 
VLDL-fraction and to the presence of an extra lntermedl·ate band 
after electrophoresis of serum and the VLDL-fraction. 
We have attempted at grouping these sera, based on the 
amount of lipid material in the intermediate S— pre-B-region 
after electrophoresis of serum and of the VLDL-fraction. Only 
untreated patients were studied, to prevent confusion of the 
characteristics. Furthermore, the sera were analysed within the 
time that a reliable judgement of the lipoprotein pattern was 
possible (4 days). 
Based on the amount of intermediate β— pre-b-lipoproteins 
after electrophoresis of serum and the VLDL-fraction, a division 
into 5 groups could be made. Most sera having normal serum cho­
lesterol and triglyceride values were classified in group 1 and 
the remaining in group 2. The other sera m our groups 1 and 2 
with elevated cholesterol and/or triglyceride concentrations 
could be classified according to the criteria of Frednckson as 
type II A, II B, IV and V. The sera m our group 3, 4 and 5 were 
not classified in view of the considerable amount of lipoproteins 
detectable in the intermediate ß— pre-ß-region after electropho-
resis of serum and the VLDL-fraction. 
The characteristics of the different groups were rather 
distinct. Nevertheless, the classification of the same lipopro-
tein pattern determined by the same investigator on two different 
days did not agree in 6% of the cases. In these cases the classi-
fication may be arbitrary. 
The classification of different samples from the same 
patient was the same in nearly all cases. Only 5 patients who 
were arranged in group 4 on one occasion had to be arranged in 
group 3 on another occasion. This was not caused by significant 
changes in the concentrations of serum cholesterol and trigly-
cerides or VLDL-cholesterol. 
In the literature, the presence of lipoproteins in the 
intermediate ß— pre-ß-region after electrophoresis of serum and 
the VLDL-fraction has been described several times (2, 13-17). 
If an extra band was visible in the electrophoretic pattern 
of serum, in most cases it proved to be sinking pre-ß-lipopro-
tems (10, 11, 18). In the case of an extra band being present 
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in the VLDL-fraction, a distinction was usually made between 
either a band with approximate ß-mobility (ß-VLDL) or a band 
with slow pre-ß-mobility (2, 13, 14). The first band was con-
sidered characteristic for type III hyperlipoproteinema, where-
as a slow pre-β band could be observed in serum samples from 
many normal subjects and patients having other types of hyper­
lipoproteinemia. However, as has been stated by Vessby (13), the 
choice between a slow pre-3 band and S-VLDL is sometimes arbi­
trary. We agree with this opinion. Therefore, m our classifica­
tion procedure only the amount of the intermediate lipoproteins, 
expressed in the width and intensity of the extra band, was 
considered important. Going from group 3 to group 5 the inten­
sity and width of the extra band increases. However, there is 
also a slight decrease m the mean mobility of this band. Espe­
cially the extra -bands in the VLDL-fraction of the groups 4 and 
5 show a striking difference in their mobility. 
Comparing the electrophoretic mobility of the intermediate 
lipoproteins of groups 3, 4 and 5 with the criteria given m the 
literature, it appears that the lipoproteins in the ß— pre-ß-
region of VLDL of group 3 may be called slow pre-S-lipoprotems, 
while the extra band in the VLDL of the patients of group 5 may 
be called ß-VLDL. Thus the patients in group 3 probably do not 
have type III hyperlipoproteinemia, whereas the patients in 
group 5 do have type III hyperlipoproteinemia. Without taking 
the amount of intermediate lipoproteins into account, 19 of the 
28 patients arranged in group 3 then have type IV; 8 patients 
show type II В and one shows a type II A pattern. 
The mobility of the extra band in serum and the VLDL-
fraction of the patients classified in group 4 is closer to slow 
pre-ß than to β. Based on this criterion the patients in group 4 
would not have type III hyperlipoproteinemia. Application of the 
Fredrickson criteria then reveals that 14 of the 15 patients 
arranged in group 4 would have type IV and one patient would 
have type II В hyperlipoproteinemia. However, the lipoprotein 
pattern in this group is characterized by an extra intermediate 
band of such intensity, that it often dominates the S and pre-ß 
bands. So, in the sera of this group there is a considerable 
accumulation of lipoproteins of very low density in the inter-
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mediate β— pre-ß-region. If it is accepted, that type III hyper-
lipoproteinemia is mainly characterized by an accumulation of 
intermediate lipoprotein remnants (19), we feel that most if not 
all patients of group 4 should be regarded as having Fredrick-
sons' type III hyperlipoproteinemia. 
In order to further characterize these patients it seems 
necessary to compare the electrophoretic patterns with quantita-
tive data concerning the composition of the VLDL (chapter 6). 
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ABSTRACT 
Sera of normal subjects and of patients wxth different types 
of hyperlipoproteinemia were divided into 5 groups according to 
the amount of intermediate lipoproteins in the ß— pre-ß-region 
after electrophoresis of serum and the VLDL-fraction (chapter 5). 
Subsequently, the sera of these subjects were further studied as 
to the lipid composition of their VLDL and as to the outcome of 
different diagnostic tests for type III hyperlipoproteinemia. 
Application of the diagnostic methods revealed that the 
percentage of positive findings gradually increased from group 
1 to 5. Group 5 met all the criteria and the patients in this 
group were therefore characterized as having type III hyperlipo-
proteinemia. The patients in group 4, although not meeting all 
the criteria for type III, were nevertheless considered as such, 
the electrophoretic pattern being decisive. The results suggest 
that two different forms of type III may exist. 
The results of the methods used for the diagnosis of type 
III hyperlipoproteinemia appeared to be related to the serum 
concentrations for cholesterol and triglycerides. During therapy, 
changes in the electrophoretic characteristics of serum and the 
VLDL-fraction of patients with type III hyperlipoproteinemia 
occur; the polyanion precipitation becomes less frequently posi-
tive and the ratios VLDL-chol/serum TG and VLDL-chol/VLDL-TG are 
lowered. 
The results give a better insight into the value of the dif-
ferent diagnostic criteria used for the diagnosis of type III 
hyperlipoproteinemia. 
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INTRODUCTION 
Several methods for the diagnosis of type III hyperlipopro­
teinemia have been used till now. At first, the detection of 
VLDL* with л-mobility on paper electrophoresis was considered to 
be diagnostic (1). Later, other methods were introduced based on 
the abnormal lipid composition of the VLDL, such as the deter­
mination of VLDL-chol/VLDL-TG (2) and VLDL-chol/scrum TG (3). A 
combined agarose gel electrophoresis-polyanion precipitation 
method was also considered to be diagnostic for type III hyper­
lipoproteinemia (4). 
Ir order to achieve more precision in the diagnosis of type 
III hyperlipoproteinemia, it seemed necessary to standardize the 
description of the electrophoretic patterns. With application of 
an improved agarose method, the electrophoretic behaviour of the 
VLDL-fractions from a large group of normo- and nyperlipemic 
subjects was studied (chapter 5). Based on the amount of inter­
mediate lipid material in tne ß— pre-3-region after electropho-
resis of serum and the d < 1.006 and d > 1.006 g/nl fractions, 
a division into five groups could be made. The classification of 
sera in tnese groups was found to be well reproducible. 
It was concluded that most if not all subjects of group 4 
and all subjects of group 5 could be considered as having type 
III hyperlipoproteinemia. 
In the present study, the electrophoretic behaviour of the 
serum lipoproteins of the subjects in the five groups was related 
to the chemical composition of the VLDL-fraction. In addition, 
cholesterol was determned in the lipoproteins isolated in the 
density range 1.006 - 1.019 g/ml (LDL.), because in type III 
'ABBREVIATIONS 
VLDL: very low density lipoproteins (d < 1.006 g/ml; S > 20) 
LDL : low density lipoproteins (1.006 < d < 1.063 g/ml; S = 0-20) 
LDL : intermediate density lipoproteins (1.006 < d < 1.019 g/irl; 
S = 12-20) 
Chol: cholesterol 
TG triglycerides ( trlacy lglycerois) . 
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hyperlipoproteinemia there is an accumulation of lipoproteins in 
this fraction (5, 6). Moreover, the polyanion precipitation on 
agarose was perforned on the sera of most of the subjects. 
In evaluating tne different diagnostic tests for type III 
hyperlipoproteinenia, it was also studied how the outcome was 
changed by treating the patients whose sera were arranged in 
group 4 and 5. 
MATERIALS AND METHODS 
The VLDL were isolated by ultracentnfugation as described 
in chapter 4. For the isolation of VLDL + LDL., 3 ml of serun 
was mixed witn 3 ml of a solution with a density of 1.032 g/ml. 
This density solution was prepared by dissolving 7.285 g of KBr 
in 200 ml of d = 1.006 density solution at 20 0C. After deter-
mination of cholesterol in tne top layers with the Róscnlau 
method (chapter 2), LDL -chol was calculated by subtraction of 
VLDL-chol from (VLDL + LDL )-chol. 
The methods for the determination of cholesterol and trigly-
cerides were described in the chapters 2 and 3. The precision of 
the methods is also giver, there. 
The polyanion precipitation of lipoproteins after electro-
phoresis on agarose, which is a qualitative test for the diagno-
sis of type III hyperlipoproteinemia, was performed as originally 
described by Wieland and Seidel (4). The lipoproteins were sepa-
rated using the agarose gel electrophoresis method as described 
in chapter 5. Subsequently the agarose plate was immersed for 30 
minutes in a solution containing per litre: 20.32 g MgCl_.6H_0, 
1.50 g Na-hepannate (156 U/mg, Organon-Oss, The Netherlands) and 
10 g NaCl. The precipitation bands were delineated under proper 
lighting and afterwards the normal staining procedure was carried 
out, beginning with the TCA precipitation step (chapter 5). The 
gel often let loose partly from the glass plate; therefore the 
quickened drying procedure of Johansson (7) was used. 
The correlation between different parameters was tested 
with Pearson's correlation test. Student's t-test for unpaired 
observations was used to test the differences for significance. 
Unless otherwise stated, the same sera from the same patients 
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were used as in the preceding study (chapter 5). 
RESULTS 
The clinical and biochemcal characteristics of the supjects 
arranged in the different groups 
The different groups which were formed on the basis of the 
amount of lipid material in the ß— pre-ß-region after electro-
phoresis of serum and the VLDL-fraction, were compared as to 
their clinical and biochemical characteristics (table 1). 
The subjects were also arranged in the different types of 
hyperlipoproteinemia according to the criteria of Fredrickson 
et al. (8) also given m chapter 5. In first instance the pa-
tients in our groups 3, 4 and 5 could not be classified owing to 
the considerable amount of intermediate ß— pre-3-lipoproteins. 
However with application of additional criteria discussed m 
chapter 5, the patients arranged in our groups 4 and 5 were as 
yet diagnosed as having type III hyperlipoproteinemia, whereas 
the patients in group 3 were as yet classified too, according to 
Fredrickson et al. without taking into account the amount of 
intermediate lipoproteins (table 1). 
As shown in the table, most normal subjects with normal 
lipid values are arranged in the first group. Group 1 and es-
pecially group 2 also contain many patients with types II B, IV 
and V hyperlipoproteinemia and therefore the average triglyceride 
concentration is elevated in these groups. There is an increase 
in the percentage of clinical disorders in the groups 1 to 5 
successively, but there is also an increase in the average age 
of the patients in that order. 
The most striking observation is the gradual increase in 
the serum cholesterol concentration, which is not caused by an 
elevation of LDL-chol, as could be expected if this effect was 
dependent on age. The gradual increase in serum cholesterol is 
caused by the significant increase of the VLDL-chol concentra-
tion (table 1 and figure 1). The increase of the VLDL-chol con-
centration might be caused by an increase of the total amount 
of VLDL, but this is not very likely, as the average VLDL-TG 
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GROUP 1 GROUP 2 GROUP 3 GROUP 4 GROUP 5 
number of subjects 
women (%) 
age: mean 
range 
92 
30 
42 
(13-74) 
32 
25 
46 
(27-61) 
28 
21 
50 
(31-61) 
15 
20 
54 
(22-64) 
15 
33 
59 
(43-67) 
xanthomata 
ischaemic heart disease 
peripheral-vascular disease 
5 
16 
5 
17 
7 
0 
10 
6 
0 
36 
21 
0 
53 
20 
total cholesterol (mean + SD) 
total triglyceride " 
VLDL-cholesterol 
VLDL-triglyceride 
LDL-cholesterol " 
6.79+1.85 
3.98+2.99 
1.08+1.43 
3.01+2.78 
4.46+1.69 
7.81+2.16 
4.97+4.60 
2.03+1.75 
4.38+4.51 
4.58+2.59 
8.07+1.64 
4.16+1.57 
2.05+0.77 
3.29+1.48 
4.93+1.60 
8.62+1.50 
4.83+2.00 
3.13+1.59 
3.80+2.00 
4.35+1.42 
normal 
type II A 
type II В 
43 
13 
8 
5 
3 
10 
10 
8 
7 
67 
53 
47 
10.80+3.84 
5.27+2.69 
5.96+3.11 
3.72+1.51 
3.57+1.18 
VLDL-chol 
(mmol/1 ) 
14 π ρ<0001 ρ>ΟΘ ρ<0005<0 0 0 5 
12 
10 
8 
4 -
ί 
ΙΑ 
Λ. 
group 1 
Fig. 1. Comparison of the VLDL-choles terol concentrations m 
serum of the subjects arranged in the groups 1 to 5. 
Between nearest groups tnere irostly are significant 
differences (Student's t-test). The values ir group 1 
and 2 also differed significantly when tested with the 
Wilcoxon test (p < 0.001). In the figure the mean + SD 
values are given as horizontal lines. 
concentration scarcely shows an increase in the groups 1 to 5. It 
is therefore more probable, that going from group 1 to group 5 
the composition of the VLDL changes, resulting in lipoproteins 
that are richer in cholesterol and poorer in triglycerides than 
the VLDL in group 1, as is clearly demonstrated in figure 3. 
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The VLDL-lipid c o m p o s i t i o n 
The l i p i d c o n p o s i t i o n of t h e VLDL of a l l s u b j e c t s i n t h e 
d i f f e r e n t g r o u p s , e x p r e s s e d in t h e r a t i o s VLDL-chol/serum TG ι 
and VLDL-chol/VLDL-TG (R ) i s shown, i n f i g u r e s 2 and 3. 
R VLDL- chol 1" serum TG 
p < 0 0 0 5 < 0 0 0 5 < 0 0 0 1 < 0 001 
ι 
2 0 
1 8 
1 6 -
14 
1 2 
1 0 -
0 8 
0 6 -
0 4 
0 2 
І 
* 
« 
+ 
group 1 
Fig. 2. Comparison of the ratios VLDL-chol/serum TG in the sera 
obtained from the subjects arranged in the different 
groups . 
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Fig. 3. Comparison of the ratios VLDL-chol/VLDL-TG in the sera 
obtained from the subjects arranged in the different 
groups. 
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From the figures it can be concluded that in tne same group 
a considerable variation exists in the ratios R. and R-. Never-
theless, going from group 1 to 5 the mean ratio gradually in-
creases. In all but one case the ratios of two nearest groups 
differ significantly. Group 5 may be a separate class. The mean 
R. and R9 of group 5 are considerably higher than those of the 
other groups; furthermore, there is almost no overlap with the 
other groups. 
The LDL -cholesterol concentration 
It is supposed, that in type III hyperlipoproteinemia there 
is a defect in the conversion of VLDL to LDL. Normally this con-
version goes via intermediate lipoproteins (LDL , d = 1.006-1.019 
g/ml) to LDL2 (d = 1.019-1.063 g/ml) (9). The defect in type III 
hyperlipoproteinemia results in the accumulation of these inter-
mediate lipoproteins (5, 6). In order to further characterize our 
patients, the LDL -chol concentrations in the sera of a number of 
subjects in the different groups were compared (table 2). 
Although there is a great variation in the LDL -chol values 
within the different groups, the mean LDL -chol values increase 
in the groups 1 to 5. The mean values of group 1 and 2, group 2 
and 4 and group 4 and 5 differ significantly. Especially the mean 
LDL.-chol value found in group 5 is considerably higher than that 
found in the other groups. 
Polyamon precipitation of lipoproteins on agarose 
The precipitation technique on agarose after electrophoresis 
as introduced by Wieland and Seidel (4) was applied to the sera 
of patients from the different groups. The test was considered 
to be positive, if a precipitation band was visible in the ß-
region or in the intermediate ß— pre-ß-region. The sera of six 
patients from the groups 1 and 2, with triglyceride concentra-
tions varying from 7.6-20 mmol/1, showed after testing a trail, 
beginning at the anode side of the 3 band, throughout the inter-
mediate region up to the mid-pre-3-region. These results were 
rejected. 
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Table 2 
Comparison of the cnolesterol concentrations in the LDL -
fraction (d = 1.006-1.019 g/ml) of serum obtained from 
subjects in the different groups 
LDL -cholesterol (mmol/1) Student's t-test 
group η mean + S.D. range 
1 23 0.38 + 0.22 
2 14 0.59 + 0.24 
3 12 0.74 + 0.30 
4 9 0.81 + 0.26 
5 9 1.47+0.65 
Ггот table 3 it can be concluded, tnat there is an increase 
of the relative number of positive reactions in the groups 1 to 
5. Especially in the groups 4 and 5 the results are often posi­
tive . 
Therapy induced changes in the characteristics of groups 4 and 5 
All fifteen patients of group 5 were treated for their hyper­
lipoproteinemia with a reducing diet and/or Clofibrate. The bio­
chemical characteristics used for the diagnosis of type III hyper­
lipoproteinemia in group 5 were studied before and during treat­
ment. Altogether 187 analyses were done on 15 subjects before 
and during therapy. In this way serum samples with a wide spec­
trum of lipid values could be obtained from patients who had, 
before treatment, the characteristics of group 5. 
The electrophoretic pattern of serum showed slight varia­
tions which were related to the height of the serum lipid values 
0.11 - 0.93 
0.25 - 1.07 
0.25 - 1.14 
0.39 - 1.13 
0.76 - 2.90 
ρ < 0.01 
ρ > 0.1 
ρ > 0.5 
ρ < 0.02 
Sp < 0.05 
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Table 3 
Comparison of the percentage of positive reactions with the 
polyanion precipitation on agarose in sera obtained from 
suDjects in the different groups 
group nurrber of sera tested positive % 
1 53 0 0 
2 17 1 6 
3 19 3 16 
4 13 8 62 
5 12 11 92 
(fig. 4). When serum lipid values were high, the β band was very 
broad and intensely stained, while the normal pre-ß band and the 
widened 3 band were incompletely separated. Lowering of the lipid 
values to almost normal or normal values resulted in changes in 
this pattern. The widened \i band narrowed, resulting in a more 
distinct separation between the 3 band and the pre-3 band. These 
bands were less intensely stained. In most cases the remaining 
widened 3 band was not stained homogeneously (figure 4d). Some-
times this band was split up into two bands. If the serum lipid 
values of these patients approached to normal, the widened 3 band 
could m some cases hardly be distinguished from a normal β band. 
After a successful treatment there were also changes in the 
electrophoretic behaviour of the VLDL-fraatvon. The normal pre-ß 
band and the extra band could hardly be distinguished; sometimes 
only a diffuse trail was visible, beginning at the intermediate 
3— pre-3-region with the greatest colour intensity at the anode 
side. There remained a partial overlap between lipoproteins of 
the d < 1.006 and d > 1.006 fractions. 
When the serum values for cholesterol and triglycerides 
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Ш***«1 
Fig. 4. The relation between the height of serum lipid values 
and the presence of tne extra intermediate band in the 
VLDL fraction (middle). Total serum and the d > 1.006 
g/ml fraction are shown on the left and on the right 
respectively. The samples A and D were obtained from the 
same patient before and during treatment; the samples В 
and С were obtained from two other patients, who all were 
arranged in group 5. The cholesterol and triglyceride 
concentrations were in A: 13.5 and 7.2 mmol/1, in B: 
10.θ and 5.7 mmol/1, in C: 8.7 and 3.5 mmol/1 and in D: 
6.8 and 2.2 mmol/1 respectively. 
approached to normal, the characteristics for classification in 
group 5 in most cases remained present. However, when these 
values fell within the normal limits the characteristics dis­
appeared. 
The influence of large variation in the lipid levels upon 
the ratio's Ε
η
 and /?„ was also studied. To obtain a wide spectrum 
of serum lipid values, 1 or 2 analyses before and 2 analyses 
during treatment were selected from each of the 15 patients. 
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There was a significant correlation between the ratios R and R_ 
and the serum values for cholesterol and triglycerides (table 4), 
These correlations only pertain to sera with a triglyceride con­
centration lower than 6 mmol/l. In the figures 5 and 6 the cor­
relations between 3 and the serum cholesterol and triglyceride 
concentrations are shown. It can be seen, that R is lower than 
would be expected, if the serun triglyceride concentration is 
above 6 mmol/l. In these cases chylomicrons or large-size VLDL 
may be present, containing more triglycerides in relation to 
cholesterol than the other VLDL. 
Table 4 
The relation between the values of R. (VLDL-chol/serum TG) 
and R2 (VLDL-chol/VLDL-TG) and either the cholesterol or 
the triglyceride concentrations in the sera of subjects 
classified m group 5 
serum cholesterol(x) serum triglycerides(x) 
η = 50 η = 50 
R1 (y) r = 0.92 r = 0.60 
y = 0.09x + 0.26* y = 0.16x + 0.51* 
ρ < 0.001 ρ < 0.001 
η = 50 η = 50 
R2 (y) r = 0.86 r = 0.45 
y = O . l l x + 0 . 4 6 y = 0 . 1 6 x + 0 . 9 1 
ρ < 0 . 0 0 1 ρ < 0 . 0 0 1 
Demonstrated in the figures 5 and 6 
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VLDL-chol 
1
"serum TG 
2.4 
20 
16 
12 
0 8 
0 4 
n=50 
y = 009x *0 26 
r=0 92 
• serum TG <60nnmoi / l ( n-50 ) 
o serum TG ¿.6 0 m m d / I ( n-.13 ) 
0 o 0 o 
10 12 14 16 18 20 
serum cholesterol (mmol/l ) 
Fig. 5. The relation between the ratio VLDL-chol/ser ara TG and 
the serum cholesterol concentration. The open circles 
(TG values above 6 irir.ol/l) were not used m the regres-
sion analysis. 
The OolyaKioK pre -¡¿pit? :ion also appeared to be related to 
the height of the serum lipid values. From each subject of group 
5 at most two analyses before and during treatment were used. Of 
subjects showing no lowering of their lipid values (3 patients) 
only one analysis was used. The results were divided into two 
groups: one group showing a positive precipitation and the other 
group showing no precipitation. The lipid values and other char-
acteristics of these groups were compared and brought together in 
figure 7. From this figure it can be concluded, that the poly-
anion precipitation is negative if the serum lipid values are 
low; the test is positive if these values are high. At inter-
mediate, slightly elevated values the test may be positive or 
negative. The polyanion precipitation gives doubtful results if 
the serum cholesterol, serum triglycerides, VLDL-cholesterol and 
VLDL-triglycerides are lower than: 8.0; 3.75; 3.70 and 2.40 
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mmol/1 r e s p e c t i v e l y . These v a l u e s a r e marked i n f i g u r e 7. From 
t i e f i g j r e i t can a l s o be concluded t h a t t i e r e s u l t s of t h e 
r e a c t i o n i s a lmost i n d e p e n d e n t on t h e h e i g h t of R and R . 
R _ VLDL-chol 
1
 " s e r u m - Τ G 
2 8
 "i η - 5 0 
. y - 0 1 6 x * 0 51 
г - 0 6 0 
• serum TG<6 Ommol/1С π 50) 
2 4 - o serum JG> 6 Ommol /It n. 131 
2 0 
1 6 
1 2 -
0 8 
0 4 
• I-
10 12 14 16 1Θ 
serum triglycerides (mmol/I ) 
Fig. 6. The relation between the ratio VLDL-chol/serum TG and 
the serum triglyceride concentration. The open circles 
(TG values aoove 6 irmcl/1) were rot used in the regres-
sion analysi s . 
In group 4 the effects of treatment were studied in 4 sub­
jects. Three subjects received Clofibrate and one diabetic sub­
ject showed a drastic fall of the serun lipid values as a result 
of changing oral antidiabetic treatment into insulin treatment. 
In all subjects the serum values for cholesterol and triglyce­
rides approached normal limits; the intensity of the intermediate 
band after electrophoresis of serum diminished strongly. In the 
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Fig. 7. Comparison of serum lipid- and lipoprotein values and of 
tne ratios VLDL-chol/serum TG (R ) and VLDL-chol/VLDL-TG 
(R-) in the polyamon positive and negative samples of 
sjD~ects arranged in group 5. Below the limits that are 
given as horizontal lines, the value of the test is 
doubtful. 
serum as well as in the VLDL-fraction a faint intermediate band 
remained, provided that the serum lipid values were slightly 
above normal (figure 8). Without foreknowledge of the fact that 
the patient was treated, it was sometimes difficult to decide be­
tween a group 3 or group 4 pattern. 
During treatment, the abnormal lipoproteins recorded with 
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the polyanion precipitation of Wieland and Seidel (4), had also 
diminished or were even absent. This is comprehensible consider­
ing the earlier finding, that the result of the polyanion preci­
pitation is doubtful if the serum lipid values are below certain 
limits. 
«Mi» 
I m 
A 
1 · 
В 
• Ml 
c 
! 
! 
! 
i • 
1 
1 
1 
1 
υ 1 
Fig. 8. The relation between the height of serum lipid values 
and the presence of an extra intermediate band in serum 
(left) and -n the VLDL-fraction (middle). The d > 1.006 
g/ml fraction is shown on the right. The samples were 
obtained froir the same patient before and during therapy, 
who was arranged in group 4, Tie cholesterol and trigly­
ceride concentrations were in A: 10.2 and 9.0 mmol/1, in 
B. 9.6 and 6.1 mmol/1, in C: 7.8 and 4.2 mmol/1 and in 
D: 6.1 and 2.9 mmol/l respectively. 
DISCUSSION 
The different criteria for the diagnosis of type III hyper­
lipoproteinemia were studied starting from a standardized de­
scription of the electrophoretic pattern of serum lipoproteins. 
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On the basis of the amount of lipid material in the inter­
mediate ύ— pre-¿-region, detectable after electrophoresis of 
serum and the VLDL-fraction, a division into 5 groups could be 
made. Characteristic for this classification is, that tne sera 
of the subjects in the groups 1 to 5 contain an increasing amount 
of lipid material with an intermediate f— pre-3-migration on 
agarose and with very low density. Comparison with other methods 
jsed for the diagnosis of type III hyperlipoproteinemia shows in 
tnese groups a gradual increase of the percentage of subjects 
who meet the different criteria. This holds for the ratio R. 
(VLDL-chol/serum TG) and FL· (VLDL-chol/VLDL-TG), for the choles-
terol concentrations m the LDL fraction and also for the poly-
anion precipitation after agarose electrophoresis. 
It may be assumed that group 5 is a separate group because 
the ratios R and R- and the LDL -chol concentration show little 
or no overlap with the former group. In the literature different 
limits for the ratios R and R_ have been given dependent on the 
selection of patients and on the method used for the determina-
tion of VLDL-cholesterol (10). According to sone authors (3, 10) 
the borderline for R (expressed as mmol/mmol) is 0.57, according 
to others (11) it is 0.69. Patients with lower ratios (preferably 
the mean of repeated determination) do not have type III, patients 
with higher ratios do have type III hyperlipoproteinemia. For the 
ratio R_, in a small and select group of patients a limit of 0.92 
has beer, found (2). Others found: 0.80 (3, 10) or 0.76 (12). 
Generally a value of 0.69 for R. is accepted as the limit between 
non-type III patients (< 0.69) and type III-patients (> 0.69). 
For the ratios R^ this value is 0.80 (when concentrations are 
expressed in mg/100 ml these limits for R. and R? are 0.30 and 
0.35 respectively). As can be concluded from our results, the 
patients in group 5 meet these criteria. Untreated subjects of 
group 5 had values for R. of 0.70 or higher and for R_ of 1.11 
or higher, while treated subjects had values of at least 0.68 or 
0.92 respectively. Most sera of the subjects of group 5 also 
reacted positive with the polyanion precipitation and the mean 
LDL.-chol value was considerably higher than in the former groups. 
From our results it is clear that all the patients of group 
5 have type III hyperlipoprotemema. It is more difficult to 
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characterise the subjects in group 3 and 4 who had also a con-
siderable amount of lipid material with intermediate ß— pre-ß-
migration on agarose electrophoresis, but with considerably lower 
ratios and often showing a negative reaction with the polyanion 
precipitation. 
According to Hazzard et al. (13) the presence of 3-VLDL is 
not specific for type III hyperlipoproteinemia, as 3-VLDL repre-
sent intermediate lipoproteins originating from the catabolism of 
normal VLDL. So, normal subjects and patients with type IV hyper-
lipoproteinemia do not differ qualitatively from type III patients 
with respect to the P-VLDL, but they do quantitatively. Whereas 
in normal sera the 3-VLDL can hardly be found as a result of the 
rapid breakdown, there is an accumulation of these lipoproteins 
in sera from patients with type III hyperlipoproteinemia, pos-
sibly caused by a defect in the catabolism (5, 6). It could be 
assumed that the subjects m the groups 2 to 5 have increasing 
difficulty in breaking down these VLDL-remnants. 
Defining type III hyperlipoproteinemia as an accumulation of 
VLDL-remnants, we should consider all the patients of group 4 as 
having type III hyperlipoproteinemia, because the serum of these 
subjects shows an extra intermediate β— pre-3 band often domina­
ting the normal pre-ß and 3 bands after electrophoresis. The 
density of these lipoproteins is lower than 1.006 g/ml and pro-
bably intermediate between the densities of the normal VLDL and 
the LDL. The amount of these lipoproteins, as derived from the 
intensity and width of this extra band, is strongly related to 
the height of the serum lipid values, as was clearly demonstrated 
by our observations before and during treatment. 
The patients in the groups 4 and 5 partly have the same and 
partly have different characteristics. In both groups the serum 
contains a considerable amount of lipoproteins with intermediate 
ß— pre-ß-migration and with very low density. In most cases there 
was a positive polyanion precipitation. Beside these similarities 
there are also differences. The serum lipoprotein pattern on 
agarose of the subjects in group 4 and 5 is different; serum of 
group 4 shows an extra band intermediate between the 3 and pre-3 
band, while serum of group 5 shows a broad β band. The amount of 
lipoproteins with intermediate ß— pre-ß-migration and isolated 
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in the VLDL-fraction is larger in group 5 and the mobility is 
also slower as compared to those in the VLDL of group 4. Moreover, 
these groups differ considerably as to the chol/TG ratio of tne 
VLDL-fraction and as to the occurence of xantnomata. 
In the literature the presence of an extra band in the VLDL-
fraction with intermediate h- pre-"-migration has been described 
several times earlier (10, 12, 14, 15). Most of the sera from 
which these VLDL were isolated reacted positively with all type 
III tests and thus it concerns sera having the characteristics 
as described for group 5, obtained fron patients who have a 
clear type III hyperlipoproteinemia. 
Sometimes such an extra band in the VLDL was also detectable 
in sera which reacted negatively m most diagnostic tests for 
type III. Most authors considered this forn of hyperlipoprotein­
emia as type IV having an increased accumulation of intermediary 
particles (12). Because the different types of hyperlipoprotein­
emia have been introduced to describe lipoprotein patterns and 
not diseases, this characterisation may be correct. Our patients 
arranged in group 4 could then be considered in this manner. Of 
course, this does not exclude the possibility, that the patients 
arranged in the groups 4 and 5 have the same underlying metabolic 
cause for their hyperlipoproteinemia. So long as it is not pos­
sible to demonstrate this metabolic cause, we prefer to consider 
these group 4 patients as having type III hyperlipoproteinemia. 
Dependent on unknown factors, one common cause may ultimately 
result m the two variants for type III hyperlipoproteinemia. 
In this study it has been shown that most of the criteria 
used for the diagnosis of type III hyperlipoproteinemia are re­
lated to the height of the serum lipid values. There is a good 
correlation between either the serum cholesterol or triglyceride 
concentration and the ratios R or R?, unless the serum trigly­
ceride concentration is above б mmol/1. The polyamon precipita­
tion is apparently not sensitive being often negative when the 
serum lipid values are normal or slightly above normal. It could 
also be shown, that in some patients with type III hyperlipopro­
teinemia, values for serum lipids became normal when they were 
treated. However, most characteristics for the presence of type 
III hyperlipoproteinemia did not disappear. 
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Tnese results give nore insight into the value of tie dif­
ferent criteria used for the diagnosis of type III hyperlipopro-' 
tememia. Fredrickson et al. suggested (11) that the quantitative 
criteria based on the VLDL-lipid composition are more specific 
than tne qualitative criteria. By means of a qualitative test 
agarose gel electrophoresis - we could distinguish two 
variants in type III hyperlipoproteinena. Application of the 
quantitative criteria η patients having the characteristics of 
group 5 is of decisive diagnostic importance. For tracing this 
group the ratio R^  seems to be more specific than the ratio R.. . 
So, in fact, the determination of the ratio R- in this group 
would be sufficient. 
When only quantitative tests are used, the patients with the 
characteristics of group 4 cannot be selected from the whole 
population of patients having hyperlipoproteinemia. In addition 
to the quantitative determination of the VLDL-compositior., it is 
therefore also necessary to determine the amount and the mobility 
of the intermediate r— pre- ·> lipoproteins. 
Unfortunately, this need of a combined analysis does not 
facilitate diagnosing type III hyperlipoproteinemia in the rou­
tine laboratory. However, such an analysis is a prerequisite for 
those centers searching for tne primary defect of type III hyper­
lipoproteinemia. These studies may result in a simple diagnostic 
test. Recent findings of abnormalities in the arginine-rich 
apoproteins in type III hyperlipoproteinemia (15, 16) may change 
the diagnostic criteria in the near future. 
ACKNOWLEDGEMENTS 
This investigation was financially supported oy the Nether­
lands Heart Foundation. 
169 
REFERENCES 
1. Fredrickson, D.S., Levy, R.I., Lees, R.S.: Fat transport in 
lipoproteins - an integrated approach to mechanism and dis­
orders. New Engl. J. Med. 276, 273 (1967) 
2. Hazzard, W.R., Porte, D. jr., Bierman, E.L.: Abnormal lipid 
composition of very low density lipoproteins in diagnosis of 
broad-beta disease (type III hyperlipoproteinemia). Metabo­
lism 21, 1009 (1972) 
3. Mishkel, M.A., Nazir, D.J., Crowther, S.: A longitunidal 
assessment of lipid ratios in the diagnosis of type III 
hyperlipoproteinemia. Clin. Chim. Acta 58, 121 (1975) 
4. Wieland, H., Seidel, D.: Improved techniques for assessment 
of serum lipoprotein pattern II. Rapid method for diagnosis 
of type III hyperlipoproteinemia without ultracentnfugation. 
Clin. Chem. 19, 1139 (1973) 
5. Bilheimer, D., Eisenberg, S., Levy, R.I.: Abnormal metabolism 
of very low density lipoproteins (VLDL) m type III hyper­
lipoproteinemia (Abstract). Circulation, 44, 11-56 (1971) 
6. Havel, R.J.: Hyperlipoproteinemia: problems in diagnosis and 
challenges posed by the "type III" disorder. Ann. Intern. 
Med. 82, 273 (1975) 
7. Johansson, B.C.: Agarose gel electrophoresis. Scand. J. Clin. 
Lab. Invest. 29, suppl. 124, 8 (1972) 
8. Fredrickson, D.S., Lees, S.: Familial hyperlipoproteinemia. 
In: Stanbury, Wijngaarden, Fredrickson, eds., The metabolic 
basis of inherited disease. New York: McGraw-Hill, pg 545 
(1970) 
9. Bilheimer, D.W., Eisenberg, S., Levy, R.I.: The metabolism 
of very low density lipoproteins. I. Preliminary in vitro and 
in vivo observations. Biochem. Biophys. Acta 260, 212 (1972) 
10. Albers, J.J., Warnick, G.R., Hazzard, W.R.: Type III hyper­
lipoproteinemia: A comparative study of current diagnostic 
techniques. Clin. Chim. Acta 75, 193 (1977) 
11. Fredrickson, D.S., Morganroth, J., Levy, R.I.: Type III hyper­
lipoproteinemia: An analysis of two contemporary definitions. 
Ann. Intern. Med. 82, 150 (1975) 
12. Vessby, В., Hedstrand, H., Zundin, L.G., Olsson, U.: Inhen-
170 
tance of type III hyperlipoproteinema-a. Lipoprotein patterns 
in first-degree relatives. Metabolism 26, 225 (1977) 
13. Hazzard, W.R., Bierman, E.L.: The spectrun of electrophoretic 
mobility of very low density lipoproteins: role of slower 
migrating species in endogenous hypertriglyceridemia (type 
IV hyperlipoproteinemia) and broad .-> disease (type III). J. 
Lab. Clin. Med. 86, 239 (1975) 
14. Carlson, K., Carlson, L.A.: Comparison of the behaviour of 
very low density lipoproteins of type III hyperlipoprotein-
emia on electrophoresis on paper and on agarose gel with a 
note on a late (slow) pre ß-VLDL-lipoprotein. Scand. J. Clin. 
Lab. Invest. 35, 655 (1975) 
15. Pagman, Α., Havel, R.J., Kane, J.P., Kotite, L.: Characteri­
sation of human very low density lipoproteins containing two 
electrophoretic populations: double pre-beta lipoprotememia 
and primary dysbeta lipoprotememia. J. Lipid Res. 18, 613 
(1977) 
16. Utermann, G., Jaeschke, M., Menzel, J.: Familial hyperlipo­
proteinemia type III: deficiency of a specific apolipoprotem 
(Apo E-III) in the very low density lipoproteins. FEBS lett. 
56, 352 (1975) 

SAMENVATTING 
Een verhoogd vetgehalte m het bloed (nyperlipemie), met 
name een verhoogd gehalte aan cholesterol en tnglyceriden is 
een belangrijke risicofactor voor het ontstaan van hart- en 
vaatziekten. 
Cholesterol en tnglyceriden circuleren in het bloed in de 
vorm van vet-eiwit complexen, de zg. lipoproteïnen. De in het 
menselijke bloed voorkomende lipoproteïnen verschillen in grootte, 
dichtheid, electroforetisch gedrag en chemische samenstelling. 
Op basis van deze verschillen m fysische en chemische eigen-
schappen kunnen, met behulp van diverse technieken zoals ultra-
centrifugatie en electroforese, 4 verschillende groepen worden 
onderscheiden. 
In 1967 introduceerden Frednckson en medewerkers een clas-
sificeringssysteem voor patiënten met een verhoogd vetgehalte in 
het bloed. De basis van deze indeling was, dat werd nagegaan welk 
lipoprotéine verantwoordelijk was voor deze verhoging. De hyper-
lipemie moest dus worden gezien als een hyperlipoproteïnemie. De 
patiënten met een verhoogd vetgehalte werden door Frednckson 
e.a. in 5, later in 6 groepen onderverdeeld, de zg. types I, II A, 
II B, III, IV en V. Momenteel wordt het indelingssysteem van 
Frednckson algemeen gebruikt. De verdienste van dit systeem is 
de standaardisering van de beschrijving van de diverse vormen van 
hyperlipemia. Het systeem gaat uit van een zeer eenvoudige nomen-
clatuur. 
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In dit proefschrift worden een aantal onderzoekingen be-
schreven, verricht ter verbetering van laboratoriummethoder. 
Verbetering van deze methodes was nodig, enerzijds om bi] patiën-
ten het type hyperlipoproteïnemie exact te kunnen diagnostiseren 
en anderzijds om op betrouwbare wijze lipoproteïnen te kunnen 
isoleren ten behoeve van research. 
In hoofdstuk 1 wordt de noodzakelijk basiskennis verschaft. 
Besproken worden o.a. de verschillende chemische en fysische 
eigenschappen van de lipoproteïnen en hun apoproteïnensamen-
stelling. Ook wordt een kort overzicht gegeven van het metabo-
lisme van de lipoproteïnen. Aan de hand van de recente literatuur 
worden processen besproken die mogelijk ten grondslag liggen aan 
de verschillende vormen van hyperlipoproteïnemie. Het mdelmgs-
systeem van Frednckson wordt behandeld. Tenslotte wordt de 
werkwijze beschreven, die in ons laboratorium wordt gevolgd bij 
de diagnostiek van de hyperlipoproteïnemieën. 
In hoofdstuk 2 zijn de resultaten weergegeven van een onder-
zoek naar de betrouwbaarheid van cholesterolbepalmgen. Vier 
verschillende methodes werden onderzocht: 2 chemische methodes 
(de methode van Huang en een geautomatiseerde versie van deze 
methode) en 2 enzymatische methodes (de Röschlau-methode en de 
methode volgens Allain). Deze methodes werden onderzocht op 
nauwkeurigheid (juistheid en precisie), het effect van storende 
stoffen, hanteerbaarheid en kosten. Alle methodes bleken op een 
of meer punten niet aan de verwachtingen te voldoen. De Röschlau-
methode werd het meest geschikt bevonden voor de bepaling van 
cholesterol voor research-doeleinden, terwijl de methode van 
Allam het meest geschikt geacht werd voor gebruik op het routine 
laboratorium. 
In hoofdstuk 3 is een methode beschreven die het mogelijk 
maakt de triglycendenconcentratie m serum nauwkeurig en goed-
koop te bepalen. Het betreft een semi-automatische methode vol-
gens het continue stromingsprincipe (continuous-flow) . De t n -
glycenden worden uit het serum door extraktie overgebracht in 
een organische fase, die voornamelijk uit nonaan bestaat (methode 
van Royer en Ko). De organische fase (bovenlaag), die de trigly-
cenden bevat, splitst zich door ontmenging van de waterfase af. 
Een gedeelte van de bovenlaag wordt automatisch afgezogen en 
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geanalyseerd. Het continue stromingssysteen is eenvoudig, omdat 
slechts één fase door het systeen stroomt. Het nonaan-extract 
wordt door menging met de reagentia, die een voldoende Hoeveel-
heid isopropanol en zo weinig mogelijk water bevatten, in oplos-
sing gehouden. Hierdoor wordt ontmenging m 2 fasen voorkomen. 
Door middel van de extraktie worden stoffen geëlimineerd die de 
chemische reaktie - gebaseerd op verzeping van de triglycenden 
en bepaling van het vri]<omerde glycerol - storen. De resulta-
ten verkregen met deze methode stemmen goed overeen met de door 
Eggstein en Kreuz beschreven methode. 
Met behulp van de bepaling van cholesterol en triglycenden 
en een eenvoudige electroforese van lipoproteïnen is het mogelijk 
een groot aantal patiënten met hyperlipemieën in te delen m een 
van de types van Frednckson. Het betreft die patiënten, bij wie 
slechts het cholesterolgehalte of het triglycendengehalte van 
het serum verhoogd is. De patiënten met een verhoogde serumcon-
centratie van zowel cholesterol als triglycenden kunnen op deze 
manier echter niet worden ingedeeld en in deze gevallen is aan-
vullende informatie vereist: de lipoproteïnenconcentraties moeten 
kwantitatief worden bepaald. Voorts is het voor de diagnose van 
type III noodzakelijk de hoeveelheid intermediaire lipoproteïnen 
te bepalen. 
In hoofdstuk 4 zijn enkele methodes voor de kwantitatieve 
bepaling van de verschillende lipoproteïnen geëvalueerd. Precipi-
tatiemethodes voor de bepaling van VLDL-cholesterol en HDL-
cholesterol werden vergeleken met de referentiemethode gebaseerd 
op ultracentnfugatie. 
Uit dit onderzoek bleek, dat voor de kwantitatieve bepaling 
van lipoproteïnen een ultracentrifuge nog steeds onmisbaar is. 
Een gecombineerde ultracentnfugatie-precipitatiemethode werd het 
meest gescnikt bevonden. De VLDL worden hierbij geïsoleerd met 
behulp van ultracentnfugatie; omdat de precipitatie van de VLDL 
niet volledig blijkt te zijn bij lipemische sera. De HDL worden 
geïsoleerd door precipitatie van de LDL in de (LDL+HDL)-fractie. 
Voor de isolering van HDL waren de ultracentnfugatie- en 
precipitatiemethodes gelijkwaardig. De laatste methode kreeg de 
voorkeur, omdat bij de ultracentnfugatie eventuele "sinking 
pre-3 lipoproteïnen" in de HDL-fraktie terechtkomen. De verschil-
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lende frakties worden kwantitatief bepaald op basis van hun 
cholesterolgehalte. Daar de LDL niet worden geïsoleerd, wordt 
LDL-cholesterol berekend als het verschil van totaal serum cho-
lesterol en het cholesterolgehalte m de VLDL-fraktie en de HDL-
fraktie. 
Uit onderzoek bleek, dat de stabiliteit van de serum lipo-
proteïnen dusdanig is, dat verzending van sera naar laboratoria 
die over een ultracentrifuge beschikken, mogelijk is. Ook kan de 
capaciteit van een ultracentrifuge worden verdubbeld door halve-
ring van de gebruikelijke centrifugatietijd. 
In de hoofdstukken 5 en б zijn methodes besproken, die wor­
den gebruikt voor de diagnostiek van type III hyperlipoproteïne-
mie. De aanwezigheid van ß-VLDL is volgens de literatuur van 
doorslaggevende betekenis voor de diagnose van type III hyper-
lipoproteïnemie. Deze kwalitatieve test, die berust op papier-
electroforese, wordt echter beïnvloed door vele factoren. De 
agarose methode heeft momenteel de electroforese op papier 
grotendeels vervangen. Uitgaande van een agarose-electroforese-
methode met een groot scheidend vermogen en een goede reproduceer-
baarheid werd getracht het begrip ß-VLDL te standaardiseren. 182 
Normo- en hyperlipemische sera, afkomstig van patiënten met ver-
schillende types hyperlipoproteïnemie, konden in 5 groepen worden 
ingedeeld op grond van de hoeveelheid lipoproteïnen met inter-
mediaire β tot pre-ß mobiliteit. Deze methode van indeling bleek 
goed reproduceerbaar te zijn. Door vergelijking met literatuur-
gegevens kon worden geconcludeerd dat alle patiënten van groep 5 
en veel, zo niet alle, patiënten van groep 4, type III hyper-
lipoproteïnemie hadden. 
In hoofdstuk 6 is de toepassing beschreven van een aantal 
andere methodes die worden gebruikt voor de diagnose van type III 
hyperlipoproteïnemie. Het betreft hier recent geïntroduceerde 
kwantitatieve methodes die gebaseerd zijn op de lipidensamen-
stelling van de VLDL, zoals de ratios VLDL-chol/serum-TG en VLDL-
chol/VLDL-TG. Verder is de polyanion-precipitatiemethode van 
Wieland en Seidel toegepast en is de concentratie in het serum 
bepaald van de intermediaire lipoproteïnen met behulp van de 
ultracentrifugetechniek (LDL-cholesterol concentratie). De sera 
die op grond van de criteria, zoals vermeld m hoofdstuk 5, m 5 
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groepen konden worden ingedeeld, werden eveneens getest met elk 
van de bovengenoemde methodes. Het aantal positieve reakties voor 
elk van deze methodes nam toe, gaande van groep 1 naar groep 5. 
De patiënten ingedeeld in groep 5 voldeden aan alle criteria en 
werden daarom beschouwd als patiënten met type III. De patiënten 
in groep 4 voldeden niet aan alle criteria maar werden, gezien 
de aanwezigheid van een extra intermediaire band, wel als zo-
danig beschouwd. 
De betrouwbaarheid van de kwalitatieve zowel als kwantita-
tieve methodes, die worden gebruikt voor de diagnostiek van type 
III, bleek sterk afhankelijk te zijn van de hoogte van de serum 
cholesterol- en de tnglyceridenconcentratie van het serum. Door 
toepassing van deze methodes in een groot aantal sera afkomstig 
van type III patiënten, voor en tijdens therapie, kon een goed 
inzicht verkregen worden in deze afhankelijkheid. 
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STELLINGEN 
1 
De meeste test-sera die in gebruik zi^n voor de contrôle van de 
juistheid van de cholesterol- en triglyceridenbepalingen zijn 
daarvoor niet geschikt. 
Dit proefschrift en andere eigen 
waarnemingen 
2 
De enzymatische methodes voor de bepaling van cholesterol zullen 
in de nabije toekomst algemeen worden gebruikt. 
Gabi, F., Keller, H., Rick, W.: Med. 
Labor. 30, 250 (1977) 
Dit proefschrift 
3 
Voor de bepaling van HDL-cholesterol verdient isolatie van de 
HDL door precipitatie van de andere lipoproteïnen de voorkeur 
boven isolatie van de HDL op basis van hun dichtheid met de 
ultracentrifuge. 
Dit proefschrift 
4 
Het idee, dat het mogelijk zou zijn in de klinische chemie 
"definitieve methodes" te ontwikkelen, zoals gedefinieerd door 
de "International Federation of Clinical Chemistry (IFCC)", is 
een illusie. 
Büttner, J., Borth, R., Boutwell, J.H., 
Broughton, P.: Clin. Chim. Acta 63, 
F25-F38 (1975) 
5 
Reeds bij het ontwikkelen en evalueren van nieuwe bepalings-
methodes in het klinisch-chemisch laboratorium moet rekening 
gehouden worden met de aard en de hoeveelheid van het chemische 
afval en met de mate van milieubelasting. 
6 
Dieetmaatregelen die het cholesterolgehalte van het serum doen 
dalen, zoals o.a. geadviseerd door de Voedingsraad*, mogen pas 
als heilzaam beschouwd worden, wanneer is aangetoond dat deze 
daling niet een gevolg is van een afname van de concentratie van 
high-density-lipoproteïnen. 
*Verslag no. 25 van het Ministerie van 
Volksgezondheid en Milieuhygiëne (1973) 
7 
Wanneer bij een intraveneuze pyelografie een nier te klem lijkt, 
dient, behalve aan een hypoplasie of een atrofie, ook gedacht te 
worden aan een abnormale ligging van deze nier. 
8 
Hetzelfde reaktiemechanisme dat door Bodanzky et al. ten grond-
slag wordt gelegd aan de nevenreaktie die optreedt bij de akti-
vatie van tertiaire butyloxycarbonylaminozuren, zou ook het 
ontstaan van optisch zuivere n-carboxy-anhydrides uit n-alkoxy-
carbonylaminozuren kunnen verklaren. 
Bodanzky, M., Klausner, Y.S., Bodanzky, 
Α.: J. Org. Chem. 40, 1507 (1975) 
9 
De aanwezigheid van insulmebindende antilichamen heeft geen in­
vloed op de concentratie van vrij insuline in het plasma tijdens 
de behandeling van de diabetische keto-acidose; hun aanwezigheid 
is dus geen argument voor het kiezen van hoge doses insuline. 
10 
Niettegenstaande het feit, dat een enkele meters brede en dicht­
begroeide vegetatiestrook langs verkeersintensieve wegen slechts 
leidt tot een geringe demping van geluid, zal het aantal klachten 
over geluidhinder door de aanwezigheid van een dergelijke strook 
sterk verminderen. 
Martens, M.J.M.: Gemeentewerken 6, 58 
(1977) 
11 
De "oorhanger" of het "achter-het-oor-toestel" dat door vele 
slechthorenden wordt gebruikt heeft de neiging om snel te gene­
reren, hetgeen als een hinderlijke fluittoon wordt gehoord. Het 
ρ 
periodiek omwikkelen van het oorstukje met een laagje Parafilm 
kan deze problemen grotendeels opheffen. 
12 
De liefde van de man dient in deze tijd van overconsumptie niet 
door de maag, maar door het hart en de bloedvaten te gaan; een 
liefhebbende echtgenote zou hiermee uit eigenbelang meer rekening 
moeten houden. 
P.N.M. Demacker, 
Nijmegen, 19 mei 1978 



